<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000343.pub3" GROUP_ID="NEONATAL" ID="872499091620095074" MERGED_FROM="" MODIFIED="2016-05-03 18:41:33 +0100" MODIFIED_BY="Colleen Ovelman" REVIEW_NO="" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2016-04-24 12:31:59 +0100" MODIFIED_BY="William McGuire">
<TITLE MODIFIED="2016-04-04 01:41:38 +0100" MODIFIED_BY="[Empty name]">Multi-nutrient fortification of human milk for preterm infants</TITLE>
<CONTACT>
<PERSON ID="11151" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>William</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>McGuire</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Child Health</POSITION>
<EMAIL_1>William.McGuire@hyms.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Hull York Medical School &amp; Centre for Reviews and Dissemination, University of York</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>York</CITY>
<ZIP/>
<REGION>Y010 5DD</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>44 01904 321695</PHONE_1>
<PHONE_2/>
<FAX_1>44 01904 321696</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2016-04-24 12:31:59 +0100" MODIFIED_BY="William McGuire">
<PERSON ID="00537277744985685311111102161515" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Jennifer</FIRST_NAME>
<MIDDLE_INITIALS>VE</MIDDLE_INITIALS>
<LAST_NAME>Brown</LAST_NAME>
<SUFFIX/>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>jennifer.brown@york.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Centre for Reviews and Dissemination</DEPARTMENT>
<ORGANISATION>University of York</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>York</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z1506091030548413077285440334581" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Nicholas</FIRST_NAME>
<MIDDLE_INITIALS>D</MIDDLE_INITIALS>
<LAST_NAME>Embleton</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant Neonatal Paediatrician</POSITION>
<EMAIL_1>nicholas.embleton@ncl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Newcastle Neonatal Service</DEPARTMENT>
<ORGANISATION>Newcastle Hospitals NHS Foundation Trust and University of Newcastle</ORGANISATION>
<ADDRESS_1>Richardson Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Newcastle upon Tyne</CITY>
<ZIP>NE1 4LP</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>0044 191 282 5156</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="4677" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Jane</FIRST_NAME>
<MIDDLE_INITIALS>E</MIDDLE_INITIALS>
<LAST_NAME>Harding</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>j.harding@auckland.ac.nz</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Liggins Institute</DEPARTMENT>
<ORGANISATION>The University of Auckland</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Auckland</CITY>
<ZIP>1001</ZIP>
<REGION/>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<PHONE_1>+64 9 373 7599 ext: 86439</PHONE_1>
<PHONE_2>+64 9 638 9909</PHONE_2>
<FAX_1>+64 9 373 7497</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="11151" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>William</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>McGuire</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Child Health</POSITION>
<EMAIL_1>William.McGuire@hyms.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Hull York Medical School &amp; Centre for Reviews and Dissemination, University of York</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>York</CITY>
<ZIP/>
<REGION>Y010 5DD</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>44 01904 321695</PHONE_1>
<PHONE_2/>
<FAX_1>44 01904 321696</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2016-03-09 17:35:41 +0000" MODIFIED_BY="Yolanda Brosseau">
<UP_TO_DATE>
<DATE DAY="29" MONTH="2" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="29" MONTH="2" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="28" MONTH="2" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="1998"/>
<LAST_CITATION_ISSUE ISSUE="5" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-04-02 17:14:53 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2016-04-02 17:14:53 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="3" YEAR="2016"/>
<DESCRIPTION>
<P>This review updates the review titled "Multicomponent fortified human milk for promoting growth in preterm infants" (<LINK REF="REF-Kuschel-2009" TYPE="REFERENCE">Kuschel 2009</LINK>)</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-04-02 17:16:34 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-04-02 17:16:34 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="29" MONTH="8" YEAR="2003"/>
<DESCRIPTION>
<P>This review updates the existing review titled "Multicomponent fortified human milk for promoting growth in preterm infants", published in <I>The Cochrane Library</I>, Issue 4, 1998<BR/>
<BR/>This review presents 6 new studies (included - Zuckerman, Nicholl, Faerk; excluded - Gupta, Porcelli, Reiss) and 1 follow-up report (Wauben)</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2016-04-04 01:12:00 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2016-03-21 17:07:49 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2015-05-12 17:43:42 +0100" MODIFIED_BY="[Empty name]">
<NAME>University of York</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2016-03-21 17:07:03 +0000" MODIFIED_BY="[Empty name]">
<NAME>University of Auckland</NAME>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2016-03-21 17:07:49 +0000" MODIFIED_BY="[Empty name]">
<NAME>Newcastle Hospitals NHS Foundation Trust and University of Newcastle</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2016-04-04 01:12:00 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2016-04-04 01:12:00 +0100" MODIFIED_BY="[Empty name]">
<NAME>National Institute of Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>This report describes independent research funded by a UK NIHR Cochrane Programme Grant (13/89/12). The views expressed in this publication are those of the review authors and are not necessarily those of the NHS, the NIHR or the UK Department of Health</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2015-05-19 17:50:58 +0100" MODIFIED_BY="[Empty name]">
<NAME>Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION>
<P>Editorial support of the Cochrane Neonatal Review Group has been funded with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-04-24 12:33:05 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2016-04-02 18:27:22 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2016-04-02 18:04:47 +0100" MODIFIED_BY="[Empty name]">Multi-nutrient fortification of breast milk for preterm infants</TITLE>
<SUMMARY_BODY MODIFIED="2016-04-02 18:27:22 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Review question:</B> Does feeding preterm infants with breast milk fortified with extra nutrients (including protein and energy) compared with unfortified breast milk increase growth rate and improve development?</P>
<P>
<B>Background: </B>Breast milk alone may not provide preterm infants with sufficient quantities of nutrients to support optimal growth and development. Mutli-nutrient fortifiers (powder or liquid supplements of protein, energy from carbohydrates or fat and other nutrients, usually extracted from cow's milk) can be added to breast milk to increase nutrient content by about 10%. Feeding preterm infants, particularly very preterm infants, with multi-nutrient fortified breast milk may increase nutrient intake and growth rates, and may improve development.</P>
<P>
<B>Study characteristics: </B>We found 14 trials; most were small (involving 1071 infants in total) and were flawed methodologically.</P>
<P>
<B>Key results:</B> Multi-nutrient fortification of breast milk for preterm infants is associated with small increases in rates of weight gain, length gain and head growth during neonatal unit admission. Only very limited data are available for growth and developmental outcomes assessed beyond infancy, and these show no effects of fortification. Trials report no consistent evidence of other potential benefits or harms of fortification, including effects on risk of feeding or bowel problems.</P>
<P>
<B>Conclusions: </B>Although available trial data show that multi-nutrient fortification increases growth rates of preterm infants during their initial hospital admission, they do not provide consistent evidence on effects on longer-term growth or development. Additional trials are needed to resolve this issue.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-04-04 06:45:38 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2016-04-02 17:54:58 +0100" MODIFIED_BY="[Empty name]">
<P>Exclusively breast milk-fed preterm infants may accumulate nutrient deficits leading to extrauterine growth restriction. Feeding preterm infants with multi-nutrient fortified human breast milk rather than unfortified breast milk may increase nutrient accretion and growth rates and may improve neurodevelopmental outcomes.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-04-02 17:36:12 +0100" MODIFIED_BY="[Empty name]">
<P>To determine whether multi-nutrient fortified human breast milk improves important outcomes (including growth and development) over unfortified breast milk for preterm infants without increasing the risk of adverse effects (such as feed intolerance and necrotising enterocolitis).</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-04-02 17:38:41 +0100" MODIFIED_BY="[Empty name]">
<P>We used the standard search strategy of the Cochrane Neonatal Review Group. This included electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 2), MEDLINE, EMBASE and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (until February 2016), as well as conference proceedings and previous reviews.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2016-04-02 17:54:26 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised and quasi-randomised controlled trials that compared feeding preterm infants with multi-nutrient (protein and energy plus minerals, vitamins or other nutrients) fortified human breast milk versus unfortified (no added protein or energy) breast milk.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-04-02 17:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>We extracted data using the standard methods of the Cochrane Neonatal Review Group. We separately evaluated trial quality, data extracted by two review authors and data synthesised using risk ratios (RRs), risk differences and mean differences (MDs). We assessed the quality of evidence at the outcome level using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-04-04 06:45:38 +0100" MODIFIED_BY="[Empty name]">
<P>We identified 14 trials in which a total of 1071 infants participated. The trials were generally small and weak methodologically. Meta-analyses provided low-quality evidence that multi-nutrient fortification of breast milk increases in-hospital rates of growth (MD 1.81 g/kg/d, 95% confidence interval (CI) 1.23 to 2.40); length (MD 0.12 cm/wk, 95% CI 0.07 to 0.17); and head circumference (MD 0.08 cm/wk, 95% CI 0.04 to 0.12). Only very limited data are available for growth and developmental outcomes assessed beyond infancy, and these show no effects of fortification. The data did not indicate other potential benefits or harms and provided low-quality evidence that fortification does not increase the risk of necrotising enterocolitis in preterm infants (typical RR 1.57, 95% CI 0.76 to 3.23; 11 studies, 882 infants).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-04-02 18:04:40 +0100" MODIFIED_BY="[Empty name]">
<P>Limited available data do not provide strong evidence that feeding preterm infants with multi-nutrient fortified breast milk compared with unfortified breast milk affects important outcomes, except that it leads to slightly increased in-hospital growth rates.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-04-24 12:33:05 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2016-04-24 12:24:48 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2016-04-02 18:32:10 +0100" MODIFIED_BY="[Empty name]">
<P>Most preterm infants accumulate energy, protein, mineral and other nutrient deficits during the initial neonatal unit admission (<LINK REF="REF-Embleton-2001" TYPE="REFERENCE">Embleton 2001</LINK>; <LINK REF="REF-Cooke-2004" TYPE="REFERENCE">Cooke 2004</LINK>). By the time they are ready to go home, typically at around 36 to 40 weeks' postmenstrual age, many infants, especially those born very preterm or very low birth weight (VLBW), are substantially growth-restricted relative to their term-born peers (<LINK REF="REF-Ehrenkranz-1999" TYPE="REFERENCE">Ehrenkranz 1999</LINK>; <LINK REF="REF-Steward-2002" TYPE="REFERENCE">Steward 2002</LINK>; <LINK REF="REF-Clark-2003" TYPE="REFERENCE">Clark 2003;</LINK> <LINK REF="REF-Dusick-2003" TYPE="REFERENCE">Dusick 2003</LINK>). Although very preterm or VLBW infants usually attain some "catch-up" growth following hospital discharge, growth deficits can persist through childhood and adolescence and into adulthood (<LINK REF="REF-Dusick-2003" TYPE="REFERENCE">Dusick 2003</LINK>; <LINK REF="REF-Euser-2008" TYPE="REFERENCE">Euser 2008</LINK>). Slow postnatal growth is associated with neurodevelopmental impairment in later childhood and with poorer cognitive and educational outcomes (<LINK REF="REF-Brandt-2003" TYPE="REFERENCE">Brandt 2003</LINK>; <LINK REF="REF-Leppanen-2014" TYPE="REFERENCE">Leppanen 2014</LINK>). Preterm infants who have accumulated mineral deficits have higher risks of metabolic bone disease and slow skeletal growth compared with infants born at term, although uncertainty remains about long-term effects on bone mass and health (<LINK REF="REF-Fewtrell-2011" TYPE="REFERENCE">Fewtrell 2011</LINK>). Furthermore, researchers have expressed concern that nutritional deficiency and growth restriction in utero and during early infancy may have consequences for long-term metabolic and cardiovascular health (<LINK REF="REF-Embleton-2013" TYPE="REFERENCE">Embleton 2013</LINK>; <LINK REF="REF-Lapillonne-2013" TYPE="REFERENCE">Lapillonne 2013</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2016-04-04 01:41:56 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Multi-nutrient fortification of breast milk</HEADING>
<P>Human breast milk is the recommended form of enteral nutrition for newborn infants for at least the first six months of postnatal life (<LINK REF="REF-Johnston-2012" TYPE="REFERENCE">Johnston 2012</LINK>). Breast milk alone, however, may not meet the recommended nutritional needs of growing preterm infants (<LINK REF="REF-Embleton-2007" TYPE="REFERENCE">Embleton 2007</LINK>; <LINK REF="REF-Agostoni-2010" TYPE="REFERENCE">Agostoni 2010</LINK>). International consensus guidelines state that "standard" volumes (about 150 to 180 mL/kg/d) of breast milk do not provide the recommended amount of energy (110 to 135 kcal/kg/d) or protein (3.5 to 4.5 g/kg/d) to meet the metabolic needs of preterm infants (<LINK REF="REF-AAP-2004" TYPE="REFERENCE">AAP 2004</LINK>; <LINK REF="REF-Agostoni-2010" TYPE="REFERENCE">Agostoni 2010</LINK>). The strategy most commonly employed in neonatal care facilities in high-income countries to address these potential nutrient deficits is to supplement breast milk with extra nutrients, usually in the form of a powder or liquid "multi-nutrient fortifier" (<LINK REF="REF-Gregory-2012" TYPE="REFERENCE">Gregory 2012</LINK>; <LINK REF="REF-Klingenberg-2012" TYPE="REFERENCE">Klingenberg 2012</LINK>; <LINK REF="REF-Cormack-2013" TYPE="REFERENCE">Cormack 2013</LINK>; <LINK REF="REF-Tudehope-2013" TYPE="REFERENCE">Tudehope 2013</LINK>; <LINK REF="REF-Dutta-2015" TYPE="REFERENCE">Dutta 2015</LINK>). Most commercially available multi-nutrient fortifiers are derived from cow's milk, but fortifiers derived from human milk have been developed recently (<LINK REF="REF-Rochow-2015" TYPE="REFERENCE">Rochow 2015</LINK>).</P>
<P>Fortifiers are intended to be mixed with expressed breast milk with the aim of achieving about 10% nutrient enrichment while maintaining optimal protein-to-energy ratios to promote lean mass growth (<LINK REF="REF-Embleton-2007" TYPE="REFERENCE">Embleton 2007</LINK>; <LINK REF="REF-Agostoni-2010" TYPE="REFERENCE">Agostoni 2010</LINK>; <LINK REF="REF-Johnston-2012" TYPE="REFERENCE">Johnston 2012</LINK>; <LINK REF="REF-Moya-2012" TYPE="REFERENCE">Moya 2012</LINK>; <LINK REF="REF-Tudehope-2013" TYPE="REFERENCE">Tudehope 2013</LINK>). Multi-nutrient fortification may be especially important for infants who receive donated (donor) expressed breast milk, which contains lower levels of protein, energy and minerals than their own mother's expressed breast milk (<LINK REF="REF-Arslanoglu-2013" TYPE="REFERENCE">Arslanoglu 2013</LINK>). Commercially available fortifiers are expensive, and their use is less feasible in resource-poor settings in low- or middle-income countries (<LINK REF="REF-Chawla-2008" TYPE="REFERENCE">Chawla 2008</LINK>; <LINK REF="REF-Kler-2015" TYPE="REFERENCE">Kler 2015</LINK>). An alternative strategy, more commonly employed in resource-limited settings, is to enrich breast milk by adding cow's milk formula powder to achieve the required level of nutrient enrichment (<LINK REF="REF-Gross-1993" TYPE="REFERENCE">Gross 1993</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Targeted and adjustable fortification</HEADING>
<P>Nutrient (especially energy and protein) content of expressed breast milk varies between mothers and between different batches of a woman's expressed breast milk (<LINK REF="REF-de-Halleux-2013" TYPE="REFERENCE">de Halleux 2013</LINK>). If the nutrient levels in expressed breast milk are measured, the amount of fortifier added can be <I>targeted</I> (also referred to as <I>individualised</I>) to achieve a desired overall content (<LINK REF="REF-Rochow-2013" TYPE="REFERENCE">Rochow 2013</LINK>; <LINK REF="REF-Rochow-2015" TYPE="REFERENCE">Rochow 2015</LINK>). The level of fortification may be <I>adjusted</I> in response to the metabolic demands and responses of individual infants, for example, by titration to the infant's serum urea level (<LINK REF="REF-Arslanoglu-2010" TYPE="REFERENCE">Arslanoglu 2010</LINK>).</P>
</SUBSECTION>
</INTERVENTION>
<THEORY MODIFIED="2016-04-24 12:22:12 +0100" MODIFIED_BY="[Empty name]">
<P>Feeding preterm infants with human milk fortified with energy and protein (as well as minerals and other nutrients) may be expected to promote nutrient accretion and growth (increase in weight, length and head circumference). Higher levels of nutrient intake during this critical period may be especially important for infants who are not able to consume larger quantities of milk, who have slow growth or who have ongoing additional nutritional and metabolic requirements (<LINK REF="REF-Agostoni-2010" TYPE="REFERENCE">Agostoni 2010</LINK>).</P>
<P>A potential disadvantage of multi-nutrient fortification is that increasing nutrient density and osmolarity of breast milk might interfere with gastric emptying and intestinal peristalsis, resulting in feed intolerance or increasing the risk of necrotising enterocolitis (<LINK REF="REF-Ewer-1996" TYPE="REFERENCE">Ewer 1996</LINK>; <LINK REF="REF-McClure-1996" TYPE="REFERENCE">McClure 1996</LINK>; <LINK REF="REF-Gathwala-2008" TYPE="REFERENCE">Gathwala 2008</LINK>; <LINK REF="REF-Yigit-2008" TYPE="REFERENCE">Yigit 2008</LINK>; <LINK REF="REF-Morgan-2011" TYPE="REFERENCE">Morgan 2011</LINK>). Several cases of subacute bowel obstruction due to impaction with "milk curd" have been reported in very preterm infants fed with multi-nutrient fortified expressed breast milk, putatively due to the high calcium content causing fat malabsorption (<LINK REF="REF-Flikweert-2003" TYPE="REFERENCE">Flikweert 2003</LINK>; <LINK REF="REF-Wagener-2009" TYPE="REFERENCE">Wagener 2009</LINK>; <LINK REF="REF-Stanger-2014" TYPE="REFERENCE">Stanger 2014</LINK>). Investigators have been concerned that rapid growth with accelerated weight gain during this critical early phase might be associated with altered fat distribution and related 'programmed' metabolic consequences that may increase long-term risks of insulin resistance and hypertension (<LINK REF="REF-Euser-2005" TYPE="REFERENCE">Euser 2005</LINK>; <LINK REF="REF-Singhal-2007" TYPE="REFERENCE">Singhal 2007</LINK>; <LINK REF="REF-Euser-2008" TYPE="REFERENCE">Euser 2008</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2016-04-24 12:24:48 +0100" MODIFIED_BY="[Empty name]">
<P>Given the potential for multi-nutrient fortification of breast milk to affect important outcomes for preterm infants, this review aims to detect, appraise and synthesise available evidence from randomised controlled trials to inform practice and research.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-04-02 17:28:52 +0100" MODIFIED_BY="[Empty name]">
<P>To determine whether multi-nutrient fortified human breast milk improves important outcomes (including growth and development) over unfortified breast milk for preterm infants without increasing the risk of adverse effects (such as feed intolerance and necrotising enterocolitis).</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-04-03 11:16:37 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2016-04-02 20:30:37 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2016-04-02 20:23:30 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised and quasi-randomised controlled trials, including cluster-randomised controlled trials. We did not include cross-over trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-04-02 20:23:37 +0100" MODIFIED_BY="[Empty name]">
<P>Preterm (&lt; 37 weeks' gestational age) and low birth weight (&lt; 2500 g) infants receiving enteral breast milk.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-04-02 20:27:47 +0100" MODIFIED_BY="[Empty name]">
<P>Fortification of human breast milk (expressed maternal or donor or both) with both energy (carbohydrate or fat) <I>and</I> protein. Multi-nutrient fortifiers additionally could contain minerals, iron, vitamins or other nutrients. Multi-nutrient fortifiers could be cow (or another animal) milk-based or human milk-based. The control group should not have received energy <I>or</I> protein fortification but could have received milk supplemented with minerals, iron, vitamins or other nutrients.</P>
<P>Eligible trials should have planned to allocate the trial intervention for a sufficient period (at least two weeks) to allow measurable effects on growth. Infants in comparison groups within each trial should have received similar care other than the level of fortification of breast milk. No between-group differences in target levels of volume of milk intake should have occurred.</P>
<P>We did not include trials of:</P>
<UL>
<LI>targeted fortification (vs standard fortification);</LI>
<LI>adjustable fortification (vs standard fortification);</LI>
<LI>early versus later introduction of multi-nutrient fortifier; or</LI>
<LI>human milk-based versus cow milk-based fortifier.</LI>
</UL>
<P>Separate Cochrane reviews will consider these comparisons.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-04-02 20:30:37 +0100" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-04-02 20:29:11 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Growth: weight, length, head growth, skinfold thickness, body mass index and measures of body composition (lean/fat mass) and growth restriction (proportion of infants who remain &lt; 10th percentile for the index population distribution of weight, length or head circumference).</LI>
<LI>Neurodevelopmental outcomes assessed after 12 months post term: neurological evaluations, developmental scores and classifications of disability, including auditory and visual disability. We defined neurodevelopmental impairment as the presence of one or more of the following: non-ambulant cerebral palsy, developmental quotient more than two standard deviations below the population mean and blindness (visual acuity &lt; 6/60) or deafness (any hearing impairment requiring or unimproved by amplification).</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-04-02 20:30:37 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Duration of hospital admission (weeks).</LI>
<LI>Feed intolerance that results in cessation or reduction in enteral feeding.</LI>
<LI>Necrotising enterocolitis (modified Bell stage 2/3; <LINK REF="REF-Walsh-1986" TYPE="REFERENCE">Walsh 1986</LINK>).</LI>
<LI>Measures of bone mineralisation such as serum alkaline phosphatase level, or bone mineral content assessed by dual energy x-ray absorptiometry (DEXA) and clinical or radiological evidence of rickets on long-term follow-up (restricted to trials without mineral supplementation of the control group).</LI>
<LI>Measures of long-term metabolic or cardiovascular health, including insulin resistance, obesity, diabetes and hypertension.</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-04-02 20:42:16 +0100" MODIFIED_BY="[Empty name]">
<P>We used the standard search strategy of the Cochrane Neonatal Review Group.</P>
<ELECTRONIC_SEARCHES MODIFIED="2016-04-02 20:31:01 +0100" MODIFIED_BY="[Empty name]">
<P>We searched MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Maternity and Infant Care (see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>).</P>
<P>We searched <A HREF="http://clinicaltrials.gov/">ClinicalTrials.gov</A> and <A HREF="http://www.controlled-trials.com/">Current Controlled Trials</A> for completed or ongoing trials.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-04-02 20:42:16 +0100" MODIFIED_BY="[Empty name]">
<P>We examined the references in studies identified as potentially relevant. We also searched abstracts from annual meetings of the Pediatric Academic Societies (1993 to 2015), the European Society for Paediatric Research (1995 to 2015), the UK Royal College of Paediatrics and Child Health (2000 to 2016) and the Perinatal Society of Australia and New Zealand (2000 to 2015). We considered trials reported only as abstracts to be eligible if sufficient information was available from the report, or from contact with study authors, to fulfil the inclusion criteria.<BR/>
</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-04-03 11:16:37 +0100" MODIFIED_BY="[Empty name]">
<P>We used the standard methods of the Cochrane Neonatal Review Group.</P>
<STUDY_SELECTION MODIFIED="2016-04-02 20:43:15 +0100" MODIFIED_BY="[Empty name]">
<P>One review author (JB) screened titles and abstracts of all records identified by the search and coded records as "order" or "exclude". A second review author (WM) assessed all records coded as "order" and made the final decision about which records were ordered as full-text articles. JB read the full texts and used a checklist to assess each article's eligibility for inclusion on the basis of pre-specified inclusion and exclusion criteria. MM checked these decisions.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-04-02 20:44:37 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors (JB and WM) extracted data independently using a data collection form to aid extraction of information on design, methods, participants, interventions, outcomes and treatment effects from each included study. We discussed disagreements until we reached consensus. If data from the trial reports were insufficient, we contacted trialists for further information.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-04-02 20:52:57 +0100" MODIFIED_BY="[Empty name]">
<P>We used criteria and standard methods of the Cochrane Neonatal Review Group to assess the methodological quality of included trials. Two review authors (JB and WM) assessed risk of bias. We resolved disagreements by discussion and requested additional information from trial authors to clarify methods and results if necessary.</P>
<P>We made explicit judgements about whether studies are at high risk of bias across four domains according to the criteria suggested in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<UL>
<LI>Random sequence generation: We categorised the method used to generate the allocation sequence as:</LI>
</UL>
<UL>
<UL>
<LI>low risk - any truly random process (e.g. random number table, computer random number generator);</LI>
<LI>high risk - any non-random process (e.g. odd or even date of birth, hospital or clinic record number); or</LI>
<LI>unclear risk - no or unclear information provided.</LI>
</UL>
</UL>
<UL>
<LI>Allocation concealment: We categorised the method used to conceal the allocation sequence as:</LI>
</UL>
<UL>
<UL>
<LI>low risk (e.g. telephone or central randomisation, consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk - open random allocation (e.g. unsealed or non-opaque envelopes, alternation, date of birth); or</LI>
<LI>unclear risk - no or unclear information provided.</LI>
</UL>
</UL>
<UL>
<LI>Blinding: We assessed blinding of participants, clinicians, caregivers and outcome assessors separately for different outcomes and categorised the methods as:</LI>
</UL>
<UL>
<UL>
<LI>low risk;</LI>
<LI>high risk; or</LI>
<LI>unclear risk.</LI>
</UL>
</UL>
<UL>
<LI>Incomplete outcome data: We described the completeness of data from the analysis including attrition and exclusions for each outcome and reasons for attrition or exclusion, when reported. We assessed whether missing data were balanced across groups or were related to outcomes. When sufficient information was reported or supplied by the trial authors, we planned to reinstate missing data in the analyses. We categorised completeness as:</LI>
</UL>
<UL>
<UL>
<LI>low risk: &#8804; 10% missing data;</LI>
<LI>high risk: &gt; 10% missing data; or</LI>
<LI>unclear risk: no or unclear information provided.</LI>
</UL>
</UL>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-04-02 20:53:17 +0100" MODIFIED_BY="[Empty name]">
<P>We analysed treatment effects in the individual trials using Review Manager 5.3 and reported risk ratios (RRs) and risk differences (RDs) for dichotomous data, and mean differences (MDs) for continuous data, with respective 95% confidence intervals (CIs). We determined the number needed to treat for an additional beneficial outcome (NNTB) or an additional harmful outcome (NNTH) for analyses with a statistically significant difference in the RD.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-04-02 20:58:38 +0100" MODIFIED_BY="[Empty name]">
<P>The unit of analysis was the participating infant in individually randomised trials. For cluster-randomised trials (had we identified any for inclusion), we planned to undertake analyses at the level of the individual while accounting for clustering in the data using methods recommended in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2016-04-02 21:17:40 +0100" MODIFIED_BY="[Empty name]">
<P>We requested additional data from trial investigators when data on important outcomes were missing or were reported unclearly. When data were still missing, we examined the impact on effect size estimates in sensitivity analyses.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-04-02 21:18:29 +0100" MODIFIED_BY="[Empty name]">
<P>We examined treatment effects in individual trials and heterogeneity between trial results by inspecting the forest plots if more than one trial was included in a meta-analysis. We calculated the I² statistic for each analysis to quantify inconsistency across studies and to describe the percentage of variability in effect estimates that may be due to heterogeneity rather than sampling error. If we detected substantial (I² &gt; 50%) heterogeneity, we explored possible causes (e.g. differences in study design, participants, interventions or completeness of outcome assessments) in sensitivity analyses.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2015-02-19 15:19:36 +0000" MODIFIED_BY="[Empty name]">
<P>We inspected funnel plots for asymmetry if more than five trials were included in a meta-analysis.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-04-03 11:15:26 +0100" MODIFIED_BY="[Empty name]">
<P>We used a fixed-effect model for meta-analyses.</P>
<SUBSECTION>
<HEADING LEVEL="3">Quality of evidence</HEADING>
<P>We assessed the quality of evidence for the main comparison at the outcome level using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach (<LINK REF="REF-Guyatt-2011a" TYPE="REFERENCE">Guyatt 2011a</LINK>). This considers evidence from randomised controlled trials as high quality that may be downgraded on the basis of consideration of any of five areas.</P>
<UL>
<LI>Design (risk of bias).</LI>
<LI>Consistency across studies.</LI>
<LI>Directness of the evidence.</LI>
<LI>Precision of estimates.</LI>
<LI>Presence of publication bias.</LI>
</UL>
<P>The GRADE approach results in assessment of the quality of a body of evidence according to four grades (<LINK REF="REF-Sch_x00fc_nemann-2013" TYPE="REFERENCE">Schünemann 2013</LINK>).</P>
<UL>
<LI>High: We are very confident that the true effect lies close to the estimate of effect.</LI>
<LI>Moderate: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different.</LI>
<LI>Low: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect.</LI>
<LI>Very low: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.</LI>
</UL>
<P>Two review authors (JB and WM) assessed independently the quality of the evidence found for outcomes identified as critical or important for clinical decision making (growth, development, necrotising enterocolitis).</P>
<P>In cases for which we considered risk of bias arising from inadequate concealment of allocation, randomised assignment, complete follow-up or blinded outcome assessment to reduce our confidence in the effect estimates, we downgraded the quality of evidence accordingly (<LINK REF="REF-Guyatt-2011b" TYPE="REFERENCE">Guyatt 2011b</LINK>). We evaluated consistency on the basis of similarity of point estimates, extent of overlap of confidence intervals and statistical criteria, including measurement of heterogeneity (I²). We downgraded the quality of evidence when inconsistency across study results was large and unexplained (i.e. some studies suggested important benefit, and others no effect or harm with no explanation) (<LINK REF="REF-Guyatt-2011c" TYPE="REFERENCE">Guyatt 2011c</LINK>). We assessed precision accordingly with the 95% confidence interval (CI) around the pooled estimation (<LINK REF="REF-Guyatt-2011d" TYPE="REFERENCE">Guyatt 2011d</LINK>). When trials were conducted in populations other than the target population, we downgraded the quality of evidence because of indirectness (<LINK REF="REF-Guyatt-2011e" TYPE="REFERENCE">Guyatt 2011e</LINK>).</P>
<P>We entered data (pooled estimates of effects and corresponding 95% CIs) and explicit judgements for each of the above aspects assessed into the Guideline Development Tool, the software used to create 'Summary of findings (SoF)' tables (<LINK REF="REF-GRADEpro-2008" TYPE="REFERENCE">GRADEpro 2008</LINK>). We explained our assessment of study characteristics in footnotes in the SoF table.</P>
</SUBSECTION>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-04-03 11:16:37 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to undertake these subgroup analyses, when possible.</P>
<UL>
<LI>Very preterm (&lt; 32 weeks' gestation) or VLBW (&lt; 1500 g) infants (vs infants 32 to 36 weeks' gestation or birth weight 1500 to 2499 g).</LI>
<LI>Fortifcation of donor breast milk (vs maternal expressed breast milk).</LI>
<LI>Trials using fortifier extracted from human milk (vs cow milk-based fortifier).</LI>
<LI>Trials supplementing breast milk with infant formula (vs cow milk-based fortifier).</LI>
<LI>Trials conducted in low- and middle-income countries versus high-income countries (see http://data.worldbank.org/about/country-classifications).</LI>
</UL>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-04-24 12:33:05 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2016-04-03 11:34:18 +0100" MODIFIED_BY="[Empty name]">
<P>See also <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
<SEARCH_RESULTS MODIFIED="2016-03-21 18:22:51 +0000" MODIFIED_BY="[Empty name]">
<P>See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> for an illustration of the study selection process.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-04-03 11:32:42 +0100" MODIFIED_BY="[Empty name]">
<P>We included in this review 14 trials (13 primary publications) in which 1071 infants participated that met our inclusion criteria (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>; <LINK REF="STD-Faerk-2000" TYPE="STUDY">Faerk 2000</LINK>; <LINK REF="STD-Bhat-2003" TYPE="STUDY">Bhat 2003</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>; <LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>). Sample sizes ranged between 14 and 275 participants.</P>
<P>All trials were set in specialist paediatric hospital settings, mainly neonatal intensive care units. Ten trials were single-centre trials (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>; <LINK REF="STD-Bhat-2003" TYPE="STUDY">Bhat 2003</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>; <LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>), and each of the remaining four was conducted at two centres (<LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Faerk-2000" TYPE="STUDY">Faerk 2000</LINK>).</P>
<P>We noted that five trials were conducted in Europe (<LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>; <LINK REF="STD-Faerk-2000" TYPE="STUDY">Faerk 2000</LINK>), four in North America (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>), three in Asia (<LINK REF="STD-Bhat-2003" TYPE="STUDY">Bhat 2003</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>; <LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>) and two in Africa (<LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK>). Publication dates span four decades, ranging from 1986 to 2012.</P>
<SUBSECTION>
<HEADING LEVEL="3">Participants</HEADING>
<P>All trials included preterm or low birth weight infants and excluded those with major congenital abnormalities. Eight trials restricted participation to very preterm or VLBW infants (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>; <LINK REF="STD-Faerk-2000" TYPE="STUDY">Faerk 2000</LINK>; <LINK REF="STD-Bhat-2003" TYPE="STUDY">Bhat 2003</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>). The other trials specified the following as an upper birth weight eligibility criterion:</P>
<UL>
<LI>1600 g (<LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>).</LI>
<LI>1800 g (<LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>).</LI>
<LI>1850 g (<LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>).</LI>
<LI>2000 g (<LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>).</LI>
</UL>
<P>Average gestational age of included infants across all trials was 30 weeks. The nature of the intervention required that babies in all trials must tolerate enteral feeds and mothers needed to supply expressed breast milk.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Interventions</HEADING>
<P>For all infants, trials relied largely on provision of the mother's own expressed breast milk. Three trials used only the mother's own milk (<LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>). It was not always reported how feeds were made up if the mother could not provide sufficient milk, but in some studies, infants were excluded on this basis. Seven trials supplemented mother's own milk with donor (or "bank") milk (<LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>; <LINK REF="STD-Faerk-2000" TYPE="STUDY">Faerk 2000</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>). Investigators in the remaining four trials used formula to top feeds up to the required volume (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Bhat-2003" TYPE="STUDY">Bhat 2003</LINK>; <LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>).</P>
<P>Types of multi-nutrient fortification added to milk for infants in the intervention groups varied. Most trials used a commercially available, cow's milk-based, powdered preparation containing varying amounts of protein, fat, carbohydrate, minerals, electrolytes and trace minerals.</P>
<UL>
<LI>Similac Human Milk Fortifier (HMF; Ross Laboratories): <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK> [<LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK> included a third group of infants receiving human milk fortified with formula (see below).</LI>
<LI>FM85 (Nestlè): <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>.</LI>
<LI>Enfamil HMF (Mead Johnson): <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>.</LI>
<LI>Nutriprem (Cow &amp; Gate Nutricia): <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>.</LI>
<LI>Eoprotin (Milupa): <LINK REF="STD-Faerk-2000" TYPE="STUDY">Faerk 2000</LINK>.</LI>
<LI>Lactodex HMF (Raptakos Brett): <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>; <LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>.</LI>
<LI>Trial-specific multi-nutrient fortifier (Wyeth-Ayerst): <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>.</LI>
</UL>
<P>Two trials mixed equal volumes of human milk and preterm formula.</P>
<UL>
<LI>Similac Special Care, Ross Laboratories: <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>.</LI>
<LI>Alprem (Nestlè): <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK>.</LI>
</UL>
<P>Three trials did not specify the name or manufacturer of the multi-nutrient fortifier used: <LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Bhat-2003" TYPE="STUDY">Bhat 2003</LINK>.</P>
<P>All trials used a fixed, pre-specified amount of fortifier for all infants in the intervention group. Some trials titrated the amount of fortifier per feed to try to prevent feed intolerance.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparators</HEADING>
<P>Most trials added vitamins, minerals or other nutrients to control infants' feeds as part of standard hospital practice. Four trials provided all infants with additional vitamin D (<LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK>; <LINK REF="STD-Faerk-2000" TYPE="STUDY">Faerk 2000</LINK>). Five trials provided all infants with several vitamins and minerals (added to feeds for infants in the control group, and included in the fortifier or added separately for infants in the intervention group) (<LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>). Researchers in five trials gave no supplements at all to control group infants (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>; <LINK REF="STD-Bhat-2003" TYPE="STUDY">Bhat 2003</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>; <LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes</HEADING>
<P>Investigators in all included trials assessed at least one of our pre-specified outcomes of interest. Ten trials contributed growth rate data (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>). Only <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK> reported size and neurodevelopmental data at follow-up beyond hospital discharge.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-04-03 11:34:18 +0100" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> for details. We excluded:</P>
<UL>
<LI>
<A HREF="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000343.pub2/full#CD000343-bbs2-0001">Carey 1987</A> and <LINK REF="STD-Greer-1988" TYPE="STUDY">Greer 1988</LINK> because they used fortification with protein only (no fortification with fat or carbohydrate);</LI>
<LI>
<LINK REF="STD-Tarcan-2004" TYPE="STUDY">Tarcan 2004</LINK>; <LINK REF="STD-Arslanoglu-2009" TYPE="STUDY">Arslanoglu 2009</LINK>; <LINK REF="STD-Reali-2010" TYPE="STUDY">Reali 2010</LINK>; and <LINK REF="STD-Hair-2014" TYPE="STUDY">Hair 2014</LINK> because they were not randomised controlled trials; and</LI>
<LI>
<LINK REF="STD-Abrams-2014" TYPE="STUDY">Abrams 2014</LINK> because it compared human versus cow's milk-based protein fortification rather than fortification versus no fortification.</LI>
</UL>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-04-03 11:37:39 +0100" MODIFIED_BY="[Empty name]">
<P>Overall, we found risk of bias difficult to assess as the result of limited reporting. Consequently, we scored most items as "unclear" (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
<ALLOCATION MODIFIED="2016-04-03 11:35:43 +0100" MODIFIED_BY="[Empty name]">
<P>Risk of selection bias was largely unclear. Only four trials described adequate methods of random sequence generation (<LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>; <LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>). Only two explicitly described adequate allocation concealment methods (<LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>). <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK> was at high risk of selection bias, as investigators performed group allocation in a quasi-randomised fashion (odd and even hospital numbers).</P>
</ALLOCATION>
<BLINDING MODIFIED="2016-04-03 11:36:34 +0100" MODIFIED_BY="[Empty name]">
<P>Risk of performance and selection bias was also unclear in most trials. Several trials were known to be at high risk as reports stated that personnel and outcome assessors were not blinded (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-04-03 11:37:05 +0100" MODIFIED_BY="[Empty name]">
<P>We judged five trials to be at high risk of attrition bias (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Faerk-2000" TYPE="STUDY">Faerk 2000</LINK>) and all other trials to be at low risk.</P>
</EXCLUSIONS>
<OTHER_BIAS_SOURCES MODIFIED="2016-04-03 11:37:39 +0100" MODIFIED_BY="[Empty name]">
<P>Authors of three trials were employees of the manufacturer of the fortifier used (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>). The manufacturer of the fortifier used funded two trials (<LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-04-24 12:33:05 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Growth rates (Outcomes 1.1 to 1.6)</HEADING>
<P>
<I>Weight gain </I>(<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>): We obtained data from 10 trials including 635 infants (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>). Several trials as well as a meta-analysis of the data from all trials showed a statistically significantly higher rate of weight gain in the intervention (fortifier) group (MD 1.81, 95% CI 1.23 to 2.40 g/kg/d). Substantial heterogeneity was present in this analysis (I² = 72%) (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
<P>
<I>Length gain </I>(<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>): We obtained data from eight trials including 555 infants (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>). Results across individual trials varied, but a meta-analysis of the data from all trials showed a statistically significantly higher rate of length gain in the fortified group (MD 0.18, 95% CI 0.10 to 0.26 cm/wk). We detected substantial heterogeneity in this analysis (I² = 69%) (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).</P>
<P>
<I>Head growth </I>(<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>): We obtained data from eight trials including 555 infants (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>). Results across individual trials varied, but a meta-analysis of the data from all trials showed a statistically significantly higher rate of head growth in the intervention group (MD 0.08, 95% CI 0.04 to 0.12 cm/wk). We detected low heterogeneity in this analysis (I² = 22%) (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
<P>
<I>Weight at 12 to 18 months </I>(<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>): We obtained data from <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK> and <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK> (270 infants). Neither trial nor a meta-analysis of the data from both trials showed a statistically significant difference (MD -0.03, 95% CI -0.31 to 0.25 kg).</P>
<P>
<I>Length at 12 to 18 months </I>(<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>): We obtained data from <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK> and <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK> (270 infants). Neither trial nor a meta-analysis of the data from both trials showed a statistically significant difference (MD -0.19, 95% CI -0.98 to 0.60 cm).</P>
<P>
<I>Head circumference at 12 to 18 months </I>(<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>): We obtained data from <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK> and <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK> (270 infants). Neither trial nor a meta-analysis of the data from both trials showed a statistically significant difference (MD 0.10, 95% CI -0.37 to 0.18 cm).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Neurodevelopmental outcomes after 12 months of age (Outcomes 1.7 and 1.8)</HEADING>
<P>Only one trial (245 infants) reported data on this outcome (<LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>). This trial reported no statistically significant differences in:</P>
<UL>
<LI>mental development index at 18 months (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>): MD 2.20 (95% CI -3.35 to 7.75); nor</LI>
<LI>psychomotor development index at 18 months (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>): MD 2.40 (95% CI -1.90 to 6.70).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Length of hospital stay in weeks (Outcome 1.9)</HEADING>
<P>We obtained data from <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK> and <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK> (210 infants) (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). Neither trial nor a meta-analysis of their data showed a statistically significant difference (MD 0.38, 95% CI -0.16 to 0.93 weeks).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Feed intolerance (Outcome 1.10)</HEADING>
<P>We obtained data from five trials (<LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>) including 255 infants (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>). Results across individual trials varied, and a meta-analysis of data showed no statistically significant differences (typical RR 0.90, 95% CI 0.54 to 1.49).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Necrotising enterocolitis (Outcome 1.11)</HEADING>
<P>We obtained data from 11 trials (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK>; <LINK REF="STD-Lucas-1996" TYPE="STUDY">Lucas 1996</LINK>; <LINK REF="STD-Wauben-1998" TYPE="STUDY">Wauben 1998</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>; <LINK REF="STD-Faerk-2000" TYPE="STUDY">Faerk 2000</LINK>; <LINK REF="STD-Bhat-2003" TYPE="STUDY">Bhat 2003</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>) including 882 infants (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>). Results across individual trials varied, and a meta-analysis of the data from all trials showed no statistically significant differences (typical RR 1.57, 95% CI 0.76 to 3.23).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Measures of bone mineralisation (Outcomes 1.12 and 1.13)</HEADING>
<P>
<I>Serum alkaline phosphatase </I>(<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>): Meta-analysis of data obtained from five trials (restricted to trials without mineral supplementation of the control group) showed that the intervention group had statistically significantly lower serum alkaline phosphatase (ALP) levels (<LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>; <LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK>; <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>; <LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>): weighted mean difference (WMD) -126 (95% CI -191 to -62) IU/L. Substantial heterogeneity was present in this analysis (I² = 58%). <LINK REF="STD-Bhat-2003" TYPE="STUDY">Bhat 2003</LINK> did not report peak ALP levels but did state that the intervention group included fewer infants who developed high ALP levels (&gt; 450 IU/L) than were included in the control group (without mineral supplementation).</P>
<P>
<I>Bone mineral content </I>(<LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>): Only <LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK> provided numerical data and reported a statistically significantly higher level of bone mineral content in the intervention group: WMD 12.0 (95% CI 6.3 to 17.7) mg/cm. <LINK REF="STD-Modanlou-1986" TYPE="STUDY">Modanlou 1986</LINK>, <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK> and <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK> detected no statistically significant differences between control and treatment groups but did not report numerical data for inclusion in meta-analyses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Measures of metabolic health on long-term follow-up</HEADING>
<P>No included trials reported these measures.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analyses</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Very preterm or VLBW infants</HEADING>
<P>Meta-analyses of data from trials that restricted participation to very preterm or VLBW infants showed no substantial differences in meta-analyses of all trial data (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>; <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>; <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Fortifcation of donor breast milk</HEADING>
<P>Seven trials supplemented mother's own milk with donor (or "bank") milk (<LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK>; <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>; <LINK REF="STD-Polberger-1989" TYPE="STUDY">Polberger 1989</LINK>; <LINK REF="STD-Porcelli-1992" TYPE="STUDY">Porcelli 1992</LINK>; <LINK REF="STD-Nicholl-1999" TYPE="STUDY">Nicholl 1999</LINK>; <LINK REF="STD-Faerk-2000" TYPE="STUDY">Faerk 2000</LINK>; <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK>). None of these investigators used donor milk exclusively (or predominantly), and none reported subgroup data for infants fed with donor breast milk exclusively.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Trials using fortifier extracted from human milk (rather than cow's milk-based fortifiers)</HEADING>
<P>All trials included in this review used cow's milk-based fortifiers.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Trials supplementing breast milk with infant formula (rather than breast milk fortifier)</HEADING>
<P>
<LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK> (for a subset of the intervention group, N = 19) and <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK> (N = 56) used preterm infant formula to fortify breast milk in their trials. <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK> reported in-hospital growth parameters and found effects consistent with the meta-analyses. <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK> reported data on length of hospital stay, incidence of necrotising enterocolitis and levels of serum ALP consistent with the meta-analyses (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>; <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Trials conducted in low- and middle-income countries</HEADING>
<P>Researchers conducted four trials in middle-income countries: <LINK REF="STD-Pettifor-1989" TYPE="STUDY">Pettifor 1989</LINK> and <LINK REF="STD-Zuckerman-1994" TYPE="STUDY">Zuckerman 1994</LINK> in South Africa (upper middle-income country) and <LINK REF="STD-Mukhopadhyay-2007" TYPE="STUDY">Mukhopadhyay 2007</LINK> and <LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK> in India (lower middle-income country). Meta-analyses were limited and showed no substantial differences from the meta-analyses of all trials together (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>; <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>; <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-04-03 23:19:31 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2016-04-03 22:58:13 +0100" MODIFIED_BY="[Empty name]">
<P>Available evidence from 14 randomised controlled trials suggests that multi-nutrient fortification (both energy and protein, as well as minerals and vitamins) results in small but statistically significant increases in rates of weight gain, length gain and head growth for preterm infants. However, most trials reported growth parameters only over short-term study periods during the initial neonatal unit admission. Very few data are available for growth and developmental outcomes assessed beyond infancy, and these show no statistically significant effects of fortification. None of these trials have reported data related to possible longer-term "programmed" metabolic or physiological consequences of multi-nutrient supplementation in early infancy.</P>
<P>Meta-analysis of data from trials that included a control group without bone mineral supplementation showed that multi-nutrient fortification reduces serum alkaline phosphatase (ALP) levels but provided limited evidence of effects on other measures of bone mineralisation or health. This review found no consistent evidence of other potential benefits or harms of fortification, including no data to suggest that fortification increases the risk of feed intolerance or necrotising enterocolitis in preterm infants.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-04-03 23:04:20 +0100" MODIFIED_BY="[Empty name]">
<P>We recommend cautious interpretation and application of these findings. Although meta-analyses indicate that multi-nutrient fortification increases rates of growth, typical effect sizes are very modest. Over the course of four weeks, multi-nutrient fortification for a very preterm infant weighing 1 kg at birth would result in an extra 50 g of weight gain, 7 mm of length gain and 3 mm of head circumference gain. As well as uncertainty about the clinical importance of these small effects on hospital growth rates, considerable uncertainty remains about longer-term impact on growth or development. Similarly, although multi-nutrient fortification that includes minerals (vs breast milk without added minerals) reduces the serum ALP level, this in itself is an insensitive measure of bone mineralisation or health (<LINK REF="REF-Tinnion-2012" TYPE="REFERENCE">Tinnion 2012</LINK>). Furthermore, in current clinical practice, mineral supplements (mainly phosphate) are available for infants at high risk of, or with biochemical or other features of, metabolic bone disease.</P>
<P>Meta-analyses of growth outcomes showed substantial statistical heterogeneity that was not explained by major differences in trial design or conduct. Participants in these trials were similar (mostly stable VLBW infants). Although we noted some variation in types of fortifier used, the overall target level of multi-nutrient fortification was similar. Most trials aimed to provide extra energy, protein and minerals by adding a powdered, commercially available multi-nutrient fortifier to breast milk to attain 75 to 80 kcal/100 mL and about 2.0 to 2.6 g of protein/100 mL (plus proportionate supplements of minerals, vitamins and trace elements). This approach maintained optimal protein-to-energy ratios to ensure that the protein contributed to growth and was not catabolised as a fuel source (<LINK REF="REF-Kashyap-1994" TYPE="REFERENCE">Kashyap 1994</LINK>). However, these total levels of protein and energy fortification are at the lower bounds of current recommended intakes needed to match intrauterine accretion (based on receiving about 150 mL/kg/d of milk), and this is a likely explanation for the limited impact of the intervention on growth parameters. These findings are broadly consistent with those of another Cochrane review which found that formula-fed preterm infants who received higher levels of protein (&gt; 3 g/kg/d) gained weight about 2.4 g/kg/d faster than infants who received standard levels of protein (<LINK REF="REF-Fenton-2014" TYPE="REFERENCE">Fenton 2014</LINK>).</P>
<P>A final major limitation of this review is that most included trials were undertaken at healthcare facilities in high-income countries, and none in community settings or low-income countries. Reported evidence therefore may be of limited use to inform care practice in the resource-limited settings where most preterm and low birth weight infants are cared for globally (<LINK REF="REF-Imdad-2013" TYPE="REFERENCE">Imdad 2013</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-04-03 23:10:07 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed the quality of the evidence as low or moderate for most outcomes (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). Included trials were small and were generally of low methodological quality, yielding no evidence of use of adequate measures to conceal random allocation and incomplete follow-up assessment during the intervention period. Blinding of participants and caregivers was not possible given the nature of the intervention, but this is not likely to be a major source of bias in growth assessments. Knowledge of the intervention group may have affected caregivers' or mothers' perceptions and views of feeding, and may have influenced decisions on whether any formula should be given as a supplement to (or instead of) breast milk. These trials did not examine whether multi-nutrient fortification affected the mother's commitment to establish breast feeding, or whether differences were noted in the proportion of infants receiving any breast milk at the end of the intervention period.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-04-03 23:19:31 +0100" MODIFIED_BY="[Empty name]">
<P>Our main concern with the review process is the possibility that findings are subject to publication and other reporting biases. We attempted to minimise this threat by screening the reference lists of included trials and related reviews and searching the proceedings of major international perinatal conferences to identify trial reports that are not (or are not yet) published in full form in academic journals. The meta-analyses that we performed did not contain sufficient trials to explore symmetry of funnel plots as a means of identifying possible publication or reporting bias.</P>
</POTENTIAL_BIASES>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-04-03 23:37:59 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2016-04-03 23:21:13 +0100" MODIFIED_BY="[Empty name]">
<P>Multi-nutrient fortification of human milk is associated with small, short-term increases in weight gain and in linear and head growth. No evidence suggests that these short-term gains in growth lead to any long-term effects on growth or development. Investigators reported no increase in adverse effects among infants who received multi-nutrient fortifiers, although the total number of infants studied was small and the data that could be abstracted from published studies were limited.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-04-03 23:37:59 +0100" MODIFIED_BY="[Empty name]">
<P>Given the potential for multi-nutrient fortification of breast milk to affect important outcomes in preterm infants, this intervention merits further assessment. As this practice is already widely established and accepted as a standard of care in many neonatal units, it is important for researchers to determine whether mothers and clinicians would support a trial of this intervention. All trials should be powered to detect potentially important effects on growth rates, as well as potential adverse consequences, during infancy and beyond. Trials should attempt to ensure that caregivers and assessors are blind to the intervention. Although this goal is more easily achievable for longer-term assessments, it is also important for ascertainment of adverse events, such as feeding intolerance and necrotising enterocolitis, when the threshold for investigation or diagnosis may be affected by knowledge of the intervention. We have identified one such planned trial (<LINK REF="STD-Mills-2015" TYPE="STUDY">Mills 2015</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">New research areas</HEADING>
<P>Most commercially available fortifiers contain varying amounts of protein, carbohydrate, calcium, phosphate, other minerals (zinc, manganese, magnesium and copper), vitamins and electrolytes. Investigators have not evaluated the benefits of many of these individual components in a controlled manner. In the future, researchers could compare different proprietary preparations to evaluate both short-term and long-term outcomes and adverse effects, while searching for the "optimal" composition of fortifiers. Investigators could also examine the effects of targeted or adjustable fortification to determine whether human milk-based fortifier provides any (cost-effective) advantages over cow's milk-based fortifier.</P>
</SUBSECTION>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-04-03 23:38:28 +0100" MODIFIED_BY="[Empty name]">
<P>We thank Dr. Carl Kuschel, the inception review lead author, and all primary investigators who provided additional information about trial methods and outcomes.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-05-19 17:46:01 +0100" MODIFIED_BY="[Empty name]">
<P>None. </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-04-24 12:16:49 +0100" MODIFIED_BY="[Empty name]">
<P>Jennifer Brown and William McGuire screened and appraised reports identified in the updated search, extracted and analysed data from included studies and drafted the review. Nick Embleton and Jane Harding arbitrated inclusion and data extraction disagreements and drafted the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-04-03 23:39:23 +0100" MODIFIED_BY="[Empty name]">
<P>We defined "multi-nutrient" fortifier as one that contains both protein and carbohydrate or fat (non-protein energy) with the option of including other nutrients, such as minerals, vitamins or electrolytes.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-04-24 12:21:15 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2016-04-04 01:42:16 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2016-04-04 01:42:16 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bhat-2003" MODIFIED="2016-04-04 01:16:51 +0100" MODIFIED_BY="[Empty name]" NAME="Bhat 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-04-04 01:16:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bhat BA, Gupta B</AU>
<TI>Effects of human milk fortification on morbidity factors in very low birth weight infants</TI>
<SO>Annals of Saudi Medicine</SO>
<YR>2001</YR>
<VL>21</VL>
<NO>5-6</NO>
<PG>292-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-20 16:52:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bhat BA, Gupta B</AU>
<TI>Effects of human milk fortification on morbidity factors in very low birth weight infants</TI>
<SO>Annals of Saudi Medicine</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>1-2</NO>
<PG>28-31</PG>
<IDENTIFIERS MODIFIED="2015-03-29 12:14:55 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="17146218"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Faerk-2000" MODIFIED="2016-04-04 01:17:25 +0100" MODIFIED_BY="[Empty name]" NAME="Faerk 2000" YEAR="">
<REFERENCE MODIFIED="2016-04-04 01:17:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faerk J, Peitersen B, Petersen S, Michaelsen KF</AU>
<TI>Bone mineralisation in preterm infants cannot be predicted from serum alkaline phosphatase or serum phosphate</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2002</YR>
<VL>87</VL>
<PG>F133-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-20 15:37:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faerk J, Petersen S, Peitersen B, Michaelsen KF</AU>
<TI>Diet and bone mineral content at term in premature infants</TI>
<SO>Pediatric Research</SO>
<YR>2000</YR>
<VL>47</VL>
<NO>1</NO>
<PG>148-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-20 15:38:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faerk J, Petersen S, Peitersen B, Michaelsen KF</AU>
<TI>Diet, growth, and bone mineralisation in premature infants</TI>
<SO>Advances in Experimental Medicine and Biology</SO>
<YR>2001</YR>
<VL>501</VL>
<PG>479-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gathwala-2012" MODIFIED="2015-04-20 15:33:05 +0100" MODIFIED_BY="[Empty name]" NAME="Gathwala 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-04-20 15:24:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gathwala G, Shaw CK, Shaw P, Batra R</AU>
<TI>Effect of fortification of breast milk on growth of preterm infants</TI>
<SO>Eastern Journal of Medicine</SO>
<YR>2012</YR>
<VL>17</VL>
<PG>30-5</PG>
<IDENTIFIERS MODIFIED="2015-03-29 12:09:18 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="17901665"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gross-1987-_x0028_1_x0029_" MODIFIED="2016-04-04 01:17:52 +0100" MODIFIED_BY="[Empty name]" NAME="Gross 1987 (1)" YEAR="1987">
<REFERENCE MODIFIED="2016-04-04 01:17:52 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Gross SJ. Bone mineralization in preterm infants fed human milk with and without mineral supplementation. J Pediatr 1987;111:450-458&lt;/p&gt;" NOTES_MODIFIED="2016-04-04 01:17:52 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gross SJ</AU>
<TI>Bone mineralization in preterm infants fed human milk with and without mineral supplementation</TI>
<SO>The Journal of Pediatrics</SO>
<YR>1987</YR>
<VL>111</VL>
<PG>450-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gross-1987-_x0028_2_x0029_" MODIFIED="2016-04-04 01:18:04 +0100" MODIFIED_BY="[Empty name]" NAME="Gross 1987 (2)" YEAR="1987">
<REFERENCE MODIFIED="2016-04-04 01:18:04 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Gross SJ. Bone mineralization in preterm infants fed human milk with and without mineral supplementation. J Pediatr 1987;111:450-458&lt;/p&gt;" NOTES_MODIFIED="2016-04-04 01:18:04 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gross SJ</AU>
<TI>Bone mineralization in preterm infants fed human milk with and without mineral supplementation</TI>
<SO>The Journal of Pediatrics</SO>
<YR>1987</YR>
<VL>111</VL>
<PG>450-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lucas-1996" MODIFIED="2016-04-04 01:18:46 +0100" MODIFIED_BY="[Empty name]" NAME="Lucas 1996" YEAR="1996">
<REFERENCE MODIFIED="2016-04-04 01:18:46 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Lucas A, Fewtrell MS, Morley R, Lucas PJ, Baker BA, Lister G, Bishop NJ. Randomized outcome trial of human milk fortification and developmental outcome in preterm infants. Am J Clin Nutr 1996;64:142-151&lt;/p&gt;" NOTES_MODIFIED="2016-04-04 01:18:46 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lucas A, Fewtrell MS, Morley R, Lucas PJ, Baker BA, Lister G, et al</AU>
<TI>Randomized outcome trial of human milk fortification and developmental outcome in preterm infants</TI>
<SO>American Journa of Clinical Nutrition</SO>
<YR>1996</YR>
<VL>64</VL>
<PG>142-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Modanlou-1986" MODIFIED="2016-04-04 01:19:01 +0100" MODIFIED_BY="[Empty name]" NAME="Modanlou 1986" YEAR="1986">
<REFERENCE MODIFIED="2016-04-04 01:19:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Modanlou HD, Lim MO, Hansen JW, Sickles V</AU>
<TI>Growth, biochemical status, and mineral metabolism in very-low-birth-weight infants receiving fortified preterm human milk</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>1986</YR>
<VL>5</VL>
<PG>762-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mukhopadhyay-2007" MODIFIED="2015-03-29 12:09:30 +0100" MODIFIED_BY="[Empty name]" NAME="Mukhopadhyay 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-03-29 12:09:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mukhopadhyay K, Narnag A, Mahajan R</AU>
<TI>Effect of human milk fortification in appropriate for gestation and small for gestation preterm babies: a randomized controlled trial</TI>
<SO>Indian Pediatrics</SO>
<YR>2007</YR>
<VL>44</VL>
<NO>4</NO>
<PG>286-90</PG>
<IDENTIFIERS MODIFIED="2015-03-29 12:09:18 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="17468524"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nicholl-1999" MODIFIED="2016-04-04 01:19:40 +0100" MODIFIED_BY="[Empty name]" NAME="Nicholl 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-04-04 01:19:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nicholl RM, Gamsu HR</AU>
<TI>Changes in growth and metabolism in very low birthweight infants fed with fortified breast milk</TI>
<SO>Acta Paediatrica</SO>
<YR>1999</YR>
<VL>88</VL>
<PG>1056-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pettifor-1989" MODIFIED="2016-04-04 01:20:08 +0100" MODIFIED_BY="[Empty name]" NAME="Pettifor 1989" YEAR="1989">
<REFERENCE MODIFIED="2016-04-04 01:20:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pettifor JM, Rajah R, Venter A, Moodley GP, Opperman L, Cavaleros M, et al</AU>
<TI>Bone mineralisation and mineral homeostasis in very low-birth-weight infants fed either human milk or fortified human milk</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>1989</YR>
<VL>8</VL>
<PG>217-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Polberger-1989" MODIFIED="2016-04-04 01:20:24 +0100" MODIFIED_BY="[Empty name]" NAME="Polberger 1989" YEAR="1989">
<REFERENCE MODIFIED="2016-04-04 01:20:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Polberger SKT, Axelsson IA, Raeihae NCE</AU>
<TI>Growth of very low birth weight infants on varying amounts of human milk protein</TI>
<SO>Pediatric Research</SO>
<YR>1989</YR>
<VL>25</VL>
<NO>4</NO>
<PG>414-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Porcelli-1992" MODIFIED="2016-04-04 01:42:16 +0100" MODIFIED_BY="[Empty name]" NAME="Porcelli 1992" YEAR="1992">
<REFERENCE MODIFIED="2016-04-04 01:42:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Porcelli F, Trifiro G, Taccone F</AU>
<TI>Bone mineralization, hair mineral content, and biochemical parameters in preterm infants fed human milk, fortified human milk or formula</TI>
<SO>International Journal of Feto-Maternal Medicine</SO>
<YR>1992</YR>
<VL>5</VL>
<NO>2</NO>
<PG>82-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Wauben-1998" MODIFIED="2016-04-04 01:21:30 +0100" MODIFIED_BY="[Empty name]" NAME="Wauben 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-04-04 01:21:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wauben I, Gibson R, Atkinson S</AU>
<TI>Premature infants fed mothers' milk to 6 months corrected age demonstrate adequate growth and zinc status in the first year</TI>
<SO>Early Human Development</SO>
<YR>1999</YR>
<VL>54</VL>
<NO>2</NO>
<PG>181-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-21 17:02:43 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Wauben IP, Atkinson SA, Grad TL, Shah JK, Paes B. Moderate nutrient supplementation of mother's milk for preterm infants supports adequate bone mass and short-term growth: a randomized, controlled trial. Am J Clin Nutr 1998;67:465-472&lt;/p&gt;" NOTES_MODIFIED="2016-03-21 17:02:43 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wauben IP, Atkinson SA, Grad TL, Shah JK, Paes B</AU>
<TI>Moderate nutrient supplementation of mother's milk for preterm infants supports adequate bone mass and short-term growth: a randomized, controlled trial</TI>
<SO>The American Journal of Clinical Nutrition</SO>
<YR>1998</YR>
<VL>67</VL>
<PG>465-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-04-04 01:21:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wauben IPM, Atkinson SA, Shah JK, Paes B</AU>
<TI>Growth and body composition of preterm infants: influence of nutrient fortification of mother's milk in hospital and breastfeeding post-hospital discharge</TI>
<SO>Acta Paediatrica</SO>
<YR>1998</YR>
<VL>87</VL>
<NO>7</NO>
<PG>780-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zuckerman-1994" MODIFIED="2016-03-21 17:03:22 +0000" MODIFIED_BY="[Empty name]" NAME="Zuckerman 1994" YEAR="1994">
<REFERENCE MODIFIED="2016-03-21 17:03:22 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Outcomes taken for ALP at assumed study end&lt;/p&gt;" NOTES_MODIFIED="2016-03-21 17:03:22 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zuckerman M, Pettifor JM</AU>
<TI>Rickets in very-low-birth-weight infants born at Baragwanath Hospital</TI>
<SO>South African Medical Journal</SO>
<YR>1994</YR>
<VL>84</VL>
<PG>216-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2016-04-04 01:24:41 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abrams-2014" MODIFIED="2016-04-04 01:22:14 +0100" MODIFIED_BY="[Empty name]" NAME="Abrams 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-04-04 01:22:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abrams SA, Schanler RJ, Lee ML, Rechtman DJ, Prolcats Study Group</AU>
<TI>Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products</TI>
<SO>Breastfeeding Medicine</SO>
<YR>2014</YR>
<VL>9</VL>
<NO>6</NO>
<PG>281-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arslanoglu-2009" MODIFIED="2016-04-04 01:22:30 +0100" MODIFIED_BY="[Empty name]" NAME="Arslanoglu 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-04-04 01:22:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arslanoglu S, Moro GE, Ziegler EE</AU>
<TI>Preterm infants fed fortified human milk receive less protein than they need</TI>
<SO>Journal of Perinatology</SO>
<YR>2009</YR>
<VL>29</VL>
<PG>489-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carey-1987" MODIFIED="2016-04-04 01:22:49 +0100" MODIFIED_BY="[Empty name]" NAME="Carey 1987" YEAR="1987">
<REFERENCE MODIFIED="2016-04-04 01:22:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carey De, Rowe JC, Goetz CA, Horak E, Clark RM, Goldberg B</AU>
<TI>Growth and phosphorus metabolism in premature infants fed human milk, fortified human milk, or special preterm formula</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1987</YR>
<VL>141</VL>
<PG>511-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Greer-1988" MODIFIED="2016-04-04 01:23:06 +0100" MODIFIED_BY="[Empty name]" NAME="Greer 1988" YEAR="1988">
<REFERENCE MODIFIED="2016-04-04 01:23:06 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Greer FR, McCormick A. Improved bone mineralization and growth in premature infants fed fortified own mother's milk. J Pediatr 1988;112:961-969&lt;/p&gt;" NOTES_MODIFIED="2016-04-04 01:23:06 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Greer FR, McCormick A</AU>
<TI>Improved bone mineralization and growth in premature infants fed fortified own mother's milk</TI>
<SO>The Journal of Pediatrics</SO>
<YR>1988</YR>
<VL>112</VL>
<PG>961-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hair-2014" MODIFIED="2016-04-04 01:23:31 +0100" MODIFIED_BY="[Empty name]" NAME="Hair 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-04-04 01:23:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hair AB, Blanco CL, Moreira AG, Hawthorne KM, Lee ML, Rechtman DJ, et al</AU>
<TI>Randomized trial of human milk cream as a supplement to standard fortification of an exclusive human milk-based diet in infants 750-1250g birth weight</TI>
<SO>The Journal of Pediatrics</SO>
<YR>2014</YR>
<VL>165</VL>
<PG>915-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Kashyap-1990" MODIFIED="2016-04-04 01:23:57 +0100" MODIFIED_BY="[Empty name]" NAME="Kashyap 1990" YEAR="1990">
<REFERENCE MODIFIED="2016-03-21 17:04:07 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Kashyap S, Schulze KF, Forsyth M, Dell RB, Ramakrishnan R, Heird WC. Growth, nutrient retention, and metabolic response of low-birth-weight infants fed supplemented and unsupplemented preterm human milk. Am J Clin Nutr 1990;52:254-262&lt;/p&gt;" NOTES_MODIFIED="2016-03-21 17:04:07 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kashyap S, Schulze KF, Forsyth M, Dell RB, Ramakrishnan R, Heird WC</AU>
<TI>Growth, nutrient retention, and metabolic response of low-birth-weight infants fed supplemented and unsupplemented preterm human milk</TI>
<SO>The American Journal of Clinical Nutrition</SO>
<YR>1990</YR>
<VL>52</VL>
<PG>254-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-04-04 01:23:57 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Kashyap S, Schulze KF, Ramakrishnan R, Dell RB, Forsyth M, Zucker C, Heird WC. Growth, nutrient retention and metabolic response of low birth weight (LBW) infants fed human milk (HM). Pediatr Res 1988;23:486A&lt;/p&gt;" NOTES_MODIFIED="2016-04-04 01:23:57 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kashyap S, Schulze KF, Ramakrishnan R, Dell RB, Forsyth M, Zucker C, et al</AU>
<TI>Growth, nutrient retention and metabolic response of low birth weight (LBW) infants fed human milk (HM)</TI>
<SO>Pediatric Research</SO>
<YR>1988</YR>
<VL>23</VL>
<PG>486A</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reali-2010" MODIFIED="2016-04-04 01:24:22 +0100" MODIFIED_BY="[Empty name]" NAME="Reali 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-04-04 01:24:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reali A, Greco F, Fanaro S, Atzei A, Puddu M, Moi M, et al</AU>
<TI>Fortification of maternal milk for very low birth weight (VLBW) pre-term neonates</TI>
<SO>Early Human Development</SO>
<YR>2010</YR>
<VL>86</VL>
<PG>S33-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tarcan-2004" MODIFIED="2016-04-04 01:24:41 +0100" MODIFIED_BY="[Empty name]" NAME="Tarcan 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-04-04 01:24:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tarcan A, Gueraka B, Tiker F, Oezbek N</AU>
<TI>Influence of feeding formula and breast milk fortifier on lymphocyte subsets in very low birth weight premature newborns</TI>
<SO>Biology of the Neonate</SO>
<YR>2004</YR>
<VL>86</VL>
<PG>22-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES MODIFIED="2015-05-14 15:00:34 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Mills-2015" MODIFIED="2015-05-14 15:00:34 +0100" MODIFIED_BY="[Empty name]" NAME="Mills 2015" YEAR="2015">
<REFERENCE MODIFIED="2015-05-14 14:59:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Mills L, Modi N</AU>
<TI>Clinician enteral feeding preferences for very preterm babies in the UK</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2015</YR>
<VL>[Epub ahead of print]</VL>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="25956669"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-04-24 12:21:15 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2016-04-24 12:21:15 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-AAP-2004" MODIFIED="2016-03-21 17:38:01 +0000" MODIFIED_BY="[Empty name]" NAME="AAP 2004" TYPE="BOOK_SECTION">
<AU>American Academy of Pediatrics Committee on Nutrition</AU>
<TI>Nutritional needs of preterm infants</TI>
<SO>Pediatric Nutrition Handbook</SO>
<YR>2004</YR>
<PG>23&#8211;54</PG>
<ED>Kleinman RE</ED>
<PB>American Academy of Pediatrics</PB>
<CY>Elk Grove Village, IL</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Agostoni-2010" MODIFIED="2015-04-17 17:15:16 +0100" MODIFIED_BY="[Empty name]" NAME="Agostoni 2010" TYPE="JOURNAL_ARTICLE">
<AU>Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, et al</AU>
<TI>Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>2010</YR>
<VL>50</VL>
<NO>1</NO>
<PG>85-91</PG>
<IDENTIFIERS MODIFIED="2015-04-17 17:01:21 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="19881390"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Arslanoglu-2010" MODIFIED="2016-04-04 01:33:08 +0100" MODIFIED_BY="[Empty name]" NAME="Arslanoglu 2010" TYPE="JOURNAL_ARTICLE">
<AU>Arslanoglu S, Moro GE, Ziegler EE, The WAPM Working Group on Nutrition</AU>
<TI>Optimization of human milk fortification for preterm infants: new concepts and recommendations</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>2010</YR>
<VL>38</VL>
<NO>3</NO>
<PG>233-8</PG>
<IDENTIFIERS MODIFIED="2015-04-17 17:13:44 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="20184400"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Arslanoglu-2013" MODIFIED="2016-03-21 16:57:20 +0000" MODIFIED_BY="[Empty name]" NAME="Arslanoglu 2013" TYPE="JOURNAL_ARTICLE">
<AU>Arslanoglu S, Corpeleijn W, Moro G, Braegger C, Campoy C, Colomb V, et al</AU>
<TI>Donor human milk for preterm infants: current evidence and research directions</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>2013</YR>
<VL>57</VL>
<NO>4</NO>
<PG>535-42</PG>
<IDENTIFIERS MODIFIED="2015-04-17 17:01:21 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="24084373"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Brandt-2003" MODIFIED="2015-04-19 15:48:30 +0100" MODIFIED_BY="[Empty name]" NAME="Brandt 2003" TYPE="JOURNAL_ARTICLE">
<AU>Brandt I, Sticker EJ, Lentze MJ</AU>
<TI>Catch-up growth of head circumference of very low birth weight, small for gestational age preterm infants and mental development to adulthood</TI>
<SO>The Journal of Pediatrics</SO>
<YR>2003</YR>
<VL>142</VL>
<NO>5</NO>
<PG>463-8</PG>
<IDENTIFIERS MODIFIED="2015-04-19 15:47:53 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="12756374"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chawla-2008" MODIFIED="2016-03-21 17:46:41 +0000" MODIFIED_BY="[Empty name]" NAME="Chawla 2008" TYPE="JOURNAL_ARTICLE">
<AU>Chawla D, Agarwal R, Deorari AK, Paul VK</AU>
<TI>Fluid and electrolyte management in term and preterm neonates</TI>
<SO>Indian Journal of Pediatrics</SO>
<YR>2008</YR>
<VL>75</VL>
<NO>3</NO>
<PG>255-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="18376094"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Clark-2003" MODIFIED="2015-04-19 15:21:12 +0100" MODIFIED_BY="[Empty name]" NAME="Clark 2003" TYPE="JOURNAL_ARTICLE">
<AU>Clark RH, Thomas P, Peabody J</AU>
<TI>Extrauterine growth restriction remains a serious problem in prematurely born neonates</TI>
<SO>Pediatrics</SO>
<YR>2003</YR>
<VL>111</VL>
<NO>5</NO>
<PG>986-90</PG>
<IDENTIFIERS MODIFIED="2015-04-19 15:21:03 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="12728076"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cooke-2004" MODIFIED="2015-04-19 15:11:43 +0100" MODIFIED_BY="[Empty name]" NAME="Cooke 2004" TYPE="JOURNAL_ARTICLE">
<AU>Cooke RJ, Ainsworth SB, Fenton AC</AU>
<TI>Postnatal growth retardation: a universal problem in preterm infants</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2004</YR>
<VL>89</VL>
<NO>5</NO>
<PG>F428-30</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="15321963"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cormack-2013" MODIFIED="2015-05-12 17:02:34 +0100" MODIFIED_BY="[Empty name]" NAME="Cormack 2013" TYPE="JOURNAL_ARTICLE">
<AU>Cormack B, Sinn J, Lui K, Tudehope D</AU>
<TI>Australasian neonatal intensive care enteral nutrition survey: implications for practice</TI>
<SO>Journal of Paediatrics and Child Health</SO>
<YR>2013</YR>
<VL>49</VL>
<NO>4</NO>
<PG>E340-7</PG>
<IDENTIFIERS MODIFIED="2015-05-12 17:01:40 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="23227901"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-de-Halleux-2013" MODIFIED="2015-04-17 17:11:56 +0100" MODIFIED_BY="[Empty name]" NAME="de Halleux 2013" TYPE="JOURNAL_ARTICLE">
<AU>de Halleux V, Rigo J</AU>
<TI>Variability in human milk composition: benefit of individualized fortification in very-low-birth-weight infants</TI>
<SO>The American Journal of Clinical Nutrition</SO>
<YR>2013</YR>
<VL>98</VL>
<NO>2</NO>
<PG>529S-35S</PG>
<IDENTIFIERS MODIFIED="2015-04-17 17:11:41 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="23824725"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dusick-2003" MODIFIED="2015-04-19 15:15:49 +0100" MODIFIED_BY="[Empty name]" NAME="Dusick 2003" TYPE="JOURNAL_ARTICLE">
<AU>Dusick AM, Poindexter BB, Ehrenkranz RA, Lemons JA</AU>
<TI>Growth failure in the preterm infant: can we catch up?</TI>
<SO>Seminars in Perinatology</SO>
<YR>2003</YR>
<VL>27</VL>
<NO>4</NO>
<PG>302-10</PG>
<IDENTIFIERS MODIFIED="2015-04-19 15:15:39 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="14510321"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dutta-2015" MODIFIED="2015-04-17 17:43:10 +0100" MODIFIED_BY="[Empty name]" NAME="Dutta 2015" TYPE="JOURNAL_ARTICLE">
<AU>Dutta S, Singh B, Chessell L, Wilson J, Janes M, McDonald K, et al</AU>
<TI>Guidelines for feeding very low birth weight infants</TI>
<SO>Nutrients</SO>
<YR>2015</YR>
<VL>7</VL>
<NO>1</NO>
<PG>423-42</PG>
<IDENTIFIERS MODIFIED="2015-04-17 17:43:09 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="25580815"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ehrenkranz-1999" MODIFIED="2015-04-19 15:10:14 +0100" MODIFIED_BY="[Empty name]" NAME="Ehrenkranz 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ehrenkranz RA, Younes N, Lemons JA, Fanaroff AA, Donovan EF, Wright LL, et al</AU>
<TI>Longitudinal growth of hospitalized very low birth weight infants</TI>
<SO>Pediatrics</SO>
<YR>1999</YR>
<VL>104</VL>
<NO>2 Pt 1</NO>
<PG>280-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="10429008"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Embleton-2001" MODIFIED="2015-04-19 15:10:14 +0100" MODIFIED_BY="[Empty name]" NAME="Embleton 2001" TYPE="JOURNAL_ARTICLE">
<AU>Embleton NE, Pang N, Cooke RJ</AU>
<TI>Postnatal malnutrition and growth retardation: an inevitable consequence of current recommendations in preterm infants?</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<NO>2</NO>
<PG>270-3</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="11158457"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Embleton-2007" MODIFIED="2015-04-19 16:23:42 +0100" MODIFIED_BY="[Empty name]" NAME="Embleton 2007" TYPE="JOURNAL_ARTICLE">
<AU>Embleton ND</AU>
<TI>Optimal protein and energy intakes in preterm infants</TI>
<SO>Early Human Development</SO>
<YR>2007</YR>
<VL>83</VL>
<NO>12</NO>
<PG>831-7</PG>
<IDENTIFIERS MODIFIED="2015-04-19 16:23:24 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="17980784"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Embleton-2013" MODIFIED="2016-03-21 16:57:56 +0000" MODIFIED_BY="[Empty name]" NAME="Embleton 2013" TYPE="JOURNAL_ARTICLE">
<AU>Embleton ND</AU>
<TI>Early nutrition and later outcomes in preterm infants</TI>
<SO>World Review of Nutrition and Dietetics</SO>
<YR>2013</YR>
<VL>106</VL>
<PG>26-32</PG>
<IDENTIFIERS MODIFIED="2015-04-19 15:59:16 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="23428677"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Euser-2005" MODIFIED="2016-03-21 16:58:07 +0000" MODIFIED_BY="[Empty name]" NAME="Euser 2005" TYPE="JOURNAL_ARTICLE">
<AU>Euser AM, Finken MJ, Keijzer-Veen MG, Hille ET, Wit JM, Dekker FW</AU>
<TI>Associations between prenatal and infancy weight gain and BMI, fat mass, and fat distribution in young adulthood: a prospective cohort study in males and females born very preterm</TI>
<SO>The American Journal of Clinical Nutrition</SO>
<YR>2005</YR>
<VL>81</VL>
<NO>2</NO>
<PG>480-7</PG>
<IDENTIFIERS MODIFIED="2015-04-19 16:41:10 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="15699238"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Euser-2008" MODIFIED="2015-04-19 15:16:42 +0100" MODIFIED_BY="[Empty name]" NAME="Euser 2008" TYPE="JOURNAL_ARTICLE">
<AU>Euser AM, de Wit CC, Finken MJ, Rijken M, Wit JM</AU>
<TI>Growth of preterm born children</TI>
<SO>Hormone Research</SO>
<YR>2008</YR>
<VL>70</VL>
<NO>6</NO>
<PG>319-28</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="18953169"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ewer-1996" MODIFIED="2015-04-19 16:36:41 +0100" MODIFIED_BY="[Empty name]" NAME="Ewer 1996" TYPE="JOURNAL_ARTICLE">
<AU>Ewer AK, Yu VY</AU>
<TI>Gastric emptying in pre-term infants: the effect of breast milk fortifier</TI>
<SO>Acta Paediatrica</SO>
<YR>1996</YR>
<VL>85</VL>
<NO>9</NO>
<PG>1112-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="8888928"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fenton-2014" MODIFIED="2015-05-19 16:25:08 +0100" MODIFIED_BY="[Empty name]" NAME="Fenton 2014" TYPE="JOURNAL_ARTICLE">
<AU>Fenton TR, Premji SS, Al-Wassia H, Sauve RS</AU>
<TI>Higher versus lower protein intake in formula-fed low birth weight infants</TI>
<SO>The Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<VL>4</VL>
<PG>CD003959</PG>
<IDENTIFIERS MODIFIED="2015-05-19 16:24:52 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="24752987"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fewtrell-2011" MODIFIED="2015-04-19 15:52:51 +0100" MODIFIED_BY="[Empty name]" NAME="Fewtrell 2011" TYPE="JOURNAL_ARTICLE">
<AU>Fewtrell M</AU>
<TI>Early nutritional predictors of long-term bone health in preterm infants</TI>
<SO>Current Opinion in Clinical Nutrition and Metabolic Care</SO>
<YR>2011</YR>
<VL>14</VL>
<NO>3</NO>
<PG>297-301</PG>
<IDENTIFIERS MODIFIED="2015-04-19 15:52:27 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="21378555"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Flikweert-2003" MODIFIED="2016-03-21 16:58:24 +0000" MODIFIED_BY="[Empty name]" NAME="Flikweert 2003" TYPE="JOURNAL_ARTICLE">
<AU>Flikweert ER, La Hei ER, De Rijke YB, Van de Ven K</AU>
<TI>Return of the milk curd syndrome</TI>
<SO>Pediatric Surgery International</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>9-10</NO>
<PG>628-31</PG>
<IDENTIFIERS MODIFIED="2015-05-14 14:15:43 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="14600769"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gathwala-2008" MODIFIED="2016-03-21 16:58:37 +0000" MODIFIED_BY="[Empty name]" NAME="Gathwala 2008" TYPE="JOURNAL_ARTICLE">
<AU>Gathwala G, Shaw C, Shaw P, Yadav S, Sen J</AU>
<TI>Human milk fortification and gastric emptying in the preterm neonate</TI>
<SO>International Journal of Clinical Practice</SO>
<YR>2008</YR>
<VL>62</VL>
<NO>7</NO>
<PG>1039-43</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="18422595"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-GRADEpro-2008" MODIFIED="2016-03-10 10:44:08 +0000" MODIFIED_BY="[Empty name]" NAME="GRADEpro 2008" TYPE="COMPUTER_PROGRAM">
<AU>Brozek J, Oxman A, Schünemann H</AU>
<TI>GRADEpro [Version 3.2 for Windows]</TI>
<YR>2008</YR>
<PB>The GRADE Working Group</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gregory-2012" MODIFIED="2015-05-12 17:02:16 +0100" MODIFIED_BY="[Empty name]" NAME="Gregory 2012" TYPE="JOURNAL_ARTICLE">
<AU>Gregory KE, Connolly TC</AU>
<TI>Enteral feeding practices in the NICU: results from a 2009 Neonatal Enteral Feeding Survey</TI>
<SO>Advances in Neonatal Care</SO>
<YR>2012</YR>
<VL>12</VL>
<NO>1</NO>
<PG>46-55</PG>
<IDENTIFIERS MODIFIED="2015-05-12 17:01:40 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="22301544"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gross-1993" MODIFIED="2015-04-19 16:16:48 +0100" MODIFIED_BY="[Empty name]" NAME="Gross 1993" TYPE="JOURNAL_ARTICLE">
<AU>Gross SJ, Slagle TA</AU>
<TI>Feeding the low birth weight infant</TI>
<SO>Clinics in Perinatology</SO>
<YR>1993</YR>
<VL>20</VL>
<NO>1</NO>
<PG>193-209</PG>
<IDENTIFIERS MODIFIED="2015-04-19 16:16:33 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8458165"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011a" MODIFIED="2016-04-04 01:36:01 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011a" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al</AU>
<TI>GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>4</NO>
<PG>383-94</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="21195583"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011b" MODIFIED="2016-04-04 01:36:14 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011b" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al</AU>
<TI>GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>4</NO>
<PG>407-15</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="21247734"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011c" MODIFIED="2016-04-04 01:36:34 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011c" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al</AU>
<TI>GRADE guidelines 6. Rating the quality of evidence - imprecision</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>12</NO>
<PG>1283-93</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="21839614"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011d" MODIFIED="2016-04-04 01:36:58 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011d" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al</AU>
<TI>GRADE guidelines: 7. Rating the quality of evidence - inconsistency</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>12</NO>
<PG>1294-302</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="21803546"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011e" MODIFIED="2016-04-04 01:37:12 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011e" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al</AU>
<TI>GRADE guidelines: 8. Rating the quality of evidence - indirectness</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>12</NO>
<PG>1303-10</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="21802903"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-04-04 01:37:26 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Imdad-2013" MODIFIED="2014-09-17 15:04:47 +0100" MODIFIED_BY="[Empty name]" NAME="Imdad 2013" TYPE="JOURNAL_ARTICLE">
<AU>Imdad A, Bhutta ZA</AU>
<TI>Nutritional management of the low birth weight/preterm infant in community settings: a perspective from the developing world</TI>
<SO>The Journal of Pediatrics</SO>
<YR>March 2013</YR>
<VL>162</VL>
<NO>3</NO>
<PG>s107-114</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnston-2012" MODIFIED="2015-04-17 16:57:19 +0100" MODIFIED_BY="[Empty name]" NAME="Johnston 2012" TYPE="JOURNAL_ARTICLE">
<AU>Johnston M, Landers S, Noble L, Szucs K, Viehmann L</AU>
<TI>Breastfeeding and the use of human milk</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>129</VL>
<NO>3</NO>
<PG>e827-41</PG>
<IDENTIFIERS MODIFIED="2015-04-17 16:56:39 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="22371471"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kashyap-1994" MODIFIED="2015-05-19 16:02:37 +0100" MODIFIED_BY="[Empty name]" NAME="Kashyap 1994" TYPE="JOURNAL_ARTICLE">
<AU>Kashyap S, Schulze KF, Ramakrishnan R, Dell RB, Heird WC</AU>
<TI>Evaluation of a mathematical model for predicting the relationship between protein and energy intakes of low-birth-weight infants and the rate and composition of weight gain</TI>
<SO>Pediatric Research</SO>
<YR>1994</YR>
<VL>35</VL>
<NO>6</NO>
<PG>704-12</PG>
<IDENTIFIERS MODIFIED="2015-05-19 16:02:22 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="7936823"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kler-2015" MODIFIED="2016-04-04 01:38:06 +0100" MODIFIED_BY="[Empty name]" NAME="Kler 2015" TYPE="JOURNAL_ARTICLE">
<AU>Kler N, Thakur A, Modi M, Kaur A, Garg P, Soni A, et al</AU>
<TI>Human milk fortification in India</TI>
<SO>Nestle Nutrition Institute Workshop Series</SO>
<YR>2015</YR>
<VL>81</VL>
<PG>145-51</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="26111571"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Klingenberg-2012" MODIFIED="2015-05-20 15:37:08 +0100" MODIFIED_BY="[Empty name]" NAME="Klingenberg 2012" TYPE="JOURNAL_ARTICLE">
<AU>Klingenberg C, Embleton ND, Jacobs SE, O'Connell LA, Kuschel CA</AU>
<TI>Enteral feeding practices in very preterm infants: an international survey</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2012</YR>
<VL>97</VL>
<NO>1</NO>
<PG>F56-61</PG>
<IDENTIFIERS MODIFIED="2015-04-19 16:23:24 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="21856644"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lapillonne-2013" MODIFIED="2016-04-04 01:38:35 +0100" MODIFIED_BY="[Empty name]" NAME="Lapillonne 2013" TYPE="JOURNAL_ARTICLE">
<AU>Lapillonne A, Griffin IJ</AU>
<TI>Feeding preterm infants today for later metabolic and cardiovascular outcomes</TI>
<SO>The Journal of Pediatrics</SO>
<YR>2013</YR>
<VL>162</VL>
<NO>3 Suppl</NO>
<PG>S7-16</PG>
<IDENTIFIERS MODIFIED="2015-04-19 15:59:16 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="23445851"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leppanen-2014" MODIFIED="2015-04-19 15:47:55 +0100" MODIFIED_BY="[Empty name]" NAME="Leppanen 2014" TYPE="JOURNAL_ARTICLE">
<AU>Leppanen M, Lapinleimu H, Lind A, Matomaki J, Lehtonen L, Haataja L, et al</AU>
<TI>Antenatal and postnatal growth and 5-year cognitive outcome in very preterm infants</TI>
<SO>Pediatrics</SO>
<YR>2014</YR>
<VL>133</VL>
<NO>1</NO>
<PG>63-70</PG>
<IDENTIFIERS MODIFIED="2015-04-19 15:47:53 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="24344103"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McClure-1996" MODIFIED="2015-04-19 16:36:41 +0100" MODIFIED_BY="[Empty name]" NAME="McClure 1996" TYPE="JOURNAL_ARTICLE">
<AU>McClure RJ, Newell SJ</AU>
<TI>Effect of fortifying breast milk on gastric emptying</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>1996</YR>
<VL>74</VL>
<NO>1</NO>
<PG>F60-2</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="8653439"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Morgan-2011" MODIFIED="2016-04-24 12:21:15 +0100" MODIFIED_BY="[Empty name]" NAME="Morgan 2011" TYPE="JOURNAL_ARTICLE">
<AU>Morgan JA, Young L, McGuire W</AU>
<TI>Pathogenesis and prevention of necrotizing enterocolitis</TI>
<SO>Current Opinion in Infectious Diseases</SO>
<YR>2011</YR>
<VL>24</VL>
<NO>3</NO>
<PG>183-9</PG>
<IDENTIFIERS MODIFIED="2016-04-24 12:20:51 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="21455063"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Moya-2012" MODIFIED="2015-05-11 14:30:34 +0100" MODIFIED_BY="[Empty name]" NAME="Moya 2012" TYPE="JOURNAL_ARTICLE">
<AU>Moya F, Sisk PM, Walsh KR, Berseth CL</AU>
<TI>A new liquid human milk fortifier and linear growth in preterm infants</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>130</VL>
<NO>4</NO>
<PG>e928-35</PG>
<IDENTIFIERS MODIFIED="2015-05-11 14:30:32 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="22987877"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rochow-2013" MODIFIED="2016-03-21 16:58:58 +0000" MODIFIED_BY="[Empty name]" NAME="Rochow 2013" TYPE="JOURNAL_ARTICLE">
<AU>Rochow N, Fusch G, Choi A, Chessell L, Elliott L, McDonald K, et al</AU>
<TI>Target fortification of breast milk with fat, protein, and carbohydrates for preterm infants</TI>
<SO>The Journal of Pediatrics</SO>
<YR>2013</YR>
<VL>163</VL>
<NO>4</NO>
<PG>1001-7</PG>
<IDENTIFIERS MODIFIED="2015-04-17 17:01:21 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="23769498"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rochow-2015" MODIFIED="2015-04-17 17:22:11 +0100" MODIFIED_BY="[Empty name]" NAME="Rochow 2015" TYPE="JOURNAL_ARTICLE">
<AU>Rochow N, Landau-Crangle E, Fusch C</AU>
<TI>Challenges in breast milk fortification for preterm infants</TI>
<SO>Current Opinion in Clinical Nutrition and Metabolic Care</SO>
<YR>2015</YR>
<VL>18</VL>
<NO>3</NO>
<PG>276-84</PG>
<IDENTIFIERS MODIFIED="2015-04-17 17:21:44 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="25807355"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2013" MODIFIED="2016-04-04 01:39:48 +0100" MODIFIED_BY="[Empty name]" NAME="Schünemann 2013" TYPE="OTHER">
<AU>Schünemann H, Bro&#380;ek J, Guyatt G, Oxman A, editors; GWG</AU>
<TI>GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations</TI>
<SO>www.guidelinedevelopment.org/handbook.</SO>
<YR>Updated October 2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Singhal-2007" MODIFIED="2016-04-04 01:40:00 +0100" MODIFIED_BY="[Empty name]" NAME="Singhal 2007" TYPE="JOURNAL_ARTICLE">
<AU>Singhal A, Cole TJ, Fewtrell M, Kennedy K, Stephenson T, Elias-Jones A, et al</AU>
<TI>Promotion of faster weight gain in infants born small for gestational age: is there an adverse effect on later blood pressure?</TI>
<SO>Circulation</SO>
<YR>2007</YR>
<VL>115</VL>
<NO>2</NO>
<PG>213-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stanger-2014" MODIFIED="2016-03-21 16:59:14 +0000" MODIFIED_BY="[Empty name]" NAME="Stanger 2014" TYPE="JOURNAL_ARTICLE">
<AU>Stanger J, Zwicker K, Albersheim S, Murphy JJ 3rd</AU>
<TI>Human milk fortifier: an occult cause of bowel obstruction in extremely premature neonates</TI>
<SO>Journal of Pediatric Surgery</SO>
<YR>2014</YR>
<VL>49</VL>
<NO>5</NO>
<PG>724-6</PG>
<IDENTIFIERS MODIFIED="2015-05-14 14:15:43 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="24851756"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Steward-2002" MODIFIED="2015-04-19 15:10:14 +0100" MODIFIED_BY="[Empty name]" NAME="Steward 2002" TYPE="JOURNAL_ARTICLE">
<AU>Steward DK, Pridham KF</AU>
<TI>Growth patterns of extremely low-birth-weight hospitalized preterm infants</TI>
<SO>Journal of Obstetric, Gynecologic, and Neonatal Nursing</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>1</NO>
<PG>57-65</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="11843020"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tinnion-2012" MODIFIED="2015-05-20 14:46:38 +0100" MODIFIED_BY="[Empty name]" NAME="Tinnion 2012" TYPE="JOURNAL_ARTICLE">
<AU>Tinnion RJ, Embleton ND</AU>
<TI>How to use... alkaline phosphatase in neonatology</TI>
<SO>Archives of Disease in Childhood. Education and Practice Edition</SO>
<YR>2012</YR>
<VL>97</VL>
<NO>4</NO>
<PG>157-63</PG>
<IDENTIFIERS MODIFIED="2015-05-20 14:46:15 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="22761487"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tudehope-2013" MODIFIED="2016-04-04 01:40:27 +0100" MODIFIED_BY="[Empty name]" NAME="Tudehope 2013" TYPE="JOURNAL_ARTICLE">
<AU>Tudehope DI</AU>
<TI>Human milk and the nutritional needs of preterm infants</TI>
<SO>The Journal of Pediatrics</SO>
<YR>2013</YR>
<VL>162</VL>
<PG>S17-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wagener-2009" MODIFIED="2016-03-21 16:59:34 +0000" MODIFIED_BY="[Empty name]" NAME="Wagener 2009" TYPE="JOURNAL_ARTICLE">
<AU>Wagener S, Cartwright D, Bourke C</AU>
<TI>Milk curd obstruction in premature infants receiving fortified expressed breast milk</TI>
<SO>Journal of Paediatrics and Child Health</SO>
<YR>2009</YR>
<VL>45</VL>
<NO>4</NO>
<PG>228-30</PG>
<IDENTIFIERS MODIFIED="2015-05-14 14:15:43 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="19426380"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Walsh-1986" MODIFIED="2016-03-21 17:31:42 +0000" MODIFIED_BY="[Empty name]" NAME="Walsh 1986" TYPE="JOURNAL_ARTICLE">
<AU>Walsh MC, Kliegman RM</AU>
<TI>Necrotizing enterocolitis: treatment based on staging criteria</TI>
<SO>Pediatric Clinics of North America</SO>
<YR>1986</YR>
<VL>33</VL>
<NO>1</NO>
<PG>179-201</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="3081865"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Yigit-2008" MODIFIED="2016-04-04 01:40:59 +0100" MODIFIED_BY="[Empty name]" NAME="Yigit 2008" TYPE="JOURNAL_ARTICLE">
<AU>Yigit S, Akgoz A, Memisoglu A, Akata D, Ziegler EE</AU>
<TI>Breast milk fortification: effect on gastric emptying</TI>
<SO>The Journal of Maternal-Fetal &amp; Neonatal Medicine</SO>
<YR>2008</YR>
<VL>21</VL>
<NO>11</NO>
<PG>843-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="18985557"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2015-06-08 15:55:33 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Kuschel-2004" MODIFIED="2015-06-08 15:55:33 +0100" MODIFIED_BY="[Empty name]" NAME="Kuschel 2004" TYPE="COCHRANE_REVIEW">
<AU>Kuschel CA, Harding JE</AU>
<TI>Multicomponent fortified human milk for promoting growth in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>1</NO>
<PG>CD000343</PG>
<IDENTIFIERS MODIFIED="2015-06-08 15:55:12 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-06-08 15:55:12 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000343"/>
<IDENTIFIER TYPE="PUBMED" VALUE="14973953"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kuschel-2009" MODIFIED="2015-06-08 15:53:34 +0100" MODIFIED_BY="[Empty name]" NAME="Kuschel 2009" TYPE="COCHRANE_REVIEW">
<AU>Kuschel CA, Harding JE</AU>
<TI>Multicomponent fortified human milk for promoting growth in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2015-06-08 15:53:34 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-06-08 15:53:34 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000343.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-04-04 00:41:22 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-04-04 00:32:45 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2016-04-03 23:44:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bhat-2003">
<CHAR_METHODS MODIFIED="2015-04-01 11:41:54 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-03 23:43:01 +0100" MODIFIED_BY="[Empty name]">
<P>100 VLBW infants</P>
<P>Excusion criterion: need for prolonged mechanical ventilation</P>
<P>Setting: Special Care Baby Unit, Khoula Hospital, Muscat, Oman</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-03 23:43:34 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 50): fortified human milk (4 g of powdered fortifier to achieve 81 kcal, 2.4 g protein, 9.0 g carbohydrates per 100 mL of milk)</P>
<P>Control (N = 50): human milk only</P>
<P>If amounts were insufficient, human milk was supplemented with formula up to a maximum of 15% of energy for 2 days. Babies who required supplementation beyond this were excluded from the study</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-03 23:43:46 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Weight gain</LI>
</UL>
<UL>
<LI>Markers of nutritional and bone mineral status</LI>
</UL>
<UL>
<LI>Adverse events including necrotising enterocolitis</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-04-03 23:44:02 +0100" MODIFIED_BY="[Empty name]">
<P>Human milk was enriched with a fortifier after babies reached a volume of 140 mL/kg/d by the enteral route</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-04 00:07:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Faerk-2000">
<CHAR_METHODS MODIFIED="2015-04-20 17:03:55 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-03 23:45:36 +0100" MODIFIED_BY="[Empty name]">
<P>103 very preterm infants</P>
<P>Excusion criterion: major congenital anomaly</P>
<P>Setting: NICUs, Rigshospitalet and Hvidovre Hospital, Copenhagen, Denmark</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-03 23:46:21 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 51): human milk (maternal or donor) supplemented with 0.4 g protein, 1.4 g carbohydrate, 35 mg calcium and 17 mg phosphorus per 100 mL (Milupa Eoprotin)</P>
<P>Control (N = 52): maternal or donor milk supplemented with 10 mg phosphate per 100 mL<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-03 23:47:00 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Weight, length and head circumference at term</LI>
</UL>
<UL>
<LI>Measures of bone mineralisation (DEXA scan)</LI>
</UL>
<UL>
<LI>Necrotising enterocolitis</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-04-04 00:07:55 +0100" MODIFIED_BY="[Empty name]">
<P>Target intake of 200 mL/kg/d<BR/>All infants received vitamin D 800 IU per day<BR/>Intervention ceased when breast-fed or at 36 weeks' postmenstrual age</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-03 23:51:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gathwala-2012">
<CHAR_METHODS MODIFIED="2015-04-16 08:31:04 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-03 23:49:39 +0100" MODIFIED_BY="[Empty name]">
<P>67 consecutive preterm infants of birth weight &lt; 1800 g</P>
<P>Eligibility criteria: healthy preterm infants, appropriate for gestational age, no birth asphyxia, enterally fed with breast milk by 14 days of life, no congenital malformations, no ventilatory support previous 7 days, no diuretic or steroid therapy</P>
<P>Setting: Neonatology Unit, Department of Paediatrics, Pt. B.D. Sharma PGIMS, Rohtak, India</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-03 23:50:35 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 34): breast milk fortified with Lactodex Human Milk Fortifier (to achieve 80 kcal, 9.4 g carbohydrate, 2.2 g protein per 100 mL, plus minerals and electrolytes)</P>
<P>Control (N = 33): unfortified breast milk</P>
<P>Infants were excluded from the study if they needed more than 25% of their daily requirements to be provided by formula or other milk</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-03 23:50:56 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Time to regain birth weight</LI>
</UL>
<UL>
<LI>Time to reach 2200 g</LI>
</UL>
<UL>
<LI>Duration of hospital stay</LI>
</UL>
<UL>
<LI>Biochemical markers of nutritional status (including serum ALP)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-04-03 23:51:03 +0100" MODIFIED_BY="[Empty name]">
<P>Incidence of feed intolerance or necrotising enterocolitis not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-03 23:53:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gross-1987-_x0028_1_x0029_">
<CHAR_METHODS MODIFIED="2016-04-03 23:52:07 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial (2-phase trial, referred to as <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK> and <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-03 23:52:36 +0100" MODIFIED_BY="[Empty name]">
<P>20 infants with birth weight &lt; 1600 g</P>
<P>Eligibility criteria: birth weight appropriate for gestational age, free from congenital anomaly or major disease, breathing room air, ability to begin enteral feeding within first week after birth<BR/>Setting: Duke University Medical Center, Durham, North Carolina, USA<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-03 23:53:09 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 10): human milk mixed with premature infant formula Similac Special Care (Ross Laboratories) containing 1.8 g protein per 100 mL, as well as carbohydrate</P>
<P>Control (N = 10): human milk with no supplementation</P>
<P>Feeding of human milk supplemented with formula commenced after 1 week of enteral feeds of unfortified human milk. All infants received intravenous dextrose and electrolytes until day 5 of feeding. All infants received supplemental vitamins with their milk from day 8 of feeding<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-03 23:53:42 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>In-hospital growth parameters</LI>
</UL>
<UL>
<LI>Growth at 44 weeks' postmenstrual age</LI>
</UL>
<UL>
<LI>Bone mineral content and biochemical indices of bone metabolism</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-04-15 15:27:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-03 23:57:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gross-1987-_x0028_2_x0029_">
<CHAR_METHODS MODIFIED="2016-04-03 23:55:09 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial (2-phase trial, referred to as <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1)</LINK> and <LINK REF="STD-Gross-1987-_x0028_2_x0029_" TYPE="STUDY">Gross 1987 (2)</LINK>)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-03 23:55:36 +0100" MODIFIED_BY="[Empty name]">
<P>30 infants with birth weight &lt; 1600 g</P>
<P>Eligibility criteria: birth weight appropriate for gestational age, free from congenital anomaly or major disease, breathing room air, ability to begin enteral feeding within first week after birth<BR/>Setting: Boston Perinatal Center, Boston, Massachusetts, USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-03 23:56:24 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention 1 (N = 11): human milk mixed with premature infant formula Similac Special Care (Ross Laboratories) containing 1.8 g protein per 100 mL, as well as carbohydrate (as above for <LINK REF="STD-Gross-1987-_x0028_1_x0029_" TYPE="STUDY">Gross 1987 (1))</LINK>
</P>
<P>Intervention 2 (N = 10): human milk mixed with powdered breast milk fortifier</P>
<P>Control (N = 9): human milk with no supplementation</P>
<P>Fortification with the powdered fortifier was introduced after 2 weeks of enteral feeds of unfortified human milk. All infants received intravenous dextrose and electrolytes until day 5 of feeding. All infants received supplemental vitamins with their milk from day 8 of feeding. For this review, participants from the 2 intervention groups were taken together as infants receiving fortification</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-03 23:57:05 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>In-hospital growth parameters</LI>
</UL>
<UL>
<LI>Growth at 44 weeks' postmenstrual age</LI>
</UL>
<UL>
<LI>Bone mineral content and biochemical indices of bone metabolism</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-04-03 23:57:50 +0100" MODIFIED_BY="[Empty name]">
<P>The full composition of powdered fortifier was not reported in the paper. Following our own Internet research, we deemed it appropriate for inclusion, as powdered fortifier appeared to include protein and energy, as required by our inclusion criteria</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-04 00:02:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lucas-1996">
<CHAR_METHODS MODIFIED="2016-04-03 23:59:55 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-04 00:00:10 +0100" MODIFIED_BY="[Empty name]">
<P>275 preterm infants with birth weight &lt; 1850 g<BR/>Eligibility criteria: no major congenital abnormalities, resident in UK, mother agreed to provide breast milk</P>
<P>Setting: 2 centres in Cambridge and Norwich, UK<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-04 00:01:25 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 137): maternal milk supplemented with (per 100 mL) 0.7 g protein (bovine), 2.73 g carbohydrate, 0.05 g fat, 90 mg calcium and 45 mg phosphate, as well as electrolytes (Enfamil, Mead Johnson)</P>
<P>Control (N = 138): maternal milk supplemented with 15 mg/100 mL phosphate<BR/>Enteral intake 180 mL/kg/d<BR/>Intervention ceased at discharge, or when weight reached 2000 g<BR/>All infants received vitamins (including vitamin D 260 IU/100 mL)<BR/>Infants whose mothers could not provide sufficient milk were supplemented with a preterm formula and were not excluded from the analysis<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-04 00:02:16 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>In-hospital growth rates</LI>
</UL>
<UL>
<LI>Growth to 9 and 18 months</LI>
</UL>
<UL>
<LI>Neurodevelopmental outcomes at 9 and 18 months</LI>
</UL>
<UL>
<LI>Serum indices of bone metabolism</LI>
</UL>
<UL>
<LI>Necrotising enterocolitis</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-04-20 14:42:15 +0100" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-04 00:04:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Modanlou-1986">
<CHAR_METHODS MODIFIED="2015-04-02 13:16:48 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-04 00:03:33 +0100" MODIFIED_BY="[Empty name]">
<P>39 infants of birth weight between 1000 and 1500 g</P>
<P>Eligibility criteria: birth weight appropriate for gestational age, no ventilatory assistance after 7 days, no supplemental oxygen after 10 days, fewer than 3 days of diuretic therapy, enteral feeding by 14 days after birth</P>
<P>Setting: Miller Children's Hospital of Long Beach, California, USA<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-04 00:04:35 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 20): mother's own milk plus fortifier (to provide supplemental 0.7 g protein, 2.7 g carbohydrate, "trace" fat, 60 mg calcium and 33 mg phosphate per 100 mL of breast milk)</P>
<P>Control (N = 19): mother's own milk</P>
<P>Formula and human milk were diluted initially and the fortifier added gradually to milk for infants in the intervention group to reach target calorific density over 7 days (approximately) in all groups. Milk was generally provided by intermittent bolus gavage until nipple feedings were tolerated. Infants received standard infant formula if their mother's milk was unavailable for "an occasional feeding" (up to a maximum of 10% of feedings per week)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-04 00:04:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Growth rates (weight, length, head circumference)</LI>
</UL>
<UL>
<LI>Feeding intolerance and necrotising enterocolitis</LI>
</UL>
<UL>
<LI>Biochemical status</LI>
</UL>
<UL>
<LI>Bone mineral content</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-04-04 00:04:58 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention ceased at discharge, or when weight reached 1800 g</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-04 00:08:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mukhopadhyay-2007">
<CHAR_METHODS MODIFIED="2015-04-16 08:40:20 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-04 00:06:30 +0100" MODIFIED_BY="[Empty name]">
<P>166 VLBW infants (and gestational age &lt; 35 weeks at birth)</P>
<P>Eligibility criteria: feed volume of 150 mL/kg/d, feeds consisting of at least 80% breast milk, no congenital malformations nor gastrointestinal abnormalities</P>
<P>Setting: PGIMER, Chandigarh, India</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-04 00:06:51 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 85): breast milk fortified with Lactodex Human Milk Fortifier (2 g sachet per 50 mL of milk: 0.2 g protein, 1.2 g carbohydrate, 6.5 kcal energy)</P>
<P>Control (N = 81): breast milk with added vitamins and minerals</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-04 00:07:26 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Growth rates (weight, length, head circumference)</LI>
</UL>
<UL>
<LI>Biochemical parameters</LI>
</UL>
<UL>
<LI>Length of hospital stay</LI>
</UL>
<UL>
<LI>Feeding intolerance and necrotising enterocolitis</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-04-04 00:08:14 +0100" MODIFIED_BY="[Empty name]">
<P>Fortification was stopped once babies reached a weight of 2000 g or were fully breast-fed</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-04 00:10:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nicholl-1999">
<CHAR_METHODS MODIFIED="2015-04-02 15:46:54 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-04 00:09:15 +0100" MODIFIED_BY="[Empty name]">
<P>23 VLBW infants receiving enteral feeds of at least 150 mL/kg/d<BR/>Eligibility criteria: no fluid restriction, no diuretics, no postnatal systemic steroid use, no significant congenital abnormality</P>
<P>Setting: neonatal intensive care unit, Kings College Hospital, London, UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-04 00:09:42 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 13): maternal (or pasteurised pooled donor milk) supplemented (per 100 mL) with 0.7 g protein, 2.0 g carbohydrate, 30 mg calcium, 40 mg phosphorus, trace minerals and vitamins</P>
<P>Control (N = 10): unsupplemented maternal or donor milk<BR/>Intervention ceased when infants no longer required nasogastric feeds</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-04 00:09:56 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>In-hospital growth parameters</LI>
</UL>
<UL>
<LI>Indices of bone metabolism</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-04-04 00:10:39 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention ceased when infants no longer required nasogastric feeds</P>
<P>One infant whose mother declined fortifier was included in results of non-fortified infants, and one baby whose mother preferred the addition of fortifier was included in results of the intervention group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-04 00:13:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pettifor-1989">
<CHAR_METHODS MODIFIED="2015-04-16 08:42:03 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-04 00:11:47 +0100" MODIFIED_BY="[Empty name]">
<P>100 consecutive infants weighing between 1000 and 1500 g at birth</P>
<P>Eligibility criteria: no major congenital abnormalities or metabolic disturbances, no requirement for ventilation at the point of entry into the study (day 4 after birth), free from serious infection, receiving at least 45 mL/kg/d of gavage feedings (expressed breast milk) at the beginning of the study</P>
<P>Setting: Baragwanath Hospital, Bertsham, South Africa<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-04 00:12:31 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 53): mother's own milk supplemented with (per 100 mL) 0.05 g protein, 1.1 g carbohydrate, 0.26 g fat, 72.3 mg calcium and 34 mg phosphate, along with electrolytes and vitamins (HMF, Ross Laboratories)</P>
<P>Control (N = 47): mother's own milk</P>
<P>Feeds were titrated as tolerated up to 200 mL/kg/d. Feeds were delivered by nasogastric tube until infants weighed 1600 g. At this point, bottle feeding was introduced gradually. Infants were removed from the study if their mother could not supply sufficient breast milk</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-04 00:12:59 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Weight gain</LI>
</UL>
<UL>
<LI>Serum calcium, phosphorus, alkaline phosphatase and albumin levels</LI>
</UL>
<UL>
<LI>Bone mineral homeostasis</LI>
</UL>
<UL>
<LI>Necrotising enterocolitis (data obtained from trial investigators)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-04-04 00:13:21 +0100" MODIFIED_BY="[Empty name]">
<P>41 infants left the study after randomisation for various reasons (insufficient maternal milk supply, death, reduced enteral intake for &gt; 72 hours, incomplete data). Data for these infants were not included in intention-to-treat analyses of growth outcomes</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-04 00:18:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Polberger-1989">
<CHAR_METHODS MODIFIED="2016-04-04 00:17:18 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-04 00:17:36 +0100" MODIFIED_BY="[Empty name]">
<P>34 VLBW infants</P>
<P>Eligibility criteria: birth weight appropriate for gestational age, tolerance of complete enteral feeding (170 mL/kg/d), no obvious disease or major malformations, no supplemental oxygen therapy</P>
<P>Setting: 2 neonatal units in Lund and Malmö, Sweden</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-04 00:18:26 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 7): maternal or donor milk supplemented with (per 100 mL) 1.0 g human milk protein and 1.0 g human milk fat</P>
<P>Control 1 (N = 7): maternal or donor milk with no fortification</P>
<P>Feeds of 170 mL/kg/d were given throughout the study. When mother's own milk was insufficient, mature human milk from a milk bank was used. All infants, regardless of group allocation, received enteral supplementation with vitamin E, folic acid, a multi-vitamin preparation and additional vitamin D. They also received one-off administration of calcium and phosphate, and from 4 weeks of age, elemental iron was given</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-04 00:18:33 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Growth parameters</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-04-04 00:18:47 +0100" MODIFIED_BY="[Empty name]">
<P>Six infants left the study after randomisation for various reasons (apnoea, intolerance to the fixed feed volume, need for intravenous therapy). These infants were not included in intention-to-treat analyses</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-04 00:20:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Porcelli-1992">
<CHAR_METHODS MODIFIED="2016-04-04 00:19:55 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-04 00:20:07 +0100" MODIFIED_BY="[Empty name]">
<P>20 preterm infants with birth weight between 1110 and 2000 g</P>
<P>Eligibility criteria: none reported</P>
<P>Setting: Pediatric Hospital "V. Buzzi", Milano, Italy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-04 00:20:19 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 10): human milk fortified with FM85 Nestlè (including energy and protein)</P>
<P>Control 1 (N =10): human milk with no fortification</P>
<P>All infants received supplemental vitamin D</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-04 00:20:34 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Growth parameters</LI>
</UL>
<UL>
<LI>Metabolic parameters</LI>
</UL>
<UL>
<LI>Measures of bone mineralisation</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-04-20 17:10:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-04 00:25:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wauben-1998">
<CHAR_METHODS MODIFIED="2015-04-14 09:00:37 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-04 00:22:50 +0100" MODIFIED_BY="[Empty name]">
<P>31 preterm infants of birth weight &lt; 1800 g<BR/>
</P>
<P>Eligibility criteria: older than 1 week of age (birth weight appropriate for gestational age), consumption of full oral feeds (enteral intake 160 mL/kg/d) for longer than 5 days, stable weight gain greater than 10 g/kg/d, no severe congenital malformations/chromosomal abnormalities, no gastrointestinal disease</P>
<P>Setting: Neonatal Units of the Children's Hospitals of the Hamilton Health Sciences Corporation and St Joseph's Hospitals, Hamilton, Ontario, Canada<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-04 00:23:50 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 15): maternal milk fortified with (per 100 mL) 0.37 g human milk protein, 3.47 g carbohydrate, 61 mg calcium, 44 mg phosphorus, electrolytes and other minerals and vitamins (including vitamin D 472 IU/d) (Wyeth-Ayerst, Toronto, Ontario, Canada) (fortification commenced when maternal milk contributed &gt; 80% of infant's enteral intake)</P>
<P>Control (N = 16): maternal milk supplemented with calcium glycerophosphate</P>
<P>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-04 00:24:13 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Short-term growth</LI>
</UL>
<UL>
<LI>Biochemical indices of bone metabolism</LI>
</UL>
<UL>
<LI>Bone mineral content</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-04-04 00:25:21 +0100" MODIFIED_BY="[Empty name]">
<P>Supplementation in both groups was increased gradually until a target amount was reached. Intervention ceased at discharge or at 38 weeks' postmenstrual age, whichever occurred later<BR/>Infants in the control arm were significantly lighter at birth and were significantly lighter and shorter at study entry than infants in the group receiving HMF<BR/>Nutrient intakes were measured: mean fluid intakes significantly greater in the control group (177 vs 164 mL/kg/d)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-04-04 00:30:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zuckerman-1994">
<CHAR_METHODS MODIFIED="2015-04-16 08:51:04 +0100" MODIFIED_BY="[Empty name]">
<P>Quasi-randomised controlled trial </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-04 00:28:18 +0100" MODIFIED_BY="[Empty name]">
<P>56 infants with birth weight &lt; 1200 g, older than 2 weeks of age<BR/>Eligibility criteria: no congenital abnormalities, infections, nor disorders causing bone disease</P>
<P>Setting: Baragwanath Hospital, Bertsham, South Africa</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-04 00:28:47 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention (N = 29): maternal milk mixed in equal proportions with premature infant formula (Alprem, Nestle) to yield supplements (per 100 mL) of fat, carbohydrate and calcium 14.5 mg, phosphate 7 mg and protein 0.6 g</P>
<P>Control (N = 27): unsupplemented human milk<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-04 00:30:45 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>In-hospital growth rates</LI>
</UL>
<UL>
<LI>Serum indices of bone metabolism</LI>
</UL>
<UL>
<LI>Radiographic changes of metabolic bone disease</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-04-20 16:29:27 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ALP - alkaline phosphatase<BR/>DEXA - dual-energy x-ray absorptiometry<BR/>NEC - necrotising enterocolitis<BR/>NICU - neonatal intensive care unit<BR/>VLBW - very low birth weight</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-04-04 00:34:32 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2016-04-04 00:34:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abrams-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-04-04 00:34:03 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison of human milk-based vs cow's milk-based protein fortification</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-04-04 00:34:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Arslanoglu-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-04-04 00:34:16 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison of different fortification regimens, with no control group receiving unfortified milk</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-04-04 00:34:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carey-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-04-04 00:34:22 +0100" MODIFIED_BY="[Empty name]">
<P>Fortification with protein only; no fortification with energy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-04-04 00:34:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Greer-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-04-04 00:34:25 +0100" MODIFIED_BY="[Empty name]">
<P>Fortification with protein only; no fortification with energy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-04-14 11:12:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hair-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-04-14 11:12:07 +0100" MODIFIED_BY="[Empty name]">
<P>Control group received fortified milk</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-04-04 00:34:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kashyap-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-04-04 00:34:32 +0100" MODIFIED_BY="[Empty name]">
<P>Fortification with protein only; no fortification with energy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-04-14 10:48:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reali-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-04-14 10:48:54 +0100" MODIFIED_BY="[Empty name]">
<P>Literature review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-03-25 17:38:20 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tarcan-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-03-25 17:38:20 +0000" MODIFIED_BY="[Empty name]">
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2016-04-04 00:41:22 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2016-04-04 00:40:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mills-2015">
<CHAR_STUDY_NAME MODIFIED="2015-05-26 15:00:59 +0100" MODIFIED_BY="[Empty name]">
<P>PREterM FOrmula Or Donor Breast Milk for Premature Babies (PREMFOOD)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-04-04 00:34:56 +0100" MODIFIED_BY="[Empty name]">
<P>Open, 3-arm randomised controlled feasibility trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-04-04 00:35:16 +0100" MODIFIED_BY="[Empty name]">
<P>Neonates at &lt; 30 weeks' gestation; babies with conditions that preclude enteral feeding or are immediately life-limiting are ineligible</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-04-04 00:40:44 +0100" MODIFIED_BY="[Empty name]">
<P>Participants will be randomised to receive fortified donor breast milk (DBM), unfortified DBM or preterm formula to make up any shortfall in maternal breast milk until 35 weeks' postmenstrual age, with a sample size of 22 in each group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-04-04 00:40:36 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome measure: total body adiposity (measured as close as possible to the baby's due date, at an average age of 10 weeks (range 8 to 15 weeks))</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-05-26 15:06:02 +0100" MODIFIED_BY="[Empty name]">
<P>2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-04-04 00:36:00 +0100" MODIFIED_BY="[Empty name]">
<P>Prof. Neena Modi, Section of Neonatal Medicine, Imperial College London, London, UK; Department of Neonatal Medicine, Chelsea and Westminster Hospital, London, UK</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-04-04 00:36:08 +0100" MODIFIED_BY="[Empty name]">
<P>Feasibility trial</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-04-04 00:31:11 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-04-04 00:30:55 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-03 23:44:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bhat-2003">
<DESCRIPTION>
<P>Report states that infants were "randomly assigned", but method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-03 23:47:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faerk-2000">
<DESCRIPTION>
<P>Method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-03 23:51:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gathwala-2012">
<DESCRIPTION>
<P>Use of a random numbers table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-03 23:53:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gross-1987-_x0028_1_x0029_">
<DESCRIPTION>
<P>Details of sequence generation not reported. Report states that infants were "assigned randomly" to receive fortified or unfortified breast milk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-03 23:58:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gross-1987-_x0028_2_x0029_">
<DESCRIPTION>
<P>Details of sequence generation not reported. Report states that infants were "assigned randomly" to receive fortified or unfortified breast milk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:02:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lucas-1996">
<DESCRIPTION>
<P>Use of permuted blocks of randomised length</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:05:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Modanlou-1986">
<DESCRIPTION>
<P>Report states that infants were "randomly assigned", but method of sequence generation was not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:08:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mukhopadhyay-2007">
<DESCRIPTION>
<P>Use of a random numbers table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:10:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nicholl-1999">
<DESCRIPTION>
<P>Report states that infants were "randomized", but method of sequence generation was not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:13:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pettifor-1989">
<DESCRIPTION>
<P>Report states that infants were "randomly assigned", but method of sequence generation was not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:18:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Polberger-1989">
<DESCRIPTION>
<P>Report states that infants were "randomly assigned", but method of sequence generation was not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:20:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Porcelli-1992">
<DESCRIPTION>
<P>Report states that infants were "randomized", but method of sequence generation was not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:30:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wauben-1998">
<DESCRIPTION>
<P>Random numbers table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:30:55 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zuckerman-1994">
<DESCRIPTION>
<P>Infants were assigned to the 2 groups according to their hospital number (odd or even)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-04-04 00:31:04 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-03 23:44:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bhat-2003">
<DESCRIPTION>
<P>No details reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-03 23:47:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faerk-2000">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-03 23:51:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gathwala-2012">
<DESCRIPTION>
<P>Details of allocation concealment not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-03 23:54:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gross-1987-_x0028_1_x0029_">
<DESCRIPTION>
<P>Report states that "sealed envelopes" were used, but it is unclear whether these were sequentially numbered and opaque</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-03 23:58:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gross-1987-_x0028_2_x0029_">
<DESCRIPTION>
<P>Report states that "sealed envelopes" were used, but it is unclear whether these were sequentially numbered and opaque.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-02 12:00:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lucas-1996">
<DESCRIPTION>
<P>Use of sealed opaque envelopes </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:05:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Modanlou-1986">
<DESCRIPTION>
<P>Report states that sealed envelopes were used. It is not reported whether these were sequentially numbered and opaque</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:08:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mukhopadhyay-2007">
<DESCRIPTION>
<P>Details of allocation concealment not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:10:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nicholl-1999">
<DESCRIPTION>
<P>Sealed opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:13:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pettifor-1989">
<DESCRIPTION>
<P>Details of allocation concealment not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:19:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Polberger-1989">
<DESCRIPTION>
<P>Report states that "closed envelopes" were used, but it is not specified whether these were sequentially numbered, opaque and sealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:21:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Porcelli-1992">
<DESCRIPTION>
<P>Details of allocation concealment were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:25:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wauben-1998">
<DESCRIPTION>
<P>Details of allocation concealment were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-04 00:31:04 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zuckerman-1994">
<DESCRIPTION>
<P>Infants were assigned to the 2 groups according to their hospital number (odd or even)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2016-04-04 00:25:57 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-03 23:44:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bhat-2003">
<DESCRIPTION>
<P>Study was described as "double-blind", but it was not specified who was blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-03 23:48:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faerk-2000">
<DESCRIPTION>
<P>Study is described as "double-blind", but it was not specified who was blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-03 23:51:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gathwala-2012">
<DESCRIPTION>
<P>It was not reported whether personnel were blinded (participant blinding irrelevant in this context)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-03 23:54:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gross-1987-_x0028_1_x0029_">
<DESCRIPTION>
<P>It was not reported whether personnel were blinded (participant blinding irrelevant in this context)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-03 23:58:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gross-1987-_x0028_2_x0029_">
<DESCRIPTION>
<P>It was not reported whether personnel were blinded (participant blinding irrelevant in this context)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-04 00:02:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lucas-1996">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-04 00:05:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Modanlou-1986">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-04 00:08:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mukhopadhyay-2007">
<DESCRIPTION>
<P>It was not reported whether personnel were blinded (participant blinding irrelevant in this context)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-04 00:10:54 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nicholl-1999">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-04 00:13:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pettifor-1989">
<DESCRIPTION>
<P>It was not reported whether personnel were blinded (participant blinding irrelevant in this context)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-04 00:19:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Polberger-1989">
<DESCRIPTION>
<P>Study is described as "double-blind", but it was not specified who was blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-04 00:20:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Porcelli-1992">
<DESCRIPTION>
<P>It was not reported whether personnel were blinded (participant blinding irrelevant in this context)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-04-04 00:25:57 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wauben-1998">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-04-20 16:25:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zuckerman-1994">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2016-04-04 00:26:00 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-03 23:44:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bhat-2003">
<DESCRIPTION>
<P>Study was described as "double-blind", but it was not specified who was blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-03 23:48:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faerk-2000">
<DESCRIPTION>
<P>Study is described as "double-blind", but it was not specified who was blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-03 23:51:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gathwala-2012">
<DESCRIPTION>
<P>It was not reported whether outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-03 23:54:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gross-1987-_x0028_1_x0029_">
<DESCRIPTION>
<P>It was not reported whether outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-03 23:58:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gross-1987-_x0028_2_x0029_">
<DESCRIPTION>
<P>It was not reported whether outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-03-29 12:24:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lucas-1996">
<DESCRIPTION>
<P>Unblinded (except for assessment of neurodevelopmental outcomes)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-04 00:05:35 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Modanlou-1986">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-04 00:08:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mukhopadhyay-2007">
<DESCRIPTION>
<P>It was not reported whether outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-04 00:11:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nicholl-1999">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-04 00:14:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pettifor-1989">
<DESCRIPTION>
<P>It was not reported whether outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-04 00:19:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Polberger-1989">
<DESCRIPTION>
<P>Study is described as "double-blind", but it was not specified who was blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-04 00:21:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Porcelli-1992">
<DESCRIPTION>
<P>It was not reported whether outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-04-04 00:26:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wauben-1998">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-04-20 16:26:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zuckerman-1994">
<DESCRIPTION>
<P>Unblinded (radiographers were reported to have been blinded)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="GROUP" MODIFIED="2016-04-04 00:31:11 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-05.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-03 23:45:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhat-2003">
<DESCRIPTION>
<P>No details of infants lost to follow-up were reported. Lack of attrition bias was assumed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-03 23:49:09 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Faerk-2000">
<DESCRIPTION>
<P>103 infants were randomised, but outcome data were reported for only 76 (74%) because of loss to follow-up or technical problems with DEXA scans. Further information about outcomes was not available from investigators</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-03 23:52:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gathwala-2012">
<DESCRIPTION>
<P>Four babies in the intervention group and 3 in the control group were excluded post randomisation, as their need for additional milk exceeded 25%. These infants were not included in intention-to-treat analyses</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-03 23:54:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gross-1987-_x0028_1_x0029_">
<DESCRIPTION>
<P>No details of infants lost to follow-up were reported. Lack of attrition bias was assumed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-03 23:59:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gross-1987-_x0028_2_x0029_">
<DESCRIPTION>
<P>Four infants (2 in intervention group 1, and 2 in intervention group 2) did not complete the study because of feed intolerance. Results of growth outcomes for these infants were not presented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-04 00:02:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lucas-1996">
<DESCRIPTION>
<P>No details of infants lost to follow-up were reported. Lack of attrition bias was assumed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-04 00:05:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Modanlou-1986">
<DESCRIPTION>
<P>19 infants left the study after randomisation because of "insufficient maternal milk supply", and another 2 infants were withdrawn because of suspected NEC. Outcome data for inclusion in intention-to-treat analyses were not available for these infants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-04 00:08:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mukhopadhyay-2007">
<DESCRIPTION>
<P>No details of infants lost to follow-up were reported. Lack of attrition bias was assumed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-04 00:11:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nicholl-1999">
<DESCRIPTION>
<P>No details of infants lost to follow-up were reported. Lack of attrition bias was assumed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-04 00:14:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Pettifor-1989">
<DESCRIPTION>
<P>41 (of 100) infants left the study after randomisation for various reasons (insufficient maternal milk supply, death, reduced enteral intake for &gt; 72 hours, incomplete data). These infants were not included in intention-to-treat analyses of growth outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-04 00:19:47 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Polberger-1989">
<DESCRIPTION>
<P>Several (up to 6, but exact number unclear) infants were excluded from the study after randomisation. Intention-to-treat analyses were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-04 00:21:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Porcelli-1992">
<DESCRIPTION>
<P>No details of infants lost to follow-up were reported. Lack of attrition bias was assumed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-04 00:26:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wauben-1998">
<DESCRIPTION>
<P>Six infants (3 in each group) were excluded from the study after randomisation. Details were reported, and no bias was apparent between groups. Intention-to-treat analyses of growth outcomes data were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2016-04-04 00:31:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zuckerman-1994">
<DESCRIPTION>
<P>Three infants in the control group were excluded because of incorrect feeding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2015-04-20 13:47:31 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-07" LEVEL="STUDY" MODIFIED="2015-03-29 11:38:10 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-04-04 01:08:58 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-04-04 01:08:58 +0100" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2016-04-04 00:42:00 +0100" MODIFIED_BY="[Empty name]">Multi-nutrient fortification of human milk for preterm infants</TITLE>
<TABLE COLS="6" ROWS="12">
<TR>
<TD ALIGN="LEFT" COLSPAN="6" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>preterm infants<BR/>
<B>Setting: </B>healthcare setting<BR/>
<B>Intervention: </B>fortified breast milk<BR/>
<B>Comparison: </B>unfortified breast milk</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with unfortified breast milk</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with fortified breast milk</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Weight gain (g/kg/d)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Comparator</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Mean weight gain was 1.81 g/kg/d more (1.23 more to 2.4 more)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>635<BR/>(10 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low<SUP>a,b</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Length gain (cm/wk)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Comparator</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Mean length gain was 0.12 cm/wk more (0.07 more to 0.17 more)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>555<BR/>(8 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low<SUP>a,b</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Head growth (cm/wk)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Comparator</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Mean head growth was 0.08 cm/wk more (0.04 more to 0.12 more)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>555<BR/>(8 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate<SUP>b</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Mental development index (MDI) at 18 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Comparator</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Mean MDI was 2.2 more (3.35 fewer to 7.75 more)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>245<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate<SUP>c</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Psychomotor development index (PDI) at 18 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Comparator</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Mean PDI was 2.4 more (1.9 fewer to 6.7 more)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>245<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate<SUP>c</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Necrotising enterocolitis</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.57<BR/>(0.76 to 3.23)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>882<BR/>(11 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low<SUP>b,d</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>25 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>40 per 1000<BR/>(19 to 82)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI </B>- confidence interval; <B>RR </B>- risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect but may be substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of the effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Unexplained heterogeneity</P>
<P>
<SUP>b</SUP>Uncertainty about methods used to generate random sequence, conceal allocation and blind assessments in most trials</P>
<P>
<SUP>c</SUP>Estimates of effect consistent with both substantial harms and benefits</P>
<P>
<SUP>d</SUP>95% CI of RR consistent with 3-fold increase in risk with intervention</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-04-24 12:27:20 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2016-04-24 12:27:20 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Fortified breast milk versus unfortified breast milk</NAME>
<CONT_OUTCOME CHI2="53.63010211788696" CI_END="2.4971775676362076" CI_START="1.5777322853570552" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="MD" EFFECT_SIZE="2.0374549264966313" ESTIMABLE="YES" I2="70.16600870005875" I2_Q="34.192614267078184" ID="CMP-001.01" MODIFIED="2016-04-04 01:09:24 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="5.958709981546129E-6" P_Q="0.2188024710800347" P_Z="3.740807219388138E-18" Q="3.0391725453385536" RANDOM="NO" SCALE="10.36" SORT_BY="YEAR" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="575" TOTAL_2="543" UNITS="" WEIGHT="300.0" Z="8.686407669977442">
<NAME>Weight gain (g/kg/d)</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fortified</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="32.630953551383996" CI_END="2.3956962039405045" CI_START="1.2331666266665615" DF="9" EFFECT_SIZE="1.814431415303533" ESTIMABLE="YES" I2="72.41882623556283" ID="CMP-001.01.01" MODIFIED="2015-05-24 12:58:40 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.5481708756792667E-4" P_Z="9.471386672506088E-10" STUDIES="10" TAU2="0.0" TOTAL_1="325" TOTAL_2="310" WEIGHT="99.99999999999999" Z="6.118072685517508">
<NAME>All trials</NAME>
<CONT_DATA CI_END="10.189867034344147" CI_START="4.410132965655855" EFFECT_SIZE="7.300000000000001" ESTIMABLE="YES" MEAN_1="26.7" MEAN_2="19.4" MODIFIED="2015-05-24 12:58:40 +0100" MODIFIED_BY="[Empty name]" ORDER="182" SD_1="3.4" SD_2="2.7" SE="1.4744490496453242" STUDY_ID="STD-Modanlou-1986" TOTAL_1="8" TOTAL_2="10" WEIGHT="4.04568727121538"/>
<CONT_DATA CI_END="5.33655480420758" CI_START="-0.936554804207582" EFFECT_SIZE="2.1999999999999993" ESTIMABLE="YES" MEAN_1="19.9" MEAN_2="17.7" MODIFIED="2015-05-24 12:58:00 +0100" MODIFIED_BY="[Empty name]" ORDER="181" SD_1="2.5" SD_2="4.4" SE="1.600312469488381" STUDY_ID="STD-Gross-1987-_x0028_1_x0029_" TOTAL_1="10" TOTAL_2="10" WEIGHT="3.434331951433906"/>
<CONT_DATA CI_END="6.723283901028113" CI_START="1.276716098971887" EFFECT_SIZE="4.0" ESTIMABLE="YES" MEAN_1="21.5" MEAN_2="17.5" MODIFIED="2015-05-24 12:58:00 +0100" MODIFIED_BY="[Empty name]" ORDER="180" SD_1="3.5" SD_2="3.3" SE="1.3894560933308104" STUDY_ID="STD-Gross-1987-_x0028_2_x0029_" TOTAL_1="17" TOTAL_2="9" WEIGHT="4.555774228201646"/>
<CONT_DATA CI_END="8.249911007317728" CI_START="1.9500889926822675" EFFECT_SIZE="5.099999999999998" ESTIMABLE="YES" MEAN_1="20.4" MEAN_2="15.3" MODIFIED="2015-05-24 12:57:59 +0100" MODIFIED_BY="[Empty name]" ORDER="177" SD_1="2.8" SD_2="3.2" SE="1.607126984048598" STUDY_ID="STD-Polberger-1989" TOTAL_1="7" TOTAL_2="7" WEIGHT="3.405269297198874"/>
<CONT_DATA CI_END="2.8884959271307094" CI_START="-3.088495927130712" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="16.7" MEAN_2="16.8" MODIFIED="2015-05-24 12:57:59 +0100" MODIFIED_BY="[Empty name]" ORDER="176" SD_1="5.0" SD_2="6.4" SE="1.5247708379866085" STUDY_ID="STD-Pettifor-1989" TOTAL_1="29" TOTAL_2="28" WEIGHT="3.783055339239159"/>
<CONT_DATA CI_END="1.9015468052608435" CI_START="-3.101546805260843" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="12.0" MODIFIED="2015-05-24 12:57:58 +0100" MODIFIED_BY="[Empty name]" ORDER="258" SD_1="2.7" SD_2="3.0" SE="1.2763228431709588" STUDY_ID="STD-Porcelli-1992" TOTAL_1="10" TOTAL_2="10" WEIGHT="5.399216775704257"/>
<CONT_DATA CI_END="1.579999615822412" CI_START="-0.3799996158224128" EFFECT_SIZE="0.5999999999999996" ESTIMABLE="YES" MEAN_1="15.6" MEAN_2="15.0" MODIFIED="2015-05-24 12:58:39 +0100" MODIFIED_BY="[Empty name]" ORDER="175" SD_1="4.7" SD_2="3.5" SE="0.5000089917735858" STUDY_ID="STD-Lucas-1996" TOTAL_1="137" TOTAL_2="138" WEIGHT="35.18003117561115"/>
<CONT_DATA CI_END="3.8147432786642836" CI_START="0.9852567213357208" EFFECT_SIZE="2.400000000000002" ESTIMABLE="YES" MEAN_1="16.6" MEAN_2="14.2" MODIFIED="2015-05-24 12:58:39 +0100" MODIFIED_BY="[Empty name]" ORDER="178" SD_1="1.6" SD_2="2.0" SE="0.7218210588682219" STUDY_ID="STD-Wauben-1998" TOTAL_1="12" TOTAL_2="13" WEIGHT="16.880789418172593"/>
<CONT_DATA CI_END="6.253455619846766" CI_START="-2.453455619846765" EFFECT_SIZE="1.9000000000000004" ESTIMABLE="YES" MEAN_1="15.1" MEAN_2="13.2" MODIFIED="2015-05-24 12:58:38 +0100" MODIFIED_BY="[Empty name]" ORDER="179" SD_1="3.3" SD_2="6.4" SE="2.22119164137008" STUDY_ID="STD-Nicholl-1999" TOTAL_1="13" TOTAL_2="10" WEIGHT="1.7827062530650946"/>
<CONT_DATA CI_END="3.4526229104182375" CI_START="0.947377089581761" EFFECT_SIZE="2.1999999999999993" ESTIMABLE="YES" MEAN_1="15.1" MEAN_2="12.9" MODIFIED="2015-05-24 12:57:57 +0100" MODIFIED_BY="[Empty name]" ORDER="160" SD_1="4.0" SD_2="4.0" SE="0.6391050653475104" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="21.53313829015794"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="16.024644196016194" CI_END="3.8045995206278556" CI_START="1.8268062838594123" DF="4" EFFECT_SIZE="2.815702902243634" ESTIMABLE="YES" I2="75.03844733729301" ID="CMP-001.01.02" MODIFIED="2015-05-11 15:33:10 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0029862807093522514" P_Z="2.3963482093675454E-8" STUDIES="5" TAU2="0.0" TOTAL_1="139" TOTAL_2="130" WEIGHT="100.0" Z="5.580640258007461">
<NAME>Trials recruiting only very preterm or VLBW infants</NAME>
<CONT_DATA CI_END="10.189867034344147" CI_START="4.410132965655855" EFFECT_SIZE="7.300000000000001" ESTIMABLE="YES" MEAN_1="26.7" MEAN_2="19.4" MODIFIED="2015-05-11 15:33:10 +0100" MODIFIED_BY="[Empty name]" ORDER="182" SD_1="3.4" SD_2="2.7" SE="1.4744490496453242" STUDY_ID="STD-Modanlou-1986" TOTAL_1="8" TOTAL_2="10" WEIGHT="11.709707902745137"/>
<CONT_DATA CI_END="2.8884959271307094" CI_START="-3.088495927130712" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="16.7" MEAN_2="16.8" MODIFIED="2015-05-11 15:33:10 +0100" MODIFIED_BY="[Empty name]" ORDER="176" SD_1="5.0" SD_2="6.4" SE="1.5247708379866085" STUDY_ID="STD-Pettifor-1989" TOTAL_1="29" TOTAL_2="28" WEIGHT="10.949554434815003"/>
<CONT_DATA CI_END="8.249911007317728" CI_START="1.9500889926822675" EFFECT_SIZE="5.099999999999998" ESTIMABLE="YES" MEAN_1="20.4" MEAN_2="15.3" MODIFIED="2015-05-11 15:33:10 +0100" MODIFIED_BY="[Empty name]" ORDER="177" SD_1="2.8" SD_2="3.2" SE="1.607126984048598" STUDY_ID="STD-Polberger-1989" TOTAL_1="7" TOTAL_2="7" WEIGHT="9.856102592034043"/>
<CONT_DATA CI_END="6.253455619846766" CI_START="-2.453455619846765" EFFECT_SIZE="1.9000000000000004" ESTIMABLE="YES" MEAN_1="15.1" MEAN_2="13.2" MODIFIED="2015-05-11 15:33:10 +0100" MODIFIED_BY="[Empty name]" ORDER="179" SD_1="3.3" SD_2="6.4" SE="2.22119164137008" STUDY_ID="STD-Nicholl-1999" TOTAL_1="13" TOTAL_2="10" WEIGHT="5.159807988203296"/>
<CONT_DATA CI_END="3.4526229104182375" CI_START="0.947377089581761" EFFECT_SIZE="2.1999999999999993" ESTIMABLE="YES" MEAN_1="15.1" MEAN_2="12.9" MODIFIED="2015-05-11 15:33:10 +0100" MODIFIED_BY="[Empty name]" ORDER="160" SD_1="4.0" SD_2="4.0" SE="0.6391050653475104" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="62.324827082202525"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.9353318251482063" CI_END="3.0115527627287175" CI_START="0.7010589665364217" DF="1" EFFECT_SIZE="1.8563058646325696" ESTIMABLE="YES" I2="48.329274235780176" ID="CMP-001.01.03" MODIFIED="2015-05-11 17:26:15 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.16417656497567656" P_Z="0.001636264195954575" STUDIES="2" TAU2="0.0" TOTAL_1="111" TOTAL_2="103" WEIGHT="100.0" Z="3.1493636944329775">
<NAME>Trials conducted in low- or middle-income countries</NAME>
<CONT_DATA CI_END="2.8884959271307094" CI_START="-3.088495927130712" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="16.7" MEAN_2="16.8" MODIFIED="2015-05-11 17:26:15 +0100" MODIFIED_BY="[Empty name]" ORDER="176" SD_1="5.0" SD_2="6.4" SE="1.5247708379866085" STUDY_ID="STD-Pettifor-1989" TOTAL_1="29" TOTAL_2="28" WEIGHT="14.943223276844765"/>
<CONT_DATA CI_END="3.4526229104182375" CI_START="0.947377089581761" EFFECT_SIZE="2.1999999999999993" ESTIMABLE="YES" MEAN_1="15.1" MEAN_2="12.9" MODIFIED="2015-05-11 17:26:15 +0100" MODIFIED_BY="[Empty name]" ORDER="160" SD_1="4.0" SD_2="4.0" SE="0.6391050653475104" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="85.05677672315524"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="31.102315626432244" CI_END="0.19100607446199114" CI_START="0.11925293031058819" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="MD" EFFECT_SIZE="0.15512950238628967" ESTIMABLE="YES" I2="64.63285842726233" I2_Q="57.60437860013987" ID="CMP-001.02" MODIFIED="2016-04-04 01:09:38 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0010610755996278698" P_Q="0.0945400326204715" P_Z="2.3540118210406488E-17" Q="4.717468299701814" RANDOM="NO" SCALE="0.57" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="462" TOTAL_2="439" UNITS="" WEIGHT="300.0" Z="8.47484082300812">
<NAME>Length gain (cm/wk)</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fortified</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="22.70985478526739" CI_END="0.16848871211013092" CI_START="0.07084637699180013" DF="7" EFFECT_SIZE="0.11966754455096552" ESTIMABLE="YES" I2="69.17637710065357" ID="CMP-001.02.01" MODIFIED="2015-05-11 15:33:44 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0019146129858568228" P_Z="1.5541243497171612E-6" STUDIES="8" TAU2="0.0" TOTAL_1="283" TOTAL_2="272" WEIGHT="99.99999999999999" Z="4.804147241132559">
<NAME>All trials</NAME>
<CONT_DATA CI_END="0.5688442093982123" CI_START="-0.20884420939821247" EFFECT_SIZE="0.17999999999999994" ESTIMABLE="YES" MEAN_1="0.99" MEAN_2="0.81" MODIFIED="2015-04-21 15:55:25 +0100" MODIFIED_BY="[Empty name]" ORDER="188" SD_1="0.4" SD_2="0.44" SE="0.19839354828219594" STUDY_ID="STD-Modanlou-1986" TOTAL_1="8" TOTAL_2="10" WEIGHT="1.576395008093796"/>
<CONT_DATA CI_END="0.26016749716545806" CI_START="-0.10016749716545817" EFFECT_SIZE="0.07999999999999996" ESTIMABLE="YES" MEAN_1="0.89" MEAN_2="0.81" MODIFIED="2015-04-21 15:55:25 +0100" MODIFIED_BY="[Empty name]" ORDER="184" SD_1="0.19" SD_2="0.22" SE="0.09192388155425117" STUDY_ID="STD-Gross-1987-_x0028_1_x0029_" TOTAL_1="10" TOTAL_2="10" WEIGHT="7.342829292138678"/>
<CONT_DATA CI_END="0.1923704480687954" CI_START="-0.09237044806879555" EFFECT_SIZE="0.04999999999999993" ESTIMABLE="YES" MEAN_1="0.84" MEAN_2="0.79" MODIFIED="2015-04-23 11:42:00 +0100" MODIFIED_BY="[Empty name]" ORDER="185" SD_1="0.25" SD_2="0.12" SE="0.07263931847309206" STUDY_ID="STD-Gross-1987-_x0028_2_x0029_" TOTAL_1="17" TOTAL_2="9" WEIGHT="11.759168649004694"/>
<CONT_DATA CI_END="0.5480996189280116" CI_START="0.19190038107198842" EFFECT_SIZE="0.37" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="0.83" MODIFIED="2015-04-21 15:55:25 +0100" MODIFIED_BY="[Empty name]" ORDER="189" SD_1="0.17" SD_2="0.17" SE="0.0908688222502243" STUDY_ID="STD-Polberger-1989" TOTAL_1="7" TOTAL_2="7" WEIGHT="7.514331360380669"/>
<CONT_DATA CI_END="0.12347027692519572" CI_START="-0.3234702769251957" EFFECT_SIZE="-0.09999999999999998" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.7" MODIFIED="2015-04-23 11:44:15 +0100" MODIFIED_BY="[Empty name]" ORDER="50" SD_1="0.2" SD_2="0.3" SE="0.1140175425099138" STUDY_ID="STD-Porcelli-1992" TOTAL_1="10" TOTAL_2="10" WEIGHT="4.77283903989014"/>
<CONT_DATA CI_END="0.0810995932900945" CI_START="-0.14109959329009433" EFFECT_SIZE="-0.029999999999999916" ESTIMABLE="YES" MEAN_1="0.93" MEAN_2="0.96" MODIFIED="2015-04-23 11:55:01 +0100" MODIFIED_BY="[Empty name]" ORDER="187" SD_1="0.47" SD_2="0.47" SE="0.05668450755546216" STUDY_ID="STD-Lucas-1996" TOTAL_1="137" TOTAL_2="138" WEIGHT="19.310405095619064"/>
<CONT_DATA CI_END="0.3569227071844307" CI_START="0.043077292815569435" EFFECT_SIZE="0.20000000000000007" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="0.9" MODIFIED="2015-04-21 15:55:25 +0100" MODIFIED_BY="[Empty name]" ORDER="190" SD_1="0.2" SD_2="0.2" SE="0.08006407690254358" STUDY_ID="STD-Wauben-1998" TOTAL_1="12" TOTAL_2="13" WEIGHT="9.679317572897203"/>
<CONT_DATA CI_END="0.259151837178358" CI_START="0.10084816282164213" EFFECT_SIZE="0.18000000000000005" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="0.86" MODIFIED="2015-04-28 17:53:57 +0100" MODIFIED_BY="[Empty name]" ORDER="51" SD_1="0.3" SD_2="0.2" SE="0.04038433246870733" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="38.04471398197575"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.6749925414630367" CI_END="0.28140040338356154" CI_START="0.13917919226070374" DF="2" EFFECT_SIZE="0.21028979782213264" ESTIMABLE="YES" I2="45.57812084147012" ID="CMP-001.02.02" MODIFIED="2015-05-11 15:34:08 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.15921564015231227" P_Z="6.789614041609488E-9" STUDIES="3" TAU2="0.0" TOTAL_1="97" TOTAL_2="92" WEIGHT="100.0" Z="5.7960472533389495">
<NAME>Trials recruiting only very preterm or VLBW infants</NAME>
<CONT_DATA CI_END="0.5688442093982123" CI_START="-0.20884420939821247" EFFECT_SIZE="0.17999999999999994" ESTIMABLE="YES" MEAN_1="0.99" MEAN_2="0.81" MODIFIED="2015-05-11 15:34:08 +0100" MODIFIED_BY="[Empty name]" ORDER="188" SD_1="0.4" SD_2="0.44" SE="0.19839354828219594" STUDY_ID="STD-Modanlou-1986" TOTAL_1="8" TOTAL_2="10" WEIGHT="3.3443943588377643"/>
<CONT_DATA CI_END="0.5480996189280116" CI_START="0.19190038107198842" EFFECT_SIZE="0.37" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="0.83" MODIFIED="2015-05-11 15:34:08 +0100" MODIFIED_BY="[Empty name]" ORDER="189" SD_1="0.17" SD_2="0.17" SE="0.0908688222502243" STUDY_ID="STD-Polberger-1989" TOTAL_1="7" TOTAL_2="7" WEIGHT="15.941998853753992"/>
<CONT_DATA CI_END="0.259151837178358" CI_START="0.10084816282164213" EFFECT_SIZE="0.18000000000000005" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="0.86" MODIFIED="2015-05-11 15:34:08 +0100" MODIFIED_BY="[Empty name]" ORDER="51" SD_1="0.3" SD_2="0.2" SE="0.04038433246870733" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="80.71360678740825"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.259151837178358" CI_START="0.10084816282164213" DF="0" EFFECT_SIZE="0.18000000000000005" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.03" MODIFIED="2015-05-11 17:26:36 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="8.304716148898129E-6" STUDIES="1" TAU2="0.0" TOTAL_1="82" TOTAL_2="75" WEIGHT="100.0" Z="4.457174082039784">
<NAME>Trials conducted in low- or middle-income countries</NAME>
<CONT_DATA CI_END="0.259151837178358" CI_START="0.10084816282164213" EFFECT_SIZE="0.18000000000000005" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="0.86" MODIFIED="2015-05-11 17:26:36 +0100" MODIFIED_BY="[Empty name]" ORDER="51" SD_1="0.3" SD_2="0.2" SE="0.04038433246870733" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="14.917594449167115" CI_END="0.11826676333566635" CI_START="0.061352394965396684" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="MD" EFFECT_SIZE="0.08980957915053152" ESTIMABLE="YES" I2="26.261569601698373" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2016-04-04 01:09:50 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.18630071823766847" P_Q="0.6914916449593475" P_Z="6.188348931001812E-10" Q="0.7378088075902375" RANDOM="NO" SCALE="0.43" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="462" TOTAL_2="439" UNITS="" WEIGHT="300.0" Z="6.185557202588246">
<NAME>Head growth (cm/wk)</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fortified</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="8.964621554654688" CI_END="0.12234763326621961" CI_START="0.04456826002633316" DF="7" EFFECT_SIZE="0.08345794664627638" ESTIMABLE="YES" I2="21.91527598434537" ID="CMP-001.03.01" MODIFIED="2015-05-11 15:34:33 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2552062048414734" P_Z="2.5979584278649354E-5" STUDIES="8" TAU2="0.0" TOTAL_1="283" TOTAL_2="272" WEIGHT="100.00000000000001" Z="4.206116939149713">
<NAME>All trials</NAME>
<CONT_DATA CI_END="0.42645988730301887" CI_START="0.11354011269698142" EFFECT_SIZE="0.27000000000000013" ESTIMABLE="YES" MEAN_1="1.09" MEAN_2="0.82" MODIFIED="2015-04-21 15:55:25 +0100" MODIFIED_BY="[Empty name]" ORDER="197" SD_1="0.07" SD_2="0.24" SE="0.07982793997091495" STUDY_ID="STD-Modanlou-1986" TOTAL_1="8" TOTAL_2="10" WEIGHT="6.178212771548327"/>
<CONT_DATA CI_END="0.20377924338709247" CI_START="-0.023779243387092308" EFFECT_SIZE="0.09000000000000008" ESTIMABLE="YES" MEAN_1="0.92" MEAN_2="0.83" MODIFIED="2015-04-21 15:55:25 +0100" MODIFIED_BY="[Empty name]" ORDER="193" SD_1="0.09" SD_2="0.16" SE="0.05805170109479997" STUDY_ID="STD-Gross-1987-_x0028_1_x0029_" TOTAL_1="10" TOTAL_2="10" WEIGHT="11.68268869041297"/>
<CONT_DATA CI_END="0.11585555254642362" CI_START="-0.11585555254642362" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.84" MEAN_2="0.84" MODIFIED="2015-04-23 12:17:49 +0100" MODIFIED_BY="[Empty name]" ORDER="194" SD_1="0.21" SD_2="0.09" SE="0.05911106196862668" STUDY_ID="STD-Gross-1987-_x0028_2_x0029_" TOTAL_1="17" TOTAL_2="9" WEIGHT="11.267697560164295"/>
<CONT_DATA CI_END="0.3787417510305545" CI_START="-0.03874175103055422" EFFECT_SIZE="0.17000000000000015" ESTIMABLE="YES" MEAN_1="1.11" MEAN_2="0.94" MODIFIED="2015-04-21 15:55:25 +0100" MODIFIED_BY="[Empty name]" ORDER="198" SD_1="0.13" SD_2="0.25" SE="0.10650285039780458" STUDY_ID="STD-Polberger-1989" TOTAL_1="7" TOTAL_2="7" WEIGHT="3.4709650655773547"/>
<CONT_DATA CI_END="0.2234702769251957" CI_START="-0.2234702769251957" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="0.7" MODIFIED="2015-04-23 12:16:47 +0100" MODIFIED_BY="[Empty name]" ORDER="53" SD_1="0.3" SD_2="0.2" SE="0.1140175425099138" STUDY_ID="STD-Porcelli-1992" TOTAL_1="10" TOTAL_2="10" WEIGHT="3.028512375899362"/>
<CONT_DATA CI_END="0.15799996158224128" CI_START="-0.037999961582241185" EFFECT_SIZE="0.06000000000000005" ESTIMABLE="YES" MEAN_1="1.01" MEAN_2="0.95" MODIFIED="2015-04-23 12:15:32 +0100" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="0.47" SD_2="0.35" SE="0.050000899177358574" STUDY_ID="STD-Lucas-1996" TOTAL_1="137" TOTAL_2="138" WEIGHT="15.747697950645877"/>
<CONT_DATA CI_END="0.2225605522929594" CI_START="-0.022560552292959432" EFFECT_SIZE="0.09999999999999998" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="0.9" MODIFIED="2015-04-21 15:55:25 +0100" MODIFIED_BY="[Empty name]" ORDER="199" SD_1="0.1" SD_2="0.2" SE="0.06253204306798564" STUDY_ID="STD-Wauben-1998" TOTAL_1="12" TOTAL_2="13" WEIGHT="10.068562456268698"/>
<CONT_DATA CI_END="0.14263114552091188" CI_START="0.01736885447908805" EFFECT_SIZE="0.07999999999999996" ESTIMABLE="YES" MEAN_1="0.83" MEAN_2="0.75" MODIFIED="2015-04-23 12:12:36 +0100" MODIFIED_BY="[Empty name]" ORDER="52" SD_1="0.2" SD_2="0.2" SE="0.03195525326737552" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="38.555663129483115"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.215164086922189" CI_END="0.16684494571506278" CI_START="0.054818872801656655" DF="2" EFFECT_SIZE="0.11083190925835971" ESTIMABLE="YES" I2="61.650295816860265" ID="CMP-001.03.02" MODIFIED="2015-05-11 15:36:10 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.07371267997413022" P_Z="1.0525695801513727E-4" STUDIES="3" TAU2="0.0" TOTAL_1="97" TOTAL_2="92" WEIGHT="100.00000000000001" Z="3.8781427365057803">
<NAME>Trials recruiting only very preterm or VLBW infants</NAME>
<CONT_DATA CI_END="0.42645988730301887" CI_START="0.11354011269698142" EFFECT_SIZE="0.27000000000000013" ESTIMABLE="YES" MEAN_1="1.09" MEAN_2="0.82" MODIFIED="2015-05-11 15:36:10 +0100" MODIFIED_BY="[Empty name]" ORDER="197" SD_1="0.07" SD_2="0.24" SE="0.07982793997091495" STUDY_ID="STD-Modanlou-1986" TOTAL_1="8" TOTAL_2="10" WEIGHT="12.816581587371978"/>
<CONT_DATA CI_END="0.3787417510305545" CI_START="-0.03874175103055422" EFFECT_SIZE="0.17000000000000015" ESTIMABLE="YES" MEAN_1="1.11" MEAN_2="0.94" MODIFIED="2015-05-11 15:36:10 +0100" MODIFIED_BY="[Empty name]" ORDER="198" SD_1="0.13" SD_2="0.25" SE="0.10650285039780458" STUDY_ID="STD-Polberger-1989" TOTAL_1="7" TOTAL_2="7" WEIGHT="7.200449158169968"/>
<CONT_DATA CI_END="0.14263114552091188" CI_START="0.01736885447908805" EFFECT_SIZE="0.07999999999999996" ESTIMABLE="YES" MEAN_1="0.83" MEAN_2="0.75" MODIFIED="2015-05-11 15:36:10 +0100" MODIFIED_BY="[Empty name]" ORDER="52" SD_1="0.2" SD_2="0.2" SE="0.03195525326737552" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="79.98296925445806"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.14263114552091188" CI_START="0.01736885447908805" DF="0" EFFECT_SIZE="0.07999999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.03" MODIFIED="2015-05-11 17:27:08 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.012297142542150138" STUDIES="1" TAU2="0.0" TOTAL_1="82" TOTAL_2="75" WEIGHT="100.0" Z="2.5035007336861064">
<NAME>Trials conducted in low- or middle-income countries</NAME>
<CONT_DATA CI_END="0.14263114552091188" CI_START="0.01736885447908805" EFFECT_SIZE="0.07999999999999996" ESTIMABLE="YES" MEAN_1="0.83" MEAN_2="0.75" MODIFIED="2015-05-11 17:27:08 +0100" MODIFIED_BY="[Empty name]" ORDER="52" SD_1="0.2" SD_2="0.2" SE="0.03195525326737552" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.010372379735747226" CI_END="0.24746521731890525" CI_START="-0.3147859511807276" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.03366036693091119" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2016-04-04 01:10:02 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.9188798020046988" P_Q="1.0" P_Z="0.8144611025313887" Q="0.0" RANDOM="NO" SCALE="0.75" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="137" TOTAL_2="133" UNITS="" WEIGHT="100.00000000000001" Z="0.23467485916316794">
<NAME>Weight at 12 to 18 months (kg)</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fortified</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.26645798642365315" CI_START="-0.34645798642365144" EFFECT_SIZE="-0.03999999999999915" ESTIMABLE="YES" MEAN_1="10.05" MEAN_2="10.09" MODIFIED="2015-04-21 16:00:01 +0100" MODIFIED_BY="[Empty name]" ORDER="203" SD_1="1.34" SD_2="1.1" SE="0.15635898865538028" STUDY_ID="STD-Lucas-1996" TOTAL_1="125" TOTAL_2="120" WEIGHT="84.15091732727977"/>
<CONT_DATA CI_END="0.7061521823299378" CI_START="-0.7061521823299378" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="9.0" MODIFIED="2015-04-23 13:30:10 +0100" MODIFIED_BY="[Empty name]" ORDER="200" SD_1="0.9" SD_2="0.9" SE="0.36028834606144605" STUDY_ID="STD-Wauben-1998" TOTAL_1="12" TOTAL_2="13" WEIGHT="15.84908267272024"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.44960449854991025" CI_END="0.5989601380890566" CI_START="-0.9787827876877735" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.18991132479935852" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2016-04-04 01:10:17 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5025228584620329" P_Q="1.0" P_Z="0.6370425862732193" Q="0.0" RANDOM="NO" SCALE="3.61" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="137" TOTAL_2="133" UNITS="" WEIGHT="100.00000000000001" Z="0.471837776334522">
<NAME>Length at 12 to 18 months (cm)</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fortified</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.7314980215034923" CI_START="-0.9314980215034809" EFFECT_SIZE="-0.09999999999999432" ESTIMABLE="YES" MEAN_1="80.0" MEAN_2="80.1" MODIFIED="2015-04-23 13:52:49 +0100" MODIFIED_BY="[Empty name]" ORDER="204" SD_1="3.35" SD_2="3.29" SE="0.4242414799773041" STUDY_ID="STD-Lucas-1996" TOTAL_1="125" TOTAL_2="120" WEIGHT="90.00985280007072"/>
<CONT_DATA CI_END="1.4958604675606382" CI_START="-3.495860467560638" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="74.9" MEAN_2="75.9" MODIFIED="2015-04-23 13:51:58 +0100" MODIFIED_BY="[Empty name]" ORDER="201" SD_1="3.7" SD_2="2.5" SE="1.2734215971556961" STUDY_ID="STD-Wauben-1998" TOTAL_1="12" TOTAL_2="13" WEIGHT="9.990147199929293"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0282163353959169" CI_END="0.17885957354513832" CI_START="-0.37318286070306855" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.09716164357896512" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2016-04-04 01:10:28 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.8666012544493654" P_Q="1.0" P_Z="0.4902427618631402" Q="0.0" RANDOM="NO" SCALE="2.47" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="137" TOTAL_2="133" UNITS="" WEIGHT="99.99999999999999" Z="0.6899227678134151">
<NAME>Head circumference at 12 to 18 months (cm)</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fortified</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.17800093045304966" CI_START="-0.3780009304530525" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="48.0" MEAN_2="48.1" MODIFIED="2015-04-23 13:53:23 +0100" MODIFIED_BY="[Empty name]" ORDER="205" SD_1="1.12" SD_2="1.1" SE="0.1418398157547215" STUDY_ID="STD-Lucas-1996" TOTAL_1="125" TOTAL_2="120" WEIGHT="98.58082178948186"/>
<CONT_DATA CI_END="2.416989145835614" CI_START="-2.216989145835611" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="46.9" MEAN_2="46.8" MODIFIED="2015-04-23 13:53:57 +0100" MODIFIED_BY="[Empty name]" ORDER="202" SD_1="3.9" SD_2="1.3" SE="1.182159041753689" STUDY_ID="STD-Wauben-1998" TOTAL_1="12" TOTAL_2="13" WEIGHT="1.419178210518128"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="7.747366362931256" CI_START="-3.3473663629312504" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.200000000000003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2015-05-20 15:27:54 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.43698681067980727" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="125" TOTAL_2="120" UNITS="" WEIGHT="100.0" Z="0.777291508057111">
<NAME>Mental development index at 18 months</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fortified</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.747366362931256" CI_START="-3.3473663629312504" EFFECT_SIZE="2.200000000000003" ESTIMABLE="YES" MEAN_1="106.0" MEAN_2="103.8" MODIFIED="2015-04-21 16:07:31 +0100" MODIFIED_BY="[Empty name]" ORDER="218" SD_1="22.4" SD_2="21.9" SE="2.830340968858699" STUDY_ID="STD-Lucas-1996" TOTAL_1="125" TOTAL_2="120" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.696128986582905" CI_START="-1.896128986582922" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.3999999999999915" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2015-05-20 15:28:18 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.2735521099075111" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="125" TOTAL_2="120" UNITS="" WEIGHT="100.0" Z="1.0949190719335329">
<NAME>Psychomotor development index at 18 months</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fortified</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.696128986582905" CI_START="-1.896128986582922" EFFECT_SIZE="2.3999999999999915" ESTIMABLE="YES" MEAN_1="92.3" MEAN_2="89.9" MODIFIED="2015-04-21 16:07:31 +0100" MODIFIED_BY="[Empty name]" ORDER="219" SD_1="17.9" SD_2="16.4" SE="2.1919428216386785" STUDY_ID="STD-Lucas-1996" TOTAL_1="125" TOTAL_2="120" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.013867757406388131" CI_END="0.9253269150428578" CI_START="-0.16067178912793034" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.38232756295746373" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2015-05-20 15:28:50 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.9062566834831434" P_Q="1.0" P_Z="0.16758145781565714" Q="0.0" RANDOM="NO" SCALE="1.48" SORT_BY="YEAR" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="111" TOTAL_2="99" UNITS="" WEIGHT="100.0" Z="1.380016846826281">
<NAME>Length of hospital stay (weeks)</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours fortified</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.013867757406388131" CI_END="0.9253269150428578" CI_START="-0.16067178912793034" DF="1" EFFECT_SIZE="0.38232756295746373" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.01" MODIFIED="2015-05-11 17:22:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9062566834831434" P_Z="0.16758145781565714" STUDIES="2" TAU2="0.0" TOTAL_1="111" TOTAL_2="99" WEIGHT="100.0" Z="1.380016846826281">
<NAME>All trials</NAME>
<CONT_DATA CI_END="1.3914521392274115" CI_START="-0.5314521392274104" EFFECT_SIZE="0.4300000000000006" ESTIMABLE="YES" MEAN_1="7.86" MEAN_2="7.43" MODIFIED="2015-04-23 14:21:27 +0100" MODIFIED_BY="[Empty name]" ORDER="55" SD_1="2.0" SD_2="1.57" SE="0.490545819622821" STUDY_ID="STD-Zuckerman-1994" TOTAL_1="29" TOTAL_2="24" WEIGHT="31.89651851066268"/>
<CONT_DATA CI_END="1.0179829717521192" CI_START="-0.2979829717521202" EFFECT_SIZE="0.35999999999999943" ESTIMABLE="YES" MEAN_1="4.56" MEAN_2="4.2" MODIFIED="2015-04-23 14:22:42 +0100" MODIFIED_BY="[Empty name]" ORDER="54" SD_1="2.31" SD_2="1.89" SE="0.33571176661520585" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="68.10348148933733"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="3.3048070913035335" CI_END="1.0526892577717792" CI_START="0.5708969486825775" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7752271184451921" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="68" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.02230019117460204" LOG_CI_START="-0.24344227819468425" LOG_EFFECT_SIZE="-0.11057104351004116" METHOD="MH" MODIFIED="2015-05-20 15:29:31 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.7697317060657931" P_Q="0.7764733149943919" P_Z="0.10288670002120719" Q="0.5059860326506487" RANDOM="NO" SCALE="107.77" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="310" TOTAL_2="276" WEIGHT="300.0" Z="1.6310171537657816">
<NAME>Feed intolerance</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours fortified</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.2130013534215154" CI_END="1.485754713641521" CI_START="0.539455798769237" DF="3" EFFECT_SIZE="0.8952647629738623" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="23" I2="6.629357724816732" ID="CMP-001.10.01" LOG_CI_END="0.1719471167564325" LOG_CI_START="-0.2680441341822477" LOG_EFFECT_SIZE="-0.04804850871290757" MODIFIED="2015-05-11 15:36:52 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3599359807407184" P_Z="0.6686007570666221" STUDIES="5" TAU2="0.0" TOTAL_1="137" TOTAL_2="118" WEIGHT="100.0" Z="0.4280691781359189">
<NAME>All trials</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-11 15:27:40 +0100" MODIFIED_BY="[Empty name]" ORDER="57" O_E="0.0" SE="0.0" STUDY_ID="STD-Gross-1987-_x0028_1_x0029_" TOTAL_1="10" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="68.94232410099185" CI_START="0.2427469251771551" EFFECT_SIZE="4.090909090909091" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.838485919733708" LOG_CI_START="-0.6148462624994706" LOG_EFFECT_SIZE="0.6118198286171186" MODIFIED="2015-05-11 15:27:40 +0100" MODIFIED_BY="[Empty name]" ORDER="224" O_E="0.0" SE="1.4410994680339302" STUDY_ID="STD-Gross-1987-_x0028_2_x0029_" TOTAL_1="21" TOTAL_2="9" VAR="2.076767676767677" WEIGHT="2.7268691974339063"/>
<DICH_DATA CI_END="12.004410395970764" CI_START="0.06581943058655557" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0793408342752104" LOG_CI_START="-1.1816458791699729" LOG_EFFECT_SIZE="-0.05115252244738131" MODIFIED="2015-04-21 16:06:23 +0100" MODIFIED_BY="[Empty name]" ORDER="225" O_E="0.0" SE="1.3281147875424355" STUDY_ID="STD-Polberger-1989" TOTAL_1="9" TOTAL_2="8" VAR="1.7638888888888888" WEIGHT="4.199670207812647"/>
<DICH_DATA CI_END="102.37925903707298" CI_START="0.27566771351392755" EFFECT_SIZE="5.3125" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.010211982048814" LOG_CI_START="-0.5596140959320774" LOG_EFFECT_SIZE="0.725298943058368" MODIFIED="2015-05-11 15:27:41 +0100" MODIFIED_BY="[Empty name]" ORDER="226" O_E="0.0" SE="1.5095285590502205" STUDY_ID="STD-Wauben-1998" TOTAL_1="15" TOTAL_2="16" VAR="2.2786764705882354" WEIGHT="1.9230813072812123"/>
<DICH_DATA CI_END="1.225013614158129" CI_START="0.40776165932432884" EFFECT_SIZE="0.7067627494456763" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="22" LOG_CI_END="0.0881409152482219" LOG_CI_START="-0.3895936121201198" LOG_EFFECT_SIZE="-0.15072634843594893" MODIFIED="2015-04-23 14:39:26 +0100" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.2806236262002138" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" VAR="0.07874961958175732" WEIGHT="91.15037928747223"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.02855801948902858" CI_END="1.2244111621001312" CI_START="0.4172755267430676" DF="1" EFFECT_SIZE="0.7147844518562388" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="23" I2="0.0" ID="CMP-001.10.02" LOG_CI_END="0.08792728010236099" LOG_CI_START="-0.3795770859619508" LOG_EFFECT_SIZE="-0.1458249029297949" MODIFIED="2015-05-11 15:37:32 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8658036072126791" P_Z="0.22143858284957152" STUDIES="2" TAU2="0.0" TOTAL_1="91" TOTAL_2="83" WEIGHT="100.0" Z="1.2227118227688596">
<NAME>Trials recruiting only very preterm or VLBW infants</NAME>
<DICH_DATA CI_END="12.004410395970764" CI_START="0.06581943058655557" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0793408342752104" LOG_CI_START="-1.1816458791699729" LOG_EFFECT_SIZE="-0.05115252244738131" MODIFIED="2015-05-11 15:37:32 +0100" MODIFIED_BY="[Empty name]" ORDER="225" O_E="0.0" SE="1.3281147875424355" STUDY_ID="STD-Polberger-1989" TOTAL_1="9" TOTAL_2="8" VAR="1.7638888888888888" WEIGHT="4.404476169695458"/>
<DICH_DATA CI_END="1.225013614158129" CI_START="0.40776165932432884" EFFECT_SIZE="0.7067627494456763" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="22" LOG_CI_END="0.0881409152482219" LOG_CI_START="-0.3895936121201198" LOG_EFFECT_SIZE="-0.15072634843594893" MODIFIED="2015-05-11 15:37:32 +0100" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.2806236262002138" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" VAR="0.07874961958175732" WEIGHT="95.59552383030454"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.225013614158129" CI_START="0.40776165932432884" DF="0" EFFECT_SIZE="0.7067627494456763" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="22" I2="0.0" ID="CMP-001.10.03" LOG_CI_END="0.0881409152482219" LOG_CI_START="-0.3895936121201198" LOG_EFFECT_SIZE="-0.15072634843594893" MODIFIED="2015-05-11 17:28:31 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.2161812920977464" STUDIES="1" TAU2="0.0" TOTAL_1="82" TOTAL_2="75" WEIGHT="100.0" Z="1.236746341458893">
<NAME>Trials conducted in low- or middle-income countries</NAME>
<DICH_DATA CI_END="1.225013614158129" CI_START="0.40776165932432884" EFFECT_SIZE="0.7067627494456763" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="22" LOG_CI_END="0.0881409152482219" LOG_CI_START="-0.3895936121201198" LOG_EFFECT_SIZE="-0.15072634843594893" MODIFIED="2015-05-11 17:28:31 +0100" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.2806236262002138" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" VAR="0.07874961958175732" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.645905597142774" CI_END="2.441430779584944" CI_START="0.8480099018553571" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="1.43887368305299" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.38764441550506745" LOG_CI_START="-0.07159907663947065" LOG_EFFECT_SIZE="0.15802266943279838" METHOD="MH" MODIFIED="2016-04-24 12:27:20 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.880099644169603" P_Q="0.8659693763111825" P_Z="0.1773943171600681" Q="0.2878114917307353" RANDOM="NO" SCALE="100.81633744908991" SORT_BY="YEAR" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="890" TOTAL_2="841" WEIGHT="300.0" Z="1.3488214689025375">
<NAME>Necrotising enterocolitis</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours fortified</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.550869681857196" CI_END="3.233601235021203" CI_START="0.7647652132010164" DF="5" EFFECT_SIZE="1.5725602493729964" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="11" I2="0.0" ID="CMP-001.11.01" LOG_CI_END="0.509686462042948" LOG_CI_START="-0.11647187499246626" LOG_EFFECT_SIZE="0.19660729352524087" MODIFIED="2015-05-11 15:37:50 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6157049146120358" P_Z="0.21839127772342948" STUDIES="11" TAU2="0.0" TOTAL_1="449" TOTAL_2="433" WEIGHT="100.0" Z="1.230817164335138">
<NAME>All trials</NAME>
<DICH_DATA CI_END="17.12177745550138" CI_START="0.07210512485886156" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2335488479022445" LOG_CI_START="-1.1420338667808942" LOG_EFFECT_SIZE="0.04575749056067514" MODIFIED="2015-04-20 15:11:15 +0100" MODIFIED_BY="[Empty name]" ORDER="227" O_E="0.0" SE="1.3954290459289653" STUDY_ID="STD-Faerk-2000" TOTAL_1="36" TOTAL_2="40" VAR="1.9472222222222224" WEIGHT="8.16486171543757"/>
<DICH_DATA CI_END="93.18795082934068" CI_START="0.24333335758158653" EFFECT_SIZE="4.761904761904762" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9693597618537708" LOG_CI_START="-0.6137983513216091" LOG_EFFECT_SIZE="0.6777807052660807" MODIFIED="2015-04-20 15:11:15 +0100" MODIFIED_BY="[Empty name]" ORDER="230" O_E="0.0" SE="1.5173598625181017" STUDY_ID="STD-Modanlou-1986" TOTAL_1="20" TOTAL_2="19" VAR="2.3023809523809526" WEIGHT="4.414335805500801"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-04-23 14:45:07 +0100" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="0.0" STUDY_ID="STD-Polberger-1989" TOTAL_1="7" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="24.71249127357166" CI_START="0.28639798437231073" EFFECT_SIZE="2.660377358490566" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.392916528964507" LOG_CI_START="-0.5430300428553252" LOG_EFFECT_SIZE="0.42494324305459086" MODIFIED="2015-04-20 15:11:15 +0100" MODIFIED_BY="[Empty name]" ORDER="231" O_E="0.0" SE="1.137184599377054" STUDY_ID="STD-Pettifor-1989" TOTAL_1="53" TOTAL_2="47" VAR="1.2931888130603506" WEIGHT="9.135573052717373"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-11 15:28:27 +0100" MODIFIED_BY="[Empty name]" ORDER="257" O_E="0.0" SE="0.0" STUDY_ID="STD-Porcelli-1992" TOTAL_1="7" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="12.544542152665894" CI_START="0.054597363659053225" EFFECT_SIZE="0.8275862068965517" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0984548151763904" LOG_CI_START="-1.2628283275510905" LOG_EFFECT_SIZE="-0.08218675618735007" MODIFIED="2015-04-20 15:11:15 +0100" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="1.3870294065781892" STUDY_ID="STD-Zuckerman-1994" TOTAL_1="29" TOTAL_2="24" VAR="1.9238505747126435" WEIGHT="9.43152789351384"/>
<DICH_DATA CI_END="9.912324632696002" CI_START="0.7279121795185831" EFFECT_SIZE="2.6861313868613137" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.996175516923275" LOG_CI_START="-0.13792101388905323" LOG_EFFECT_SIZE="0.42912725151711084" MODIFIED="2015-05-11 15:28:27 +0100" MODIFIED_BY="[Empty name]" ORDER="229" O_E="0.0" SE="0.6661739160675284" STUDY_ID="STD-Lucas-1996" TOTAL_1="137" TOTAL_2="138" VAR="0.44378768644874644" WEIGHT="25.761375812465456"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-11 15:28:28 +0100" MODIFIED_BY="[Empty name]" ORDER="232" O_E="0.0" SE="0.0" STUDY_ID="STD-Wauben-1998" TOTAL_1="15" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-04-20 15:12:06 +0100" MODIFIED_BY="[Empty name]" ORDER="254" O_E="0.0" SE="0.0" STUDY_ID="STD-Nicholl-1999" TOTAL_1="13" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.3769254785758167" CI_START="0.15145615764769424" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.37601556593068625" LOG_CI_START="-0.819713065163399" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2015-04-20 15:15:19 +0100" MODIFIED_BY="[Empty name]" ORDER="256" O_E="0.0" SE="0.7023769168568492" STUDY_ID="STD-Bhat-2003" TOTAL_1="50" TOTAL_2="50" VAR="0.4933333333333333" WEIGHT="43.09232572036496"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-04-23 14:45:31 +0100" MODIFIED_BY="[Empty name]" ORDER="255" O_E="0.0" SE="0.0" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.354718204503175" CI_END="2.8772711611086046" CI_START="0.48898204997252587" DF="4" EFFECT_SIZE="1.1861424664371962" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" I2="0.0" ID="CMP-001.11.02" LOG_CI_END="0.4589807927988508" LOG_CI_START="-0.310707083086941" LOG_EFFECT_SIZE="0.07413685485595486" MODIFIED="2015-05-11 15:39:02 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6708254540133106" P_Z="0.7057499782916357" STUDIES="7" TAU2="0.0" TOTAL_1="277" TOTAL_2="262" WEIGHT="99.99999999999999" Z="0.3775701034072304">
<NAME>Trials recruiting only very preterm or VLBW infants</NAME>
<DICH_DATA CI_END="17.12177745550138" CI_START="0.07210512485886156" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2335488479022445" LOG_CI_START="-1.1420338667808942" LOG_EFFECT_SIZE="0.04575749056067514" MODIFIED="2015-05-11 15:39:02 +0100" MODIFIED_BY="[Empty name]" ORDER="227" O_E="0.0" SE="1.3954290459289653" STUDY_ID="STD-Faerk-2000" TOTAL_1="36" TOTAL_2="40" VAR="1.9472222222222224" WEIGHT="10.99813177411838"/>
<DICH_DATA CI_END="93.18795082934068" CI_START="0.24333335758158653" EFFECT_SIZE="4.761904761904762" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9693597618537708" LOG_CI_START="-0.6137983513216091" LOG_EFFECT_SIZE="0.6777807052660807" MODIFIED="2015-05-11 15:39:02 +0100" MODIFIED_BY="[Empty name]" ORDER="230" O_E="0.0" SE="1.5173598625181017" STUDY_ID="STD-Modanlou-1986" TOTAL_1="20" TOTAL_2="19" VAR="2.3023809523809526" WEIGHT="5.946144414462377"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-11 15:39:02 +0100" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="0.0" STUDY_ID="STD-Polberger-1989" TOTAL_1="7" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="24.71249127357166" CI_START="0.28639798437231073" EFFECT_SIZE="2.660377358490566" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.392916528964507" LOG_CI_START="-0.5430300428553252" LOG_EFFECT_SIZE="0.42494324305459086" MODIFIED="2015-05-11 15:39:02 +0100" MODIFIED_BY="[Empty name]" ORDER="231" O_E="0.0" SE="1.137184599377054" STUDY_ID="STD-Pettifor-1989" TOTAL_1="53" TOTAL_2="47" VAR="1.2931888130603506" WEIGHT="12.3056874405969"/>
<DICH_DATA CI_END="12.544542152665894" CI_START="0.054597363659053225" EFFECT_SIZE="0.8275862068965517" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0984548151763904" LOG_CI_START="-1.2628283275510905" LOG_EFFECT_SIZE="-0.08218675618735007" MODIFIED="2015-05-11 15:39:02 +0100" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="1.3870294065781892" STUDY_ID="STD-Zuckerman-1994" TOTAL_1="29" TOTAL_2="24" VAR="1.9238505747126435" WEIGHT="12.704340896308654"/>
<DICH_DATA CI_END="2.3769254785758167" CI_START="0.15145615764769424" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.37601556593068625" LOG_CI_START="-0.819713065163399" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2015-05-11 15:39:02 +0100" MODIFIED_BY="[Empty name]" ORDER="256" O_E="0.0" SE="0.7023769168568492" STUDY_ID="STD-Bhat-2003" TOTAL_1="50" TOTAL_2="50" VAR="0.4933333333333333" WEIGHT="58.04569547451368"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-11 15:39:02 +0100" MODIFIED_BY="[Empty name]" ORDER="255" O_E="0.0" SE="0.0" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.42578692021668657" CI_END="9.11470919613043" CI_START="0.3281220157788137" DF="1" EFFECT_SIZE="1.7293746715712035" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-001.11.03" LOG_CI_END="0.9597428170907696" LOG_CI_START="-0.48396462907606336" LOG_EFFECT_SIZE="0.23788909400735314" MODIFIED="2015-05-11 17:29:31 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5140635359936794" P_Z="0.5183362846904345" STUDIES="3" TAU2="0.0" TOTAL_1="164" TOTAL_2="146" WEIGHT="100.0" Z="0.6459121033242848">
<NAME>Trials conducted in low- or middle-income countries</NAME>
<DICH_DATA CI_END="24.71249127357166" CI_START="0.28639798437231073" EFFECT_SIZE="2.660377358490566" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.392916528964507" LOG_CI_START="-0.5430300428553252" LOG_EFFECT_SIZE="0.42494324305459086" MODIFIED="2015-05-11 17:29:31 +0100" MODIFIED_BY="[Empty name]" ORDER="231" O_E="0.0" SE="1.137184599377054" STUDY_ID="STD-Pettifor-1989" TOTAL_1="53" TOTAL_2="47" VAR="1.2931888130603506" WEIGHT="49.20301278682782"/>
<DICH_DATA CI_END="12.544542152665894" CI_START="0.054597363659053225" EFFECT_SIZE="0.8275862068965517" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0984548151763904" LOG_CI_START="-1.2628283275510905" LOG_EFFECT_SIZE="-0.08218675618735007" MODIFIED="2015-05-11 17:29:31 +0100" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="1.3870294065781892" STUDY_ID="STD-Zuckerman-1994" TOTAL_1="29" TOTAL_2="24" VAR="1.9238505747126435" WEIGHT="50.79698721317219"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-11 17:29:31 +0100" MODIFIED_BY="[Empty name]" ORDER="255" O_E="0.0" SE="0.0" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="27.259650323867913" CI_END="-88.2096151787832" CI_START="-163.8180412809965" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="MD" EFFECT_SIZE="-126.01382822988985" ESTIMABLE="YES" I2="55.978892401664154" I2_Q="0.0" ID="CMP-001.12" MODIFIED="2015-05-11 17:35:04 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.007088640189163442" P_Q="0.9667101314170495" P_Z="6.437816749882319E-11" Q="0.06771317904888863" RANDOM="NO" SCALE="860.34" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="461" TOTAL_2="438" UNITS="" WEIGHT="300.0" Z="6.53320212090411">
<NAME>Serum ALP (IU/L): restricted to trials without mineral supplementation of the control group</NAME>
<GROUP_LABEL_1>Fortified</GROUP_LABEL_1>
<GROUP_LABEL_2>Unfortified</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours fortified</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="9.597183101611234" CI_END="-61.830992576545995" CI_START="-190.89245740464025" DF="4" EFFECT_SIZE="-126.36172499059312" ESTIMABLE="YES" I2="58.321103623328234" ID="CMP-001.12.01" MODIFIED="2015-05-11 15:41:36 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.04778824293351758" P_Z="1.240758684762536E-4" STUDIES="5" TAU2="0.0" TOTAL_1="166" TOTAL_2="159" WEIGHT="100.0" Z="3.8379299403706373">
<NAME>All trials</NAME>
<CONT_DATA CI_END="293.74959476466455" CI_START="-309.74959476466455" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="711.0" MEAN_2="719.0" MODIFIED="2015-05-11 15:41:14 +0100" MODIFIED_BY="[Empty name]" ORDER="202" SD_1="646.0" SD_2="542.0" SE="153.95670387049296" STUDY_ID="STD-Gathwala-2012" TOTAL_1="30" TOTAL_2="30" WEIGHT="4.5734064250577715"/>
<CONT_DATA CI_END="35.60594155469994" CI_START="-605.6059415546999" EFFECT_SIZE="-285.0" ESTIMABLE="YES" MEAN_1="790.0" MEAN_2="1075.0" MODIFIED="2015-05-06 14:22:54 +0100" MODIFIED_BY="[Empty name]" ORDER="210" SD_1="202.0" SD_2="434.0" SE="163.577465751207" STUDY_ID="STD-Modanlou-1986" TOTAL_1="7" TOTAL_2="9" WEIGHT="4.051259435409015"/>
<CONT_DATA CI_END="-5.339076841588849" CI_START="-154.66092315841115" EFFECT_SIZE="-80.0" ESTIMABLE="YES" MEAN_1="556.0" MEAN_2="636.0" MODIFIED="2015-05-06 15:57:07 +0100" MODIFIED_BY="[Empty name]" ORDER="201" SD_1="231.0" SD_2="245.0" SE="38.0930077018389" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="74.70445083968079"/>
<CONT_DATA CI_END="-167.93129964440325" CI_START="-552.0687003555968" EFFECT_SIZE="-360.0" ESTIMABLE="YES" MEAN_1="483.0" MEAN_2="843.0" MODIFIED="2015-05-06 14:22:54 +0100" MODIFIED_BY="[Empty name]" ORDER="211" SD_1="152.0" SD_2="514.0" SE="97.99603557545451" STUDY_ID="STD-Pettifor-1989" TOTAL_1="29" TOTAL_2="30" WEIGHT="11.288077779104372"/>
<CONT_DATA CI_END="17.13923109645566" CI_START="-539.1392310964557" EFFECT_SIZE="-261.0" ESTIMABLE="YES" MEAN_1="620.0" MEAN_2="881.0" MODIFIED="2015-05-06 14:22:54 +0100" MODIFIED_BY="[Empty name]" ORDER="213" SD_1="368.0" SD_2="435.0" SE="141.91037860408784" STUDY_ID="STD-Zuckerman-1994" TOTAL_1="18" TOTAL_2="15" WEIGHT="5.382805520748062"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="8.97780486455724" CI_END="-65.97533541666319" CI_START="-198.09330154592317" DF="3" EFFECT_SIZE="-132.03431848129318" ESTIMABLE="YES" I2="66.5842592341981" ID="CMP-001.12.02" MODIFIED="2015-05-11 15:42:07 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.029587472962902317" P_Z="8.949202820580747E-5" STUDIES="4" TAU2="0.0" TOTAL_1="136" TOTAL_2="129" WEIGHT="100.0" Z="3.917446151016908">
<NAME>Trials recruiting only very preterm or VLBW infants</NAME>
<CONT_DATA CI_END="35.60594155469994" CI_START="-605.6059415546999" EFFECT_SIZE="-285.0" ESTIMABLE="YES" MEAN_1="790.0" MEAN_2="1075.0" MODIFIED="2015-05-11 15:42:07 +0100" MODIFIED_BY="[Empty name]" ORDER="210" SD_1="202.0" SD_2="434.0" SE="163.577465751207" STUDY_ID="STD-Modanlou-1986" TOTAL_1="7" TOTAL_2="9" WEIGHT="4.245419734308552"/>
<CONT_DATA CI_END="-5.339076841588849" CI_START="-154.66092315841115" EFFECT_SIZE="-80.0" ESTIMABLE="YES" MEAN_1="556.0" MEAN_2="636.0" MODIFIED="2015-05-11 15:42:07 +0100" MODIFIED_BY="[Empty name]" ORDER="201" SD_1="231.0" SD_2="245.0" SE="38.0930077018389" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="78.28472969750561"/>
<CONT_DATA CI_END="-167.93129964440325" CI_START="-552.0687003555968" EFFECT_SIZE="-360.0" ESTIMABLE="YES" MEAN_1="483.0" MEAN_2="843.0" MODIFIED="2015-05-11 15:42:07 +0100" MODIFIED_BY="[Empty name]" ORDER="211" SD_1="152.0" SD_2="514.0" SE="97.99603557545451" STUDY_ID="STD-Pettifor-1989" TOTAL_1="29" TOTAL_2="30" WEIGHT="11.82906918943869"/>
<CONT_DATA CI_END="17.13923109645566" CI_START="-539.1392310964557" EFFECT_SIZE="-261.0" ESTIMABLE="YES" MEAN_1="620.0" MEAN_2="881.0" MODIFIED="2015-05-11 15:42:07 +0100" MODIFIED_BY="[Empty name]" ORDER="213" SD_1="368.0" SD_2="435.0" SE="141.91037860408784" STUDY_ID="STD-Zuckerman-1994" TOTAL_1="18" TOTAL_2="15" WEIGHT="5.640781378747145"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="8.61694917865054" CI_END="-53.7845215941027" CI_START="-185.54250849314596" DF="3" EFFECT_SIZE="-119.66351504362433" ESTIMABLE="YES" I2="65.18489388990669" ID="CMP-001.12.03" MODIFIED="2015-05-11 17:29:54 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.03484213889036014" P_Z="3.7070555746554257E-4" STUDIES="4" TAU2="0.0" TOTAL_1="159" TOTAL_2="150" WEIGHT="100.0" Z="3.5601056948248457">
<NAME>Trials conducted in low- or middle-income countries</NAME>
<CONT_DATA CI_END="293.74959476466455" CI_START="-309.74959476466455" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="711.0" MEAN_2="719.0" MODIFIED="2015-05-11 17:29:54 +0100" MODIFIED_BY="[Empty name]" ORDER="202" SD_1="646.0" SD_2="542.0" SE="153.95670387049296" STUDY_ID="STD-Gathwala-2012" TOTAL_1="30" TOTAL_2="30" WEIGHT="4.766510115866539"/>
<CONT_DATA CI_END="-5.339076841588849" CI_START="-154.66092315841115" EFFECT_SIZE="-80.0" ESTIMABLE="YES" MEAN_1="556.0" MEAN_2="636.0" MODIFIED="2015-05-11 17:29:54 +0100" MODIFIED_BY="[Empty name]" ORDER="201" SD_1="231.0" SD_2="245.0" SE="38.0930077018389" STUDY_ID="STD-Mukhopadhyay-2007" TOTAL_1="82" TOTAL_2="75" WEIGHT="77.8587091400028"/>
<CONT_DATA CI_END="-167.93129964440325" CI_START="-552.0687003555968" EFFECT_SIZE="-360.0" ESTIMABLE="YES" MEAN_1="483.0" MEAN_2="843.0" MODIFIED="2015-05-11 17:29:54 +0100" MODIFIED_BY="[Empty name]" ORDER="211" SD_1="152.0" SD_2="514.0" SE="97.99603557545451" STUDY_ID="STD-Pettifor-1989" TOTAL_1="29" TOTAL_2="30" WEIGHT="11.76469614158764"/>
<CONT_DATA CI_END="17.13923109645566" CI_START="-539.1392310964557" EFFECT_SIZE="-261.0" ESTIMABLE="YES" MEAN_1="620.0" MEAN_2="881.0" MODIFIED="2015-05-11 17:29:54 +0100" MODIFIED_BY="[Empty name]" ORDER="213" SD_1="368.0" SD_2="435.0" SE="141.91037860408784" STUDY_ID="STD-Zuckerman-1994" TOTAL_1="18" TOTAL_2="15" WEIGHT="5.6100846025430124"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.7002775982869946E-31" CI_END="17.723492924230126" CI_START="6.276507075769872" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="11.999999999999998" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-001.13" MODIFIED="2015-05-20 15:30:47 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="1.0" P_Z="3.9685474095548515E-5" Q="0.0" RANDOM="NO" SCALE="17.91" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="29" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="4.109303204501523">
<NAME>Bone mineral content (mg/cm): restricted to trials without mineral supplementation of the control group</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fortified</GRAPH_LABEL_2>
<CONT_DATA CI_END="17.723492924230126" CI_START="6.2765070757698735" EFFECT_SIZE="12.0" ESTIMABLE="YES" MEAN_1="59.0" MEAN_2="47.0" MODIFIED="2015-05-06 14:32:32 +0100" MODIFIED_BY="[Empty name]" ORDER="274" SD_1="13.0" SD_2="9.0" SE="2.920203110555249" STUDY_ID="STD-Pettifor-1989" TOTAL_1="29" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-04-24 12:33:56 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-03-21 17:06:25 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAeEAAAGzCAYAAAAYDK/yAAA/u0lEQVR42u2df2SX6//HDzmOHElk
MskxZiZJRuZIjhnJHP0xI0nyccQxk8kcMplJIpmZOSJJkkRyJEkkk0liJsdkYuZIkphMjhz31/Py
vd6u97X7vq/rfr/f29577/HgbXu/7/u+ft3XfT3v67pf9+v1XeLw3Xff8eHDJ/IDAFAt37kCDAAF
Lh6uGQCohQgzmAAgxACwLmMIgwgAQgwAiDAAIgwAiDAAIMIAgAgDIMIAgAgDACIMAIgwACIMAIgw
rDdv3ryhERDhda8/Hz58KnPyExThr1+/Jq2trcELcWlpKTfD5eXl5Pfff09+/PHH5Icffkj6+vqS
z58/l6Xxxx9/JNu2bUu2bt1qtn/48GHdB8NapummVat01ZabUUTqqcybWYS5iQeo7prJFeFv374l
vb29URfaw4cPjXBmcfbs2WRycjL577//zEeC6+5/5cqVZGJiorT94sWLyS+//NKwIlxPaSLCCBH1
BlifaydXhCWCi4uLURebRHN8fDxz+44dO4y4ugLvzuJaWlrMbNnl+++/z0xPafX395uZc3Nzc3Ln
zp0V5RwdHU22b99uZt+Dg4PBOoTSzFhKKPv/5s2byc6dO02eAwMDZiUhNBP+999/k1OnTpkVgLa2
tmR6erq07d27d8mvv/5qtqk9tP3Bgwepy4Ax9Y5pN79+L1++TJqampKOjo6oPPLqY1c8dJy2q4/9
888/ufmFyvzo0SPTNlu2bEn27duXPH/+HDGizgAb4hrKFeGnT59GX3CaMXd3d5uBWYOlBto8NFBr
oE1DS9sa5E+cOJF5/NjYWHLp0iUzQH/8+DE5dOhQWTn//PPP5MaNG2a7BF8D9+XLl3PLFEozRoQP
HDhgREVpqA5aAQiJ8IULF5J79+6VVhTa29tL2/bv35/cvn27tEKg1QK33fwyheodqmNa/XQzof3f
v38flUdefa5evVq24qG0JNh5+YXKLAF+/Pix+f/Jkyfmhg5Bos4AG16Ei1xwu3btSm7dulWauVy7
ds0Mxllo37Ttx48fN7MkfWZmZjKP1yxJQm55/fp1WTklhu7M28628wilGSPC7qxPM/vdu3cHRVgi
5Zc1D834ssoUqneojmn1c2eqMXnk1Wfv3r1l+et/rRzk5Rcqs25KrOgjSNQZYFOKsI8GYQlzGp8+
fTJiq1lUFppJa2kxC3+pWvn5syN/udYVr0rSjBFhX3zcNLPSylt2F1qe1Q2LVgYkYnllCtU7VMeY
c180j6wbiFAbxZZZs1+7CjEyMoIgUWcARDhrwJXwnjx50iwr5qH98gbztG1uOfMEN+tZaijNGBGO
FZhYEdYzZs0sr1+/bh4PaIk2L8+iNxqh85u2rZI8qmnjmDLrRkVL30eOHEmGhoYQJOoMsLlEWEuK
X758KX3X8qGMcvwZsF5TWlhYWHG8lhRdYfaXKX06OzvLlij//vvvsnJqFq1ny0UIpem3g+rhb5+d
nS191ytYej4eEhu9Apa1fKvj3Xqk5ekSqneojjHnPpRHXn10rL8c7RropeVXpMxq/7UWCEQYANZd
hM+dO2cMkazBjQx19EqS5cWLF8nhw4cz3/3V8rOWEu3x58+fN58sZKwki2xrrNPV1VVWThkAWWMe
ffQ99MpTKE3XAEhW47Ja9gVReehYWwcZrIVEWEvNWlIVz549KzNk2rNnT8kaWuJz8ODBsmNlYaxn
qFakQvUO1THm3IfyyKuP9pUVvT1WfcR9Dz0tv1CZlb4spIXOT2h5H0GizgANIcLu73oV58yZM2ZW
o9eRNEi7yEApz5mHlp9lFavjZZQVsq4WerdYs2VZZMvK1i/n8PCwmUkqTQmmtbatNE07wGs5VsKh
gd8XVgmmnoVrZq8bE9chSZYIq+30zrTS1jNfGR5ZpqamjNGTtklsZIDkHqubHdXPnU2G6h1qt5hz
n5dHXn3sDZc1vpNl9Pz8fDC/vDJrKVr56LwoTyvICNL61blWTn50/dhX9NRfZEuS9igrNj9uala/
LOt9fEOKcBa//fYbtzPMDjjviHAZtXTyo9U1d4VMb1XoBrDS/OhDiHBDiXDeK0gMxsB535x1rqWT
H/ke0GMYV3CPHj1acX6N6Hwmq+xaNdDjIDdd23Z5dSpijFqt06SizoMQYcilFn6cARHe6HWupZMf
/eYb+bnGjkXzazTnM3llV36yIdE2Ldcrnbm5uWCdiohwtU6TijoPQoQBABEuIHghQk5+0ozssgzv
YsvUSM5nQmWXCEroJHyu9768OhUR4WqdJhV1HoQIAwAiXEMR9vGd/IScu9SiTBvZ+UyMUyKloxsD
vSIaU6ciIlyt06SizoMQYQBAhFdRhH1h85ees36rpkwb2flMqOyip6fHzHzXQoT97bV2HoQIAwAi
XEMRDjn5kQi50dX0bDPrff9Ky7SRnc+Eyq738PVMVh733OXovDoVcVBUrdOkos6DEGEA2BQi7L+v
u1oiHHLyo22uYxiJSdYSbaVl2sjOZ/LKLsOsn3/+uUwQ3759G6xTEQdF1TpNKuo8CBEGgE0lwllO
NNbKyY+ERAOzdUijpVXXAU6tbgw2svOZrLKrzO4rSvpf20N1KuKgKFSXUNvGHI8IM3ACxF5Mm+pT
KTj5AUCEEWGgL63yTDgLnPwARIhwnteWkLeVoh5pQtuVpowLFMzALtHY5xQxx29mryyACFcjwtzE
AqyTCOd5bQl5WynqkSa0XWnqWYJ96d03VsArCyDC1BmgoUQ4z2tLyNtKUY80oe1paeKVBRAk6gzQ
sCKc57Ul9kVvd/+Q15S87TEvjOOVBRAk6gzQMCIssry2FBXhkNeU0PaQCOOVBRAk6gzQcCJs8b22
xHpbsYS8poS2h0QYryyAIFFngIYS4TyvLbHeViwhrymh7SERxisLIEjUGaChRDjPa0ustxWXkNeU
vO0hEY5Jf7N6ZQEEiToDbEARBgAEiToDIMIACBJ1BkCEAQBBQoQBEGEABIk6AyDCAFxMiDAAIMIA
CBJ1BkCEARAk6g0A4WsHEQZAjKg7wDpdM4gwAEJUdf358OET90m5fhBhAEQYANZp/GAAAUCEAQAR
BkCEAQARBgBEGAAQYQBEGAAQYQBAhAEAEQZAhAGgEcYPBhEABBgA1lGEGUwAEGAAWEcRtoMKHz58
KvN8AwBQlQgDMy4AAECEAREGAECEAREGAABEGBEGAABEGBBhAABAhBFhAABAhAERBgAARBgRBgAA
RBgQYQAAQIQRYQAAQIQBEQYAAEQYEQYAAEQYEGEAAEQYEGEAAECEAREGAECEAREGAABEGBEGAABE
GBBhAABAhBFhAABAhAERBgAARBgRBgAARBgQYQAAQIQRYQAAQIQBEQYAAEQYEQYAAEQYEGEAAEQY
EGEAAECEAREGAECEAREGAABEGBEGAABEGBBhAABAhBFhAABAhAERBgAARBgRBgAARBgQYQAAQIQR
YQAAQIQBEQYAAEQYEQYAAEQYEGEAAEQYEGEAAECEARGGjdI/+fDhE/dBhBFhAPomQJ1cM1xBDHQA
9EuAdbp2uIoY7ADokwDrdA1xJTHgAdAnARBhYMAD+iQAIgwMeAD0SQBEGBjwgD4JgAgDAx4AfRIA
EWbAA9jMffLNmzecAECEAREG+qTPly9fklOnTiU//PBDsnPnzmRwcDD5/PlzTfNW2pVcHxvpOqq2
rOt9PCDCiDDAOvTJM2fOJJcvX07+++8/8xkfH096e3vr4npAhBlzEGHggoCG7pOapUp8Lfp/27Zt
mem8e/cu+fXXX5OtW7cm33//fdLW1pY8ePCgLJ+XL18mTU1NSUdHR6ofXrcs//77r5mJKz2lNT09
nVnm0dHRZPv27cmPP/5oZuwujx49MuXZsmVLsm/fvuT58+e57ZGV1vHjx5Nnz56VpXv06NFCZU31
N+z8pjbu7+837dzc3JzcuXOnUF1DxzP+IMKcLC4C2KAiLKHxl49d9u/fn9y+fbs0c56YmDCC6+Yz
MDBgtr1//z41b/f7hQsXknv37pn/Hz58mLS3t6fu9+effyY3btww6X779s0Ij2bwFgnw48ePzf9P
njxJWlpaMuuQl5bKfPDgQbPt69evJp25ublCZQ2J8NjYWHLp0iWTx8ePH5NDhw4VqmvoeECEOVlc
ELBB+qRmdlqCtqJz9uxZM5ssgru/8vnnn39y83a/S8jcm4Cs/Q4cOLBiP1dodSNgBTJEKC2JoIRO
wqf2KFrWkAhrhUA3O5bXr18XqmvoeECEOVlcELBB+qSMsLQEq5lka2urmUXmzYSFlps1Kzxx4kSy
d+/eQgLkf1e+MWXWfv7Stiv+Krd+k4CNjIzklj+UlhVCGap9+vSpcFlDbeCnI8EtUtfQ8YAIc7K4
IGCD9sm///7bPGfM4ubNm2ZGeP369eTp06dm+XYtRDhmdq6bAy0THzlyJBkaGoqauWfR09Nj6rkW
Ily0rqHjARHmZHFBwAbtk/fv3zcz3CxkDLS0tFT6vrCwUJUIa/Yds8QrYys33zxmZ2dz6xtKa3Jy
0jyT1Y2GuxwdW1Y/b7+NOjs7y5aTdeNTpK6h4wER5mRxQcAG6ZOa7Ul4hSyfNYvUM8Ys9uzZU7KG
1uAvI6aQCMuaWM+JrXD4hllaShaySs4ydrp69WrJGEkfff/ll1/K6iFLZiEDrbxZa15amtn//PPP
ZYL49u3bQmV1jcQWFxeNNbm7XYZtFy9eLBlWdXV1Fapr6HhAhDlZXBCwQfqkBFeGPvaZcMi4aWpq
yhgJaX+JkPYPibAMnPSc2T5rdveRMVhfX59JT8+X3RsAP63h4WEzE1c6EjZrfS20FK3jtZSrtKwg
Z5GVlsrivqKk/7W9SFntTYDKojZVWfy6XLlyxTxz1mtIMgQrUtfQ8Yw/iDAni4sA6JMAiDAw4AHQ
JwEQYQY8APokACIMDHhAnwQARJgBD4A+CYAIAwMe0CcBABFmwAOgTwIgwsCAB/RJAECEGfAA6JMA
iDAw4AF9EgARBgY8APokACIMDHhAnwRAhIEBD4A+CYAIc7I4TUCfBECEgQEPgD4JgAgz4AHQJwEQ
YWDAA/okACDCDHgA9EkARBgY8IA+Cbm8efOGunINIcIMeACN1SdVtjt37tR9mX/44Yc1a/Nqjn30
6FHy/fffJwcOHKhZXd3y+Omvxnl68uRJ0tPTU/q+vLyc/P7778mPP/5oytbX15d8/vy5tP3XX39N
nj17hggDIgz0yUrK1tHRkXz9+rWuy7xRrmsJ5OPHj1etrrVIP4QEfm5urvT97NmzyeTkZPLff/+Z
zx9//GGE2KJ91YcQYUCEgT5ZQdmuXbuWjIyM5JZZA69mQlu3bk1++eWX5J9//slN8+bNm8nOnTvN
MQMDA2Uir+0vX75MmpqaygbvrDy0v/uxjI6OJtu3bzfHDA4OZpZf/9+4cSPZs2dPsmXLlqCQVXps
Vjnz2s5vi7Q03L9Z22LbJK3dXV68eJF0d3eX/bZjxw4jvpZv376tmK3rGB2LCAMiDJu6T/oDdShv
u/3gwYMrxMFy9erVZGJiojQT+vPPP5NTp07lpqnZlNLT/hIGzabc7RJmbXv//n1UHn49tF3iqH0l
ClpSv3z5cqaQasnU1k8iKjGNFeFKj42tl98Wfhp+ebK2xbSJn5ePzpNuoPL4999/jZC7XL9+vewc
I8IMeACbrk+mCXBIiO22qamp5Pjx46ll3rt3rxl43UFYs9y8NKenp0vf9Uxx9+7dZdv9mXQoD78O
Enl3diZaWloyhcvPL6ZNqj02tl6h9GNFOKZN8lYw7M3Y33//nbvPrVu3kgsXLpT9pmN0LCIMiDAg
whWIsJAIS4z937UM6xOaDfpi4O6fVp5QHv4x2ubX0U0jT7iKinClx1ZSr2pEuEibZKElc//cuXz6
9Mn0E820XXSMlsARYUCEYVP2yTwBjhWNxcXF0mzGH9yrEaIY4QnlESNuqyGk1Ypw0XpVI8JF2iSL
vDQkvCdPnkw+fvyYuj3vxgwRZsADYCYcUTYZaMlQy/193759K5ZU814Z0rGzs7Ol73qdZdu2bbnt
EcrDP0b7Ly0t1b0IF61XNSJcpE2KzoQ1A9ZrSgsLC5kCzUwYEGFAhKsUYVkx69mib5g1Pj5eMi7S
6yqtra25acoKWDMm7X/+/Pmkt7c3tz1CeUgc9DzTCpr2v3TpUml/fVee9SbCoXqlpeXXNVaEi7RJ
FloJef36ddlvsno+fPhw8uHDh8zjZmZmeCYMiDDQJyu1jnaRVW3WK0r6yLp3fn4+N80HDx4ku3bt
Mla0586dK3PukFWmvDxk5asZpDuLHB4eNjNs/SYLZtfit15EOFSvtP39usaKcJE2yUIWzrKydpFR
XahfafUE62hAhIE+SX2hCmTV7s6eYzl06JB5BxkRBgYAoE9SX6gCPY4o4r9arydV46YTEWYAAKBP
1pCifp6hvpBDkmPHjkXvr33xHQ2IMNAnARr8GuJKYsADoE8CIMLAgAf0SQBEGBjwAOiTAIgwMOAB
fRIAEQYGPAD6pEORV14AEGEGPIBN0yflF1gB4OXdSk74FX5PXrNqSS1eW+Larp/2WutzgQjT8QAa
sk9++fIl6ejoMMHgra/iV69eJT/99FMwuPtatwHX9ubt04gwnQOgIfukgrPL0b+PhFji7GJ9ICvA
gFwbugHiVUcJ+Z49e0w4PM2o5fTBbvN9Duuv3Bxq9u3mE8ojj9HRUeM3eceOHcnExMQKn8u1yM9P
UzcqO3fuNGkMDAyYABh5/SCtDCr39u3bTRpakXDRjZH8Tat8bW1txq2kX+esY5WfbrLk+9kvl9JV
1KWYdBQMor+/37Rtc3Nzqm9xRBgQYaBPJsUDOLS3t5s4wiEk1BI2G6FHTv4lDm6+ChhgRUwCnBdD
WN8lWkrLBhmIySML3QAMDQ2Z4xS96eeff14hmLXIz09T7hpVZx0vIcsLYpBWBuWpsus3hQOUwCmA
g3uTdO/ePfP/w4cPzfmyhI61ZVUIQv9Ga2xszJQ3Jh3ta6MzqW3lJxoRBkQY6JMRAhwS4thA7HpO
7MfF1QzQzdudRaYJlr/N3z8mjyw6OzvLQu0pHJ+ffy3y89N0Z6bLy8tm1pl3fvwySMT9+L0tLS1l
N0lp8X1jjrVlnZubM+Wy++qvHjfYsoTS0azdbSe/bRFhQISBPlmhCGuZMwYtMecJeIxghdqkkjws
vuGXRCUUkrAWdfLFK++mJi097e+fK7dceemFjnXzUzxgzXbF7du3zapFpWXw2xYRBkQYNn2fzBPg
vPz3799vlhh9tCypmMB5YlAk7m6MCFeSR6xQ1Cq/StIseiMQm17oWDc/LWXrmbLQs+CnT59WVQZE
GBBhoE/WYCY8MjJSmiG53Lp1yzxXtWjg9pdu3dlnLUS4kjwsBw8eLLuZmJmZCQpm0fwWFhZWpDk7
O1v6/vnzZ2O8VKQfqAxLS0uZx7S2tmYuR4eO9fOT0Zye72opukg6Wup320mhCxFhQISBPlkDEZZw
6Nno5OSkeaapAf/+/fvGwnhqaqq0nwx7xsfHS0ZM2l8CESvCWvbWM0g7mKftX0keFt8wS5bOIREO
5edaeMt4TUu4fprKR/np+PPnzye9vb2F+oHKYI2e9NF3pWmRYdaTJ0/M/woX6BpmhY7185Oxlayb
XaOrmHS0fH3x4sVS23Z1dSHCgAgDfTJWiENIYE6ePGleT9HSpAxx0uLD2td59JEV8fz8fLQIa+DX
LNPONLPKVTQPFwmFXrOR0MjiN2YWnZeftfBWm0icHz16tEKEtWS/a9cu89rRuXPnzE1N0X4wPDxs
ZtAqr4TeWk4LvVrU19dXcqIio6jYY/385JRF+6U9fshLR1y5csUYral91baIMCDCQJ+ETCReeZbK
nNeNeQ3R4gx4APTJOkSzNBkf2XddNcPV8jTnFREGBjygT9IIq4ysfbWMruVUPc/W0rDEeDWphT9s
QIQZ8ADokwCIMDDgAX0SABBhBjwA+iQAIgwMeECfBOAaQoQZ8ADokwCIMDDgAX2ynnjz5g0nGRBh
QISBPlkUeYGSNyaFs6sU/1Udt761SL9W7ZflxrJo+nIj2dPTs+J3OQhx3V5a5IEqzQMZIMIMeACb
vE+6/pFXo36rnX6tBTkG3VAoRq+L3kmW3+i0tLSv3mEGRJgBD4A+WVauNB/T1p+ygi7Ikb8biF77
vXz50vhKlrCkpeH+TUt/dHTU+CBWHoODg2Vlkser/v5+48dYPqDv3LmT237adv36deMxS0467t69
awIQ6Hj/BiB2JqxZq/xQp/HixYuku7t7xe9qJ/ngziqrjtGxgAgz4AHQJzPLJgGbmJgoRdSRs34F
NnD3HxgYMNusk/+8MIX+NqWniEfWvaRE1o3qo1B7NqKPAg0cOnQoKMKnT582af31119GfM+cOWO+
2wAMRUR4enp6xY2By9mzZ5ObN2+u+N3G580qq24UdCwgwgx4APTJzLIpUo8fY1ezTHd/d2ZcVIS1
lOvHx21paSn9r9m1m7+iBoVE2J+pu7FxY4TX/q8Z/v/+97/c9lLcYsXTLXqudYyOBUSYAQ+APplZ
NoXt88maTVYiwkrLX6Z283TzEhLskAhXUhb//5mZGXODoJB9eWiJ3r+JiDnXOkbL74AIM+AB0Cdz
RTJvn2pFOE3ki+S/WiKsJfLl5eWkvb09+fDhQ2Z+ofKHjNQAEWbAA6BPZpZt3759K5aj3VeQqhVh
pe8uF/t0dnaW5a9l3LUQYYue3eYtSVc6E9YzambCiDADHgB9MrdsMswaHx8vGWZNTk6WvfuaVhcJ
k57LWvHME2Glbw2v9NF3WRZbbt++bSyTrWFWV1fXmoqwvVF49epVan56rqvn1EXPtZa7eSaMCDPg
AdAng2WzryjpI8vo+fn53P1l3azZsp0xh5avh4eHjRWz9pcjC2tlbdFzWRmD6TUmWVOvtQjrFaX9
+/en5icLZ5Wp6Lm+du0a1tGIMAMeAH0SqkGvMLkz91j0qpWsrwERZsADoE9CFciKuoi/bD3XrsZt
JyDCDHgA9En4f+QE5NixY9H7a198RyPCDHgA9EkARBgY8IA+CQCIMAMeAH0SABEGBjygTwIAIsyA
B0CfBECEgQEP6JMAgAgz4AE0aJ/0Ixq5n1rVqZr6P3r0yAQ+yHrPdrNc77HevjZaX4wtDyLMgAfQ
8H1ytcpZTboSYL2Xy/UeFmREGBjwABpQhPW7XC42NTUlHR0dK/Z99+6d8QGtQA4Szba2tuTBgwfR
9be+qnW8XEIqGETaLD2rbAo4sWfPHhNm0BftUNQn/a/ISfJVvWPHjuTu3bsmqIR8W/tpxdRTIRGz
ypJWjti8i/i9VgCMvDzVvvIJrnocPXq0LCBFqI52ZUL1U6CL58+fl6U/OjpqfH7rfA4ODpZtU1CO
/v5+U7/m5ubkzp07iDADHkBj9cmiy8qxIjwwMGAGURtswd1XwQ4U/chGRpqYmDCCHVN/iY72t8cq
OIIEIrbttL2np6ck3BIuN25vjAifPn3ahBr866+/jECcOXPGfPfTiqmnBCyrLGnliM07RoTl19oX
vrQ8FS5SMZNVh/v375syxNbRvTl48uRJ0tLSUtqmc6ebEB2nOkhkFdzDMjY2VoqgpQhZ8qeNCDPg
ATRMn6z0+W6MCFthia2TZkox++7du3dF/GLNDIuIcF7ZYkTYPV7f3XjHRetZpJ2K5B36XysVeXGQ
3f3dma8EMeTX2q2jBPnevXup+ykdP9ayK9JaRXHPtcqBCDPgASDCESIc+k0icOHCheTEiRNGWGOf
W7oDvDvbKiLCIZEtsj30vWg91yIMo2IVSwAVArKSc+zP1vPqqNmvviu/kZGRFen4/c49v34+EmxE
mAEPoCH6ZJ4Ar7YI37x5M2lvbzfPN58+fWqWrGNFOG25tojh0VqKcCX1XAsR1hLw8vKyKZuWmdP6
Q155bBzomDpakX748GFy5MiRZGhoKPeGqsi5RoQZ8ACYCVcgdHqW6S6jLiwsRAupjHv85WhXFGot
wqGy5X2vpJ5rIcIWCWdoSVr7z83NlbX37t27o+voMjs7W7ZN59I91kfPot1zrRCPiDADHgAiXKUI
yxrYWtBqYD148GC0CMswS9bN1hBocnIyaW1trZkIu4ZEi4uLxnCqUhGupJ5rKcJWCF+9epWbZ3d3
d/Lp0yfT3jKUcg2zQnXULFkW0sI3HtO5tIZX+ui7rN0tMviS5bY1zOrq6kKEGfAAGqtPrpZ1dN5v
U1NTxgBHA7IGaRnuFFlStq8o6SPL6Pn5+ZqJsBUKLZVK3CUglYpwJfVcaxHWK0qycM7LU1bMeo1I
Kw4SZNc4LFRHLUXrObF9BcsKsmV4eNjMppW2bnisNb1Fz61leKf8VQ5EmAEPgD4JsEGuIa4kBjwA
+iQAIgwMeECfBECEgQEPgD4JgAgDAx7QJwEQYWDAA6BPAiDCDHgA9EkARBgY8IA+CQCIMAMeAH0S
ABEGBjygT8Iatn8RT171fh43U79ChBnwAOiTDSzIiDAiDHRMoE+uGV++fDHRc75+/Vr2u6LcKAiA
kF9g63dZvz1//jwzPR0nv89bt25N2trakunp6bLt1j+0tsupv/VX/NNPP5lgAsJG7LEBCBSWT9uz
2lRRg+SHeMeOHcndu3dNwAD5LXaDNhSZCcvvsgIM5J1HldvW8+jRoyYwveXdu3fGX7K2qQxqBxsM
IaY9R0dHjU9ltdPg4GDZNgU96O/vN/Vrbm5O7ty5gwgDAx7ARu6Tv//+uxEul7GxMSMGwhUzBXOX
Y/8sFARezv6FYs3K+b9FeUxMTJSi68hxv4RMnDx5Mrl//775X0Iqx//abr/b/dLaVNF/vn37lvz1
119GnM6cOWO++9F9YkRYNw2+8KXlqXB8ujlQPVRuNwKRAicoUpCtp+rc1NRU2p7Xnqqz4gLrONVB
Inv58uWy82IjFCkC0aFDhxBhYMAD2Mh9UnFlNRvWwG5nW5p52lmqBMQKawiJrk3HR1F3/JjBmsEK
BZHXzYD47bffkhMnTpiPkMBJjPJmpe53N5ZtkQhEigwUisNr93dnvqrvgQMHco9xA93ntafS8dvP
FemOjo6yNlQ5EGFgwAPY4H3y8OHDZgYmNIvTcqpFszWVXQIxMjKSm44788wTIn9/3QjY0HtaolWg
eBtkXsu5WqKOadNKwwDOzMyY+inEXiXn0a+3BF2rArqR0M2He0xeeyodPwSl225+PhJsRBgY8AA2
eJ/U0rHEzorg06dPV4iK9jly5EgyNDRUkQinbXPbRM90tcRqxVeB5RVQ3n5fTRHWDcjy8rKZyWuZ
2f6eFo857Txq+dyiWb3S0bNqtaNi6frHZLVn2o1KkTZEhIEBD2CD9kmJnp45ZhlBCc1Q8+rR2tqa
uRwtcfeXo13x6u3tNcvBdhnaLknb76spwhYJZ2hJWvtr5u7Ww71R0HNpd0ncGprFtKfayD3WR8+i
3TbUTQoiDAx4AA3QJ2UAJItb1xBIaFYni17hGzv5aAlWy61CVsa+Ydb4+HjJYGlyctKItkXb9IxY
v4tr164ZC2O7TL4WImyF0FpmZ+XZ3d1trLlVDxlKuYZZupmx1tASyYMHD5blkdeeaiNreKWPvsuK
3KJHBbLctoZZXV1diDAw4AE0Qp+UqGhmqsHdRUuneq6ppVIJhhWQNPSqU19fn9lPx7gGTMK+oqSP
LJ7n5+dL2168eFH2apI1Onr79u2airBuHuzz6aw8ZcWs14jUXhJk1zhsamrKGFOpDSS4MsJy8wi1
5/DwsJlNK209m9dytoueW+tmRfmrHIgwMOAB0CcBEGFgwAP6JAAiDAx4APRJAESYAQ+APgmACAMD
HtAnAQARZsADoE8CIMLAgAf0SQBAhBnwAOiTAIgwMOABfXID8ubNG04yIMKACAN9sig20HwoJF8e
rh9ov75++mvdFnKl2dPTs+J3efhyXWda5KlKnrMAEQZEGOiTq44baH416leL9KtB4u8GXRDfvn0z
QSPSyq19FbsXEGFAhIE+uerlSgvZZ/08K4iCggi4/pG1n3wgK0C9xCotDfdv1jbL6Oio8YWs/AYH
B1eUz83LnVnL/7ICLjx//jyzfvJJLf/OPqrT4uJi5nnRMToWEGFAhIE+uaZlU/SeiYmJUjQfBQpQ
wAV3/4GBAbPNBhiIDZ7gf1faipSktDQ7vXPnTlkkp7S83Jm1lpoVMCGLs2fPmhi/PjZmctZ5UVhD
HQuIMCDCQJ9c07Ipyo8f+1eRe9z93ZlxNSKspWI/BrErqml5aVas6EQxKJSgQgoWPS82DCEgwoAI
A31yTcumZV4fN+5tWl0qFWGl6y9Zu/mn5aXZr36XgI+MjOTWTcvpvsjHnBcdo+VxQIQBEQb65JqW
zRXcGFGtRoTTBD+m3fSc+OHDh8mRI0eSoaGhzOMrTT+rHQARBkQY6JOrWjYZO/nL0e4rSLUUYeW1
tLRUcbvNzs7m7lPpTFjPp5kJI8KACAN9cs3LJsOs8fHxkmHW5ORk2fu0aXWR2OnZrRXvWBFWXpcu
XSrlpe+yXM7Lq7293VhICxlo5c1Y9Vz39evXhc/LzMwMz4QRYUCEgT65PmWzryjpI8vo+fn53P1l
0azZsp0xx4qwGB4eTrZt22aOlaMMawWdlZeWomU8pqVmCbAV5DRk4SwL7KLn5dq1a1hHI8KACAN9
Eqphenq6bGYdy6FDh4zYAyIMDHhAn4QqkBV1Ed/Wej2pGheegAhzshjwgD4J/4+eGx87dix6f+2L
72hEGBjwgD4JAIgwAx4AfRIAEQYGPKBPAiDCwIAHQJ8EQISBAQ/okwCIMDDgAWzWPlnkFSAARJgB
D4A+6ZRNcXyrKbPrW7oR23k1z18obUWN6unpWfH7169fy9yJWuR1rBFfsUKEGfAAGlaEOzo6zKBe
aZnrpX4b8doPlVmOQ+bm5sp+U4CJ3t7e1GO1r84nIgxciAAbRITlK9mPzeuX2fqTVrAGuYJUwAa7
n/vJykNuIJuamkoC8e7dOzNrU3ryAd3W1pY8ePCg7JgbN24ke/bsKfmJluMNiwI+9Pf3G7/Tzc3N
ZjYfW2ab/vXr15OdO3cmO3bsSO7evWsCSCg9Py83Xfmq1naVSVGgnj9/Xpbn6Ohosn37dpPv4OBg
2baYMru8ePEi6e7uXvG76rK4uJh5rI7RsYgwMOABrHGf9EUxlLfdrqhBvkhZJE4TExOlaEcKiqDA
DrH10/aBgQFzrA3QsH///uT27dulNJW+RNo9RiJty+RHTBobGytFYPr48aPx91y0zKdPnzazyr/+
+ssI45kzZ8x3Py83XVegtVTc0tJS2qY8dOOg/JSORFbBLWLL7KMgEjdv3lzx+9OnT3PbXTcXjRaA
AhFmwAOo+z6ZJsAhIbbbpqamkuPHj6eWWVGL/BjDmkEWEWFX4LPQ7DLvGDcfzajdMilkYdEy+zcd
bmzjrEhQulG4d+9eavm1dOzHL3ZFOlRmH90YyZd10X6lYxotFCMizIAH0NAiLCTCEmP/d1cc3Rlh
ERFOQ0vUFy5cSE6cOGFEMy8EYtqM1EXiV02Z8767/2v2q+8SXH8JX+n77e6WI1RmHy2j+6Ie0646
RsvhiDAgwgBr1CfzBDhWhPWc0c6g8gQvT6Ri669l1vb2drN0quVVLVNXI8LVljlWhO3Nw8OHD5Mj
R44kQ0NDucKfdRMQ03ah9PKOTcsLEQZEGOiTdTwTFprdyVDL/V0GSP7SrvtaUiUirGew7vLvwsJC
IRHu7OwsK5OWYKspcxERtszOzq7I062TT6jMtZoJ63k0M2FAhAE2oAjrVSUttfpGTuPj4yUjp8nJ
ybJ3VCUWer7qCkyo/rJ6ttbQ9hlmERGWUdfFixdLRk5dXV2FylypCGv2Lgtp4RtwKU9reKWPvsuS
ObbMPmoTPTcu2q9mZmZ4JgyIMMB69MlKraNd8l730UdWxvPz86VtsgDWLDPLaUdaHnr2LKMliZiE
TcZORURYXLlyxRhb6ZUgWSYXKXOlIqylaD2/tq9NWUG2DA8Pm1m+2kLW3dYaPLbMLrJw1j5F+5VW
MrCOBkQYgD4JVTA9PV02k45Frz7pZgERBgY8APokVIEeDRTxza2lfR3TqNcQVxIDHgB9EtYMPXc+
duxY9P7aF9/RwIAHQJ8EQIQZ8ADokwCIMDDgAX0SABBhBjwA+iQAIgwMeECfBABEmAEPgD5ZKUVe
oWmkvAERBkQY6JNVl00esqopc5anrLWgFnkXCUZR7blWFKaenp4Vv8tdqOtW0yKvW434yhEizIAH
QJ/8/7Ipzq1EoNIyr2f9apH3WoqwHGnMzc2V/aaAC729vanHal+dH64hRJgBD6BBRVi+hv3YuFl+
mBWsQa4UFbDB7hfyU63ADvLdrGPb2tqMO8aYtG36N27cMAEfrL9mObDIylt/5bKxqampTLxCeWTV
e3R01Ph51rGDg4Nl2xSIob+/3/iKbm5uTvW57fLixYuku7t7xe8qj8JIZh2rY3Qs1xAizIAHUOd9
stIADoq6kyVMigY0MTFRig6koAIS1dj6XbhwwQRoEIrDq4ANRdLWkqwtmx+5KC3wwsDAgEnLBk8o
Un73f+2nGwAdo9mqRFbBKixjY2OlqEmKiiSfzaGADIqj7KN4ynntqJjLjRaQARFmwANouD5ZTShD
RTU6fvx4apkVNciPzatIQLH1k+hmxcWNSdu9OQjNXNP2L1J+938tHfvlVuQni2babroKOxgKTSjf
zkX7iQ31yDWECDPgATSoCAuJsMTY/13LwD55s9G8fX0qSTskwtXk4f6vffx2dNPy6yXBzmsLLYVn
3YzktaOO0XI41xAizIAHUKd9Mk+AY0VYzyXtjMsXoyJCWESEK0m7qAgXySN081Ek3Zibgdhj89oQ
EQZEGKABZsJCBloy1HJ/37dv34rlXPfVoFD99OpN1gywkrSLinCRPPx6Ly0tZdars7OzLF0tG6/G
TFjPo5kJI8IMeACbQIT1qpKehfqGWePj4yXDpsnJybJ3WiUueg7rCpKLDLP0fqzQO6++YVZe2iER
9vNO279IHn69reGVPvouS2bL7du3k4sXL5YMs7q6uoLPhPXcuGg/mZmZ4ZkwIsyAB7AR+mSl1tEu
aa/a2Fd89JFl8fz8fGmbLIY1s8xynCFh7+vrM0uqMpLyhSgv7ZAI+3ln1Tc2D//44eFh8wqS0peV
trW4tly5csUYeek1JllTh6yjtU/RfqKVCayjEWEGPAD6JFSB3o92Z9Kx6NUnvfvMNYQIM+AB0Ceh
CrTUX8TftZ4z6xiuIUSYAQ+APglVImcjx44di95f++I7GhFmwAOgTwIgwsCAB/RJAEQYGPAA6JMA
iDAw4AF9EgARBgY8APokACLMyQKgT641RV69qec8ABEGBjygT9ZF2YqUPctjVi1ZizwaoT/ITWhP
T0/p+/LycvL7778bj2FqQ3kw+/z5c2m7vIHV86tQiPAG6dhF3PUBIMK1LdtaRYuCMHLwMTc3V/ou
t5fymW39YMuNp4TYon0VHxkRBkQYEOE6ngmPjo4aP8maUQ0ODmZef6H97TFyx9jU1FQSgHfv3plZ
mQIzyNd0W1tb8uDBg8w8YqIs+XmEypWWXmwaX758SXbv3m38ZbsowISiMhVp059++in59OmT+X9h
YcEc9+rVK/P9w4cPZnsaL168SLq7u8t+27FjR1kEJ0Vm8lcVdIyORYShJkIMsBlFuBYBHLK2K/jA
jRs3zGCuQVyBHhRAISutmP0HBgbMdhsYYf/+/SY6kZ2xTUxMGPHLyiNGhP08QuVKS69IGlr2VcQl
l7GxMSO2Rdr05MmTyf37983/d+/eNaJpA0DouwJRpKFZ782bN3PPq24K3HYV169fr9tAEYgwIgxQ
9yJci1CGedu1xOnHw21paclMK2Z/hSEMsWXLlqpE2M8jVK609IqkoaVdzYbtdv3VrNWmEdumElIJ
uvjtt9+SEydOmI84ffq0Eew0FPZQPqfzuHXrlgkx6aJj6jVkIiKMCANsehHW8rCfbp5AFt3foqVf
CYQER6EP80INxoiwT6hcMW0USuPw4cNmhis0s9cSe9E2lZhrZUBoKXt2dtaIu9AyvZao09BSvi/s
LlriPn78uJl5u+gYLYkjwoAIAyJcQwGulQjnCVVaWkX3t7O/9vZ2szT69OlTs/xbaxEOlSumnKE0
Hj58aITSCqjqUkmb6lnux48fS+K7Z88eM2O130MrBz4SXi1zK800dFOACMOGmHUAbLaZsMRkaWkp
Oq2i+4tt27aVHWMNkmJFOLR/TLliyhmThgRTz4J9A6oibdrb25v873//Ky1D2yVp+73ITFgzYC1v
Z82gJdDMhAERBvpknYqwjI0uXbpUMprSdzdIvQZ/PfeU0U/M/ml5S7isNbR9Runu5+ehmZvCA4rF
xUWz7BsS4VC5YtooJg0ZWDU3N68w+irSpuPj48nOnTvN60Xi2rVrpg3sUncaarPXr1+X/SarZy2R
y6o6i5mZmY31TDi0/MOHDx8eD6z1jWEl1tF558w/fnh42MxWZakrwbPWwlZ09Lv76kve/mllm5qa
MoZJElctS9+7d69sPz8PCbD21RJsa2tr8ujRo6AIh8oVe/5CaWjmqW3+0m+RNpV4uq8mSVz1/e3b
t5nllYWztaK2aPk61Dck8BvGOprZFgArFNQd6pHp6encmX0Whw4dMkZxdS/CXFAAiBH1hnpGrz4V
8bOtpX8dU+/X0HdcTAAIEnWGekfL9MeOHYveX/tuCN/RXEwACBJ1BkCEARAk6gyACAMAgkSdARBh
AASJOgMgwgCAICHCAIjwCoqYra9FOqudJiBI1LkxYbxAhEssLy8bn5zyuymvJ319fcnnz5+jt/vI
64u8wMS+txXjIcbiB3KulFqlk5dm7ODFILdxxAERrr+y+R/XFeRqtEGt2qMWY9CTJ0+Snp6eFb9/
/frVeODykUeren6VZ9OKsFx9yben9f/5xx9/GKGN3e5T9CIo0sFrdQGsxsBSaZqIMCJMO9eubBp7
5J+4lkJcT+OFiyY6ChnookAGCpyQlr727ejoYPCoNxFWuCk3aoVOonuXFtqed2ea1dmyhDfkrD3N
b+jo6Giyfft2M1MfHBws/a6Yk+5dn2boR48ejfJN++7dO3PXqItZNxUK62Uds9uyyEVaU1OT6dSh
esth+6lTp0x6Skuu2bLqnFUfd5VBvmYVweT58+fBFYm0fUPlcesWU67QdqUpp+1ycK/ypN2o5R2v
/tff32981MqpvAKCI8LUOats1idz3n7+uKMwhAo2oP43MDBgZpOhMSrvOsobQ4qOZWnIL3N3d/eK
3+XyUcEgstpGx+hYqCMR9lHH0gBc6fZqYmYWnQnL0bcGdw3SujnQ4GyjfsiRuKJqaJsuKDlWt3eN
oXwUjFrBrO3sf2JioqzOOl4XqrZZh+V59VaQbzlzF4rVKefuafvl1cdfZdBSlOoUsyLh7xsqj1+3
ULlC25WmBiRFkEkbJEPHK6SajdYih/LyE4sIN16dKwngUOkKm79ds0r1T/UxiaEbDCArrbzrKGYM
iR3LslYwdePgY2P/ZrWNYh3Xa6ADRPj/uXXrlulclW5fSxHWhePHnnTFRh1bA7g6c9ZFFYsbbFrH
W0GJqbcuzrQYmf5+ofroIrYXfYi8fUPl8esWKldoe6i9QsdrRm7DvwkbjQURbpw61zqUYVERdmex
soNxA89npZV3HcWMIUWuMR9NMOQzuWjb2BCLUKcirPBVWsbVnVgl29dahDWb8i9Yt6Pbzq1lJpW9
yMCiJVndbCgA9d69ewtd1P53d9aXd1yoPprR2rv2kZGR3PLn7RtbnthyhbaH2ismfRcNVogwIlxL
EfYFMGs5O/a6LjqGxIxlLlrmzrsByGobHaPlbqhDEZawnjx5ckX8yNjttRThrIvQTyuvk1pkPag7
1iIirGUeHaOlGy3vaFl2LUQ4pj66sLX0deTIkWRoaKiifYuKcKhcoe2h9godn1ZeRLhx6lxpPOda
inBen6tEhIuOITHXfrXXXOzNA6yDCEug9BrSwsJCRduLiLDSqNVMWAZHS0tLmfvLqlvPWfznIKF8
ZADkpptX5ph663WBmOXoUH1cZmdnowdIf9/Y8sSWK7Q91F6h4zs7O8uWo7WkhgjXVgAbaSYcMsxK
u551jVj0CqbGgNAYlXcdFR1Dilz71cyENZliJlxnIixLucOHDycfPnyoaHvo5LsGQrLak4FOpSKs
jqdni3ZAvnr1aslgRx99twGhdef5888/l3Xyt2/fpqbjIytea8lon6GEyumn6RtwaHlYyGI7yzAr
rz5Cx8nqOW2g8cnbN7Y8seUKbQ+JcOh4GbhcvHixZJjV1dWFCK+y+G1UEVaf17Vo+37sGKT+pr6l
Pnb+/Hnzmk9ojMq7jkJjSJGxLA2lJ9uIon11ZmaGZ8L1JsIyQMjr+KHtoZNvBUDLJ7pz1MVRqQjL
wEqvR7mvSA0PD5u7Tv2mi8ta9OpdZvcVJf2v7VnpuExNTRmjCJVbF5YMnELl9NN095F1tsqj9PRs
yL14/LSy6iO0vKzj7Ws+7kDjk7dvkfLElCu0PWblIJT+lStXzLN9vcIhg7v1FOHQ8mmjfdbzhqDo
/mmvv8WMQRLMXbt2GYPGc+fOlTkkyrr2866j0BhSZCxLQyt7ug6KivC1a9ewjq7H5WgAYCa8njNh
zmsxZM2dN1POQq/36QYdEGEABus6EuHNVOdGqaPefCjig1rL4rHuhAERBmCwps5rwmr4kl8LtMx+
7Nix6P21L76jEWEABIk6AyDCAIAgUWcARBgAQaLOAIgwACBIiDAAIgyAIFFnAEQYABBhAECEARAk
6gyACAMgwtQZABBhAASJOgMgwgAIEnUGAEQYAEGizgCIMACCRJ0BGDcQYQAEiToDrJ8Ic0EBIEbU
HWB9rp3vuKAAECHaAGB9rpnv/I18+PCJ+wDjBh8+1Y4bjCTMNgAAYL3Gd5oAEQYAAEQYEGEAAEQY
EGEAAECEAREGAECEAREGAABEGBEGAABEGBBhAABAhBFhAABAhAERBgAARBgRBgAARBgQYQAAQIQR
YQAAQIQBEQYAQIQBEQYAAEQYEGEAAEQYEGEAAECEAREGAECEAREGAABEGBEGAABEGBBhAABAhBFh
AABAhAERBgAARBgRBgAARBgQYQAAQIQRYQAAQIQBEQYAQIQBEQYAAEQYEGEAAEQYEGEAAECEAREG
AECEAREGAABEeBOJr/8BAABEGBBhAABAhDePEAMAACIMiDAAACDCiDAAACDCgAgDAAAi3JhCDAAA
iDAgwgAAsBoinPZKDB8+fL7jdTEAWF0RZlABYIUCANZBhBlMABBiAFiXMYRBBAAhBgBEGAARBgBE
GAAQYQBAhAEQYQBAhAEAEQYARBgAEQYARLixefPmDXUFRBgA1k+Ev379mrS2tqZu++OPP5Jt27Yl
W7duTfr6+pIPHz6s20Dnbq/VoPjDDz/UzWD75MmTpKenp9D5sdy7dy9Ydr+u1YpN7L6//vpr8uzZ
M0QYABBhn2/fviW9vb2pg8yVK1eSiYmJ5L///jOfixcvJr/88ktdiHAjDq4HDhxI5ubmos+PZXFx
0ZyXtW6/2PRUp46ODkQYABBhHw3eGsTT9mlpaUmWl5fLfvv+++9zB6qbN28mO3fuTH788cdkYGDA
zOLyBjJ/dvvPP/8kp06dMjPvo0ePJq9fvw7OhP/999/SMW1tbcn09HRp27t378xMTNtUdm1/8OBB
KQ3fT7BfRq0EqC46Xm2l8rlluHHjRrJnz55ky5YtJv3Hjx+Xtj969Mj8pm379u1Lnj9/ntl2L168
SLq7uwudH8uRI0eSt2/f5u6TVdeXL18mTU1NJZF008hrO3/fUF1VN9UREQYARNjh6dOnUYPM0tJS
Mjo6mpw4cSJ3oNJsTkKlmbP2P3v2bCER7uzsNEveOv7+/fvJ6dOngyJ84cIFsxwrHj58mLS3t5e2
7d+/P7l9+3ZpNq+ZvUQnq0zu96tXr5atBPz5559G7N19JVJWmCXA7k2KK8paatZNTRZqJ93AFD0/
Wp1QGStZSdB33Sipbu/fv1+xT5G2C9X1+vXrZX0BEQYARDhykDl+/LiZDeozMzOTm4Y7C9Usevfu
3YVE2J35auCXqIdEWKKrfWPRbC1GhPfu3Wtm2e6MW7N8f+aedbwEy94chDh48GDy999/Fzo/r169
Kps9VyLCeeUv0nahuqpuqiMiDACIcIWDjJZmtdSYl4Yvhu7MMEaEfbKO92dheWjJVbNlzeIlrHl5
ut9dwamkPpoR2tWBkZGR3DJqyTfvRsLP68uXL2YJ2TWUq0SEQ/vEtl2orqqbbuIQYQBAhCscZGQk
FHomXI1opW13LXorEWEt8WqmrOVQLe1q2TVWhNPSDZU3TcS0RK7ntkNDQ1EzzJi21TK9luuLnMOi
Ily07UJ1Dd0sIcIAgAg7aInx48ePpe/+cmxaGrOzs6Xvnz9/Nq83ZeWxsLCwYlB3rYOVX9Zytvu/
Xt/JmkUqfz3Pzsszqx006/eXo7NuCkKDtdol7zwUnQlXEoi+qAgXbbu8uuoGjpkwACDCBQYZLT9r
adEa5pw/f9588tKQNa+E2+6v12vcmZA13pHFr4ya/EFdzzg/ffpkjr906VK0YZaWQ4XeR3UNs2S5
bC167XNJ91iJn56LWrH1DbPGx8dL9Z+cnCx7XzckYiqHrIaFb7Tlo3K5z8MrEYHQPnl1TUsj1HZF
6ipbAp4JAwAiXGCQ0exF1rOa/WkWI1EOpaFBe9euXWYWfe7cOTMbttjBWUuvEjMN2v6gLgvk7du3
mzwlyP4rQWn/6zUoORJR2npu6YrZ1NSUsdTVNgmF79Ti8uXLJi87w816RUkfWUbPz89Hi7CWZ1Ue
+/qSFak0ZDmsuq+mCIfq6v8Warsidb127RrW0QCACDNQ1SeyKl9NRyjrzaFDh4xQI8IAgAgzUNUl
sixuRP/OWsp2XzVDhAEAEV4FYnwTQzZarj927FjD1Ut1wnc0ACDCAIAIAwAiDIAIAwAiDACIMAAg
wgCIMAAgwgCACAMAIgyACANAQ4pwrQaWatNZ7+MB6GMAsGFnwogwIMIAAFXMhPX/jRs3jNN+6//X
BlsQcvov38kKAtDW1mbcLGalk5ePAiH09/ebCD3Nzc3JnTt3VhwzOjpq/EfLX/Pg4GDZtpjjARBh
ANhwIqyoRjZggh8JR5GK5MBfKGasG6moiAiPjY2Z6EgSU0Vbkk9hd7uCGOhmQNsVQEIiq8ADsccD
IMIAsCFF2I1Y5G+X6GbFuy0iwh0dHWUxehXxyN0uH8N+PorkE3s8ACIMABtShPO258XCrSYdCa6/
3Q9Sr+Xx2OMBEGEAQIQLpONudwU3jdDxAIgwADScCLe2tla0HL2wsFD2W2dnZ9lyssLcudv37duX
LC0tZVYmdDwAIgwADSfCMsx68uSJ+V9h6bIMs1yr6sXFRWPs5W6/fft2cvHixZJhVVdXV9n2q1ev
lgyv9NF3N9h96HgARBgAGk6Ev379mvT19RmR3bt3rzGIStvPWlVrWVmz50ePHq1I+8qVK8nOnTvN
a0iyhva3Dw8Pm1eQFJ9YIv7+/ftCxwMgwgBQ9yIMAIgwACDCAIgwACDCAIAIAwAiDIAIAwAiDMBF
xDUEAIgwACIMAIgwACIMAIAIAyDCAIAIAyDCAACIMAAiDACIMAAiDACIMAAgwgCACAMgwgCACAMA
IgwAiDAAIgwAiDAAIMIAULvxg0EEAAEGgHUUYQYTAAQYANZRhO2gwocPn7gPAEC1/B/xktC3uxFp
IAAAAABJRU5ErkJggg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-04-04 00:31:12 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAR8AAAL5CAIAAAAGwLcYAAAjtElEQVR42u2dsY4bx9KFCRgwHDDY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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2016-04-04 01:09:25 +0100" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Fortified breast milk versus unfortified breast milk, outcome: 1.1 Weight gain (g/kg/d).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAzoAAAJQCAMAAABxd+EOAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2016-04-04 01:09:39 +0100" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.02" SETTINGS="SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Fortified breast milk versus unfortified breast milk, outcome: 1.2 Length gain (cm/wk).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0gAAAIACAMAAACPRbxcAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///9BjlLGAABTbElEQVR42u29C3QkR5UmfKVWZdZDLSmqJez2s9Xdi+ewtmdQy61W
Sz2Gko3H652ff1nD2QMHr+E/B9izszDM38MwHBbDPJbxzHBmODsD2Mus13g5jDk8jIfGHnDrx+hh
d9HIHBbYNUit9lMYtSqkbpVKVaXHHxn5fmdWZWWV1PezWxmVEXFvvG7Ejcy4edsIIBCIetGOTYBA
oCAhEChICMRuwZ7UTihlrp9h3nhn4qtVdneebHeIJ0wxOXO6GljNG4n0vPlFsRoHX4+q/2LPxAv9
7uRZilcSe9d5saA92QltqepOHIrBavqWJV5TqV8ylr5BQfJFP4zPm5v3hWvmgd3aHM3/wQfmzUnn
62Q1bySyfVX+D+6Pg697eWC19Nh+cCfPGmfxb275eYIVa2sk/wefHvmhqcQ7Bqymn/qWb01/f5DX
VOqXT1+db52a7ijVrksQu9i8lMskRXZhAeEE3J3N5aBwUhC3C1BI3RnZQ8hc7qFUkogjjEGsfO0Q
K1BhfKHQJQonC9CXEYRkr1I+JUk2A9IdYRTuvpL9yyrlyuU6U6CFefoCq0u6qtJqMUz/J6hOSzXd
FoWuAlQzgpiaYCUvpZJZtaZp6GN3pH7Zz2sq9U2B9w1oYZ6+cFIUUnmVFq5Ihum+58hSx5Glcj98
8f7/wiYndndWvsx/oa3wnRc/Ur6qeHbrqohWpH54KDU4X5YYxMLXvTzPbGzseflqxmzwv39j+4/K
28nVl384uymXb0Mp8ctffdOP5GJtSkVTytUPPy7cz8KJ41KYp//C4FLqyOLG5we/8C1Gq8U6+fe+
t9F+//Mw//nRpQtv+qPy3ie/uP6ml1m9LqYHz+k1vdVU08ElYeAjvG/u18I8Pav3L/N/uqHQwhVJ
WyByUIK5c3AL+3Fj1hK7DrM3QgU+AnMRjub5RdjigZj5WpE4Xj2eYNcyJGcZx1J713th21g+aaKG
hx3KxYqelcJzPMzTr8Pc4niJ/e6SaLWaxjHcd5wt/ayt50qsumv/tquL1+spU03/h7mmc7MwIveN
Fn5KrunsflZThVbD0bFDBGlcacXcBL9YsA13A2yyRmQJ6mQ0OcqfKchcRschLr7u+Pm7etg/ic9H
JY7k5vwPb5YKZigfFO52KhdPYwyPjo/IleC0Wg4fuWmN/WOtP8qKvAXkpvy5d42wKh71qelptW+U
8FFDTRVauCKZUCg4F7gNvjY+XoUpKUGdaAO257FyiYGvO/ZPVaf2S1q4xKwCRXjxF7Y0e80zolIu
WxikooJKq9xq3bs4uTG1yAelWlPRluYGEGw1rai/jGGlpu2mmyhIEpJw6CCIpmbSYxZyaUjAoQP1
MvlbOAgzZq0nFr5eut2opNmxATTTl8uwHts7Y5tgCFwAe7lsYWDVYL+SKq1WgzCi1PRglRW5HW6w
1/Tj8ITpSYxUn5Shpim9DQ5LvxRaKEjGTctA8cjZFTmcnrrGGHO2eODMCow/s1Z3fY6cLSXuOk1j
5+v1QEhebs6fvmvlzDIrQeZJ6wbyyhPPmR4aKeXSw99XY84PFK9/9gcqrVZDh1LTs0cy+RVITa+8
zVrTK5587oTxBq/P01o/aWGp3qsHzlxUaTUcbXhoFYG43PZICAQKEgKBgoRAIFCQEAgUJAQCBQmB
uMwEqdApCmOZPPSaz7Hm3A+/5LfHBDFTDZAyKHK5XBUmcsEpVbsEQeiUDgTnhORDFlIGOhMZ5wpx
hr0hGLI6J6Q6sywJ85lvM8PetFsLMoYFIScWoJpL2lIood6UQ9Mkc31SVO79Bn7Oja7dLGREoavK
OPG0ROgB6CwpLZJOiJ15a/5kgWW6U+hrxljM5VK5Xl7DVPAa5jsF4aRWwx7hAYDPTig1vFMYs9ew
8YL0yNG9lW8P/TbcPBw085vH/mdleeg/RluiDfi/QqQmg8XK6aODLDT+q45Heg0x4+PyPxn3DbmS
eBo2QjBkda4uD+2VGLz2gzeWXBnefMyVxBXw+lEYeT27lgxZTXDsgyQ/e1qBR3WO4/asJlw3tNw5
uI9VMC+lXSu+A6qb8ijtva3tteWjt1ozHD8A0F9OLzZnWhdBmpWrIAavYe5oZ2ZGquFpKe07ih+E
hY/Kr2wXbpv41XNH3xT/ivQRVprU+HpCNrnhQl/NSCYvKTYTKrPnSVG2zOnkvVGFN7AcD6qpAbrv
TFUhn0728IkkzSblLlHoBjVBLveQZAzjiek+X5sUIyrQCyfG+amRbBJKDikkOsDtiBRaVoZvgw3O
ULbbqaZEIZVlDElGdCIn15kfIeK2MXbwNhI4Q5mWvcwVmOR/iWIXJJk2pe7s4W1YYnx5bhsW+cml
Miyap+aqkGK5hV6FltxnWmlTs4zPFcCP3mwnHoZ9yiBdH1nOpsZtNXxmvbdaembZaPs0ofV3wyHX
cN1Ww0QaCkmxTx0TaZEYGrMgHW6/EvithxPb8BtKDa8cSWUL42vxC1I7DEjDrKoetWboGEoXpKNP
VXiEzxLdM+lTg91SjV+RovfAG80Dc/vZ4c/BLce+LU/xSy9B9+CpzJEePcGHMsd8zpvfvwkbktnj
gbH0ymA/dD9RWR1+RJrGO487tUkHHEmq69AvnJaWrrFTmcHuslQpjZaZwj3wTqlM/TOd6bED0FUo
F4clTlupkQ85MDTW+Xl4pz2B3EYViaFGywxWQyYOG+y6eGDwVOdMP9cHhp+VzyUl0yMfqhj6QEfi
2ZEJKI08m7DcTg2Tg8PJC/2D35NoyX2mdoh0NHAbtmDtfZkluJcplf/unBzzTrjk1PwX7y3ubTsH
SrlWL1ReOH6b1t8NB6thCSbsNUwfI/3Hk4vKmOg4lt7U4u6Va7gBJYHVEKr3Fsrn1AX8+ebskS5O
w/B9bI9kWmpnfwjwKybxv8cP3a7DXBc37ijxefZpa47zc/A4q0CXPCRK+1jarjnjOnF+FkTvAllt
UtodbFIMWBHh+M2d8iqX5WY6FtwCA3PKGVTNvsXcSz/vnU3wunG7ndK1XXs5p/kL9rSWOltsY2SU
1TYCidbv2Us9NZzfmKRTG4XhqYRuF/Q4zMnTAF105Cvh72EU/jP8jXFXJl3mxbUj00+p9kpynykQ
4FspVoLtqa7hoU/BkUyq/9GDAp/YZiHrOJS/Onw8uV+1V2IVkG2fStm4dLv/zOoo2mo4vbY+Pa+O
CRHmzhv03dRhqYhtq51D10Mqc+Sg2C/yGo5AtjmClHh1ZhqGTFrzKGSPMtVuamNhY3qRT3Dst2Lb
wnD01R+Zc2SzMMH67WhCGWcs7VFTbViCNu8CfQQ+zv5JFkF33y3ZpHxi6xw31pJsTJw6/svPTcFR
ec0rONGekHjKAkZuUmiZ8M9swPya140x3ISemzf3ck5ZsKe11NnRdkJrI2C0/vQb9lJ3QG60I9sx
eh0LbcJH79bKqbXaiEvbvHXy/YX/OvVeMO4gpBzTI9viUZnWttJnCmj+/X2T7VAsL74VvgDvr5yr
XFh/gQvulHPpYZlNTqCWi9y89UO1MWLBr6f+a0GcmrPVUBwZEbPqmBiVulTFZ/Jd5ak2KJ5OSDrs
cuXt6xfKXbyGk1BojiBBdvnV55QhMMVVPKksUmESo/9iVFDW0QLcZsix8uoMq9mkOqYK0ljeA4Wq
rgjxWxNqgrxv3RanPuJrk2ISTbowA7K9yesZO4cKFlQBc6Z1dLoyJQ1hxW5nDV7y1giUOkuw2MZo
jz/VNlqDdzvQElhxRbZp2WD/dLugtgA2TdnE7HUjHQnbtm19arpUVe2VTMZRidXKapvSKlIjHF5L
HN/PC5+AvR6clHKtOtk+NVS3S4xcx2YZWw3L01OlvDomLDWsFrfbDTXsSBxf3JTb+YbmCFIyl80+
zmbJw3xqX+jlasrhA+zyHbYe8BHxKByagWlDjlL2n1iOe6H3AL/Rf4h1UAlmOvRBM3OIrb57oE9O
cNthP9UOEr42KUakWBE65PFcWGSri8Ow5SWY4tZ6jrTuH/1LWUfgdjv3wg2HvBj+nlJnsNvGqLoG
byNpPrwXXn/IaZCOsiXwf8Nx+CeDXdDfmmyaDjvPpiLrCNH2PH3fSObbo59Taa3LfSanSYkL2ZEl
SAl9P+UNX9qAqT7e57+c6in8wNVQR6G1x6f1G/G44ahkWmWt4fH0qdGcOiZEuanUGvZlR1OQfl+v
PLRKFKYXeA1TwscL2ThMkayCdOlMUfhk/vvwtclrgU69VxrOG8+uflYaG5MwvZ/rqmeLd53VjTt+
kP/XidvyyzA8tSpPzXvWpseBPvMZIi1SfE909q7i2WWg05e+I7NbPbPkUyKzTUrabpNi3hzf2C1c
HJAsa3JXpt59wp7g/NlPF3+0wu2IUs607oNPKnWT7HaGp272XBnu4XX+/8DBNkaG0kYPTF7DaP2m
A60LrDUTsJ/J2r802AUdebbUrrYa8D5wwGwbTM1yTcGAvkGxcNv0t3oVWkqfyWkybQfWnktBZ2Ll
9rNsXzHRnoDUCp/K9j+1dcWnTr/sUkvN9mnlyXgFqTQFkyWQbf31BWnwmcJtzxztVcbEkljcA2qa
TPtK8d0FyHz54htPSzXckwDxAH/GuPjNJ68ssvEcD4LYIxXgquM/uRCYpJA+N/vRM0WnZ/4wDgiX
bXbq3N47HFvNjt5iKZI0rYuFg6VI0sSHIIIkbrenQ+zbJt6yCQnHV3oCVFBi3KZisr2dCPgiNHMh
FUma1kXnEyciSdNagoRAIBCI3Yh/22Ll6cAVCbEj0WIDF80oEAgUJASiFQUpI78Hm0wLQmfVfI9b
fPQph7il3xPqqy6bMQ0CcVkLUjWtGO3cvvlCt3J+TbsHVwDApiH1farBzTi+HEKgIBnCd6iBUnn/
88orH+0e+33G+FV/QTZbyqSkdUixWwHJMDTha3KEQOxqQcq/pIcPKQdA9Xub8KTRJEAxmXmSHzLR
7FbglmOv7T3Whe2KuIwFaXWfFpwoQtp8Lz/cdqJt2HbA4V/yeM1uBU7D1ZtfK2G7Ii7rhw0q+sZG
Zywy8zvwLPvPdphZPvGu2a1A59TwG/fjuykEChJD4WL7Kaurgg0Yyg3B/+NMRbdbKSz8eGBkDdsV
cdkLUi4Hj8LeFFieZlfhx+OfhM/pN4wmlrrdSvru9k/Dv8d2ReCKBPDhkZusX3orbMFrkIQNXXgy
k1drYd1uZSV/MfPM32O7Ii4z4OlvxI5ErsXeXuIRIQQCBQmBQEFCIFCQEAgEChICgYKEQKAgIRAo
SAgEwglGJyuU6H/N97xuGLPKn6QwX2qDntmHmvE+JWEI+zC0UXPg5M3Q1Cg+qYwVJc6EDYQslKl2
9aqDKZYFucsQQi2li7wnL0NB4o1Iaxz2anZiudQoR8Qo1x7UjPdpKMI+DG3UHDjR4I3ik8pUUUp8
amqjTALUwVgQov6hkiQ1tCcvS0GyTl7KbCX/ovrkpd7Q+81lSO3g1netU7QEzKlIRJSJZ0JKPPSN
JvVkrmE5vgn/pmGlHncRJCLNhdQ0ORqnN2KZ7/xamcYrSHUP/cAjR+HkzZCEZqNPVKTmogVK6Ka8
NrEnQ5+cC3HWLpZTeT6OKIlBPQ7SltSQRxO8uiUkuObmP7Z89X3SrB2B3F6Ea1tBRq53Qb2aPoiq
1pCebAa6m6nauajx/j1rWM8iGo0KUWLT5sOMHP89UtgUEP22wbB/CTRyLZs2EpZR3D15Oe6RoLZH
EA1pcBKUNo1tS0y1RmkIwxp0VFLLtOKRBkUnLNotMxEJpVXRmlauxuh1hJCY+l/hFB/DmtTEejQM
ioIRyYqk6MZuWpU52um+4VLXVkbeM3hR0xPWt0eyMaybU6gtl5GvslHy5W+jrKegDi+9/GvYkJ68
XIAWsrsAPsJNSR2ZWxVoIYtomP4bc1ZEuIcNiFYHqSMaNRJckRAIFCQEAgUJgUCgICEQUcP8sCHo
Ow+wmKpQw7aVEojg4L2/PZK7eU6Qcvsz9LBHCmimE6RYhpYLbo9k5W+3R3Li7Zw/gD0SxYcSIQWJ
Bj3NaLVYIaAfQdBavh5J8rdH8jLP8S+3P0MPe6SAZjqBikUcWtTPHsnOnwRoEpf8AeyRDL3bwliJ
7XyqryDxZiZqT7oYSbodBDP0fbT2DAGEjkaWKlD6YKf/AjM0CUMcTUIcg0F7N2a4VeTrDpuUwD1M
GitIhjmSuBpJEs/RYDwsTGJqfdKQtiPxFMtxjNbdcCToICXBMjbx9IMbZ9vJhpXmqp8djoo4CTID
Gy1WGtiQhp1ArbNXjQz9R3+0A4zqJxjrt0cKUH5PY414ejdCdDeXfYdtAqBOveV0QNJosdJIxQ10
ezefcRWJStm8LxQQbT1vrD2S/7oVW+/u0ocNLq2tdK+5SUnMaz+JIEWk0h1RrR01Oxp964Trrrh7
d+ej3bL6WBvNzRwo7qc4LWVD0yDFLu7yt0RZduWKZPpCg7dJivv9UF+Z89H/PeyR/M1zQm0swtgj
UfUNTBCODbBHCtskVnskpeAeJUNDpNCI3B4pGkFCRLjCoD1SzKpdNHsZinIUvyTtCI3y8n7YUPNT
AZSj2ID2SLtwRUIgUJAQCAQKEgKBgoRA7GA0xB6JqsddaofdPMjhVbHNvMbn0/fgYVtjPtJHojCA
8mlT62vdWuyRVHchxDUF8Sk/2iM1QJAiskdSDV2itEeyPad1SEEClNvNtsZ8vN3pnFloAyifNrWe
GQltj2SosIt/JBd7JFP5d7w90go0/cCqVZCiskeKefIK5guFhnjBFYxUfdUM5BqmnlIGaYrAUc18
Kehcoq8bNycB/UXFp9ppM3Jd9kgqIRqfrZq/phXiwAUlMXSLl3VgwIar9QAPCR3V1Jfrzry1kw0r
raF3NsgeKbqWD24eROI/RhrQlUyYiga3RwJS9/FT6h2FZ+1qF6RWtUfyZxK1t6KIzJsC0zE6Iwpd
YecR783bI3Yn2SN1t6YguU174eyRGtD6Xs6IwrALrNmRKGjVJODR2SPV7EIT7ZHCoiH2SA1oeC9n
RNoT23j1umDVbNzjrnpNtGgzCn15qHYR2SPR+l8k1WAeVJ9CH8b7kDbaWtYeyZzCao/kXzK0RwoN
tEfaBUB7pNZS7aLapKMcxS5JTcmKCPOwIbwk1bzJRtTZ5LVEYze16IqEQKAgIRAIFCQEAgUJgdjB
MJ3+Nm8+aYhXQQ5WLBDJSwirtY6ptCbzmmAnsv3tkQI7ZKqToS1aMS+iXmforKXUs1MgYfwjqZlJ
AHskwNdJ4QRJPeZVw3DX+sDpwHg9cmTsX2/zoGBWM/72SIEdMtXH0CGaaNMX9TiFbSqlITsJ7B/J
dAw5gD3SZfMJ8HpMmzq85z3lGLL6UpyfIyCUmO400CGSTpgESRTwMHagVPExrOkDyMSTuneHeDCM
2bVVTAhap/YQaUkAQTLObMQ4JSm/wOrfsmGzVbghH6UcxcfQQXmt+xAu8R1YLhrb7lx3gtaqHtOm
DqvkEo8iKMeiqXsRzVYs0c5ucfkto5YvIcTY3Zr/Ghpk81XzmVm3E/1x9WSroh6LjI5AkksDdZDZ
iiUqg57Y9QD9iwixbgyIeaMawPOKfxLnLvB33bk7erJ5DxtCrI3EPxmJfoBHsGJFKBzRana1bVRo
Y87/NLQndyXag2oG9pCPjRKNWY6atEFtEkNaRyLqS4I2tyl2y4pkMEMh1GKXoizzjpYqPiZMdQmR
zfjHZl4Tyc4ojPehiKcJP3skx1KCZwld7JH8O6hhPbl7UYs9EhpItOjWrqb+QnukGPdIloc5OGx3
liS1lAp7WT9swH1ny4PU2GfYobE8bEAgEChICAQKEgKBgoRAXFbwsEeyQT/BqvyChhuuOLhJCp3C
UHz/VDY3SY1maPA/ENg/kpVyg/0joT1SSEEKZo9kMA5ruOGKg0+g0ClM04RfKpubpEYzNBwUCewf
yU65sf6RmmmPtNIyH/cOI0jmuUs1P7JMSWpXuZ+GbBRIHbG1WNrQuBkGLldAf0DEMz8JSjqybq2h
Qdp9/SPV0DVxCZLF/MhxSoq/qHVaNdTyLXuIgaHT0K1PguspWWO7tQbqK77+kVpxRbIcWwjmlcF8
BLJhKkAQy4L4D7ZGyDC8f6QgRav5eFBM3eqHnaHXQe32SHrvK2dYG22x0oq73QgslsyfSnfxj0SD
2rxGVbT4unV3PmyoYRRbtPGmnoCM2F9fPFVx8Ptk0/ZIzR1U64LUSt26M9AepKfdFyVL5C6So4Zs
nR1GrIffp/qLVqsctVK37uAVycseyVWxlz+UFvEbhxrcJAWj6M+w9iKFYqgP1eD+kdwo24pmclQV
xr9Tg7t1N6ING2jnA/0j7QTVDrEDJKnJCiqiAf6RELED/SPhioRAoCAhEAgUJAQCBQmBaCWY7JGC
bTybY4jk5a4IKPGypjIWOBr/SCEYujeN1VwpuD2SlbLdHsliNeaRf2fZI0mfuW/N83cdtQxxiN8Q
yctdkT6kqW+BI/GPFIaha9NQV75+9kh2ylZ7JKev4brkR/9IDRMkzYrCcVJyNYZpgRP41MPEhoRd
eIMwDcbQJSuts/1ICOLBJ7Cm9K7bNOO8E+FxX29+GQOuSCZTJF9fSLSJ1VB7n5IgQyC4O0+Po6Bh
GIYfmTQqi6PQAtUyvUs8VDset6O+tEoczJNskwbVpa6hs1NkJjoBGdZfJRrsw9nUmj6wPVJ9TeJd
sth6d/eqdk4N6nRA0mix0rhm1mxiXDszaB8HHA3+VQrFkPqegTW49wxpj0SsH04JVVCPksXWu2HR
vWMFSX08ZWt0f29Vse2OKITYD/uniphheG7R2SPRWgsZW+/uGrT7ruuyz1jPFDHsOr0cgwcy6aEh
GUI8DGn4AkZd0JoaHeG1IskqlGFdd/eH1GAPOtG7KwpsiBQxw7B8A9gjhS0h+keKAWiPtAuA9kit
qtohdpgkNSUrIsTDBsQOANoj4YqEQKAgIRAIFCQEAgUJgWglGB42UGL6A5YYRzTceoUSn0I0yj9S
0xwyUa+3Vd42SQ5F22X2SDtCkORmDPVaoeHWK74v/hvmH6lZDplc7ZEcmZtskhyKhvZIHDF4WXJ1
66K9JKea2abuN8nPNim69YjaQm4IZv8TpfuIyBmGGK0kmoIT1wbfOQhQ4vZg78tINIJknActk5DZ
TZJ2NrnhsxSJpI4QS1nrZ0gj/2a9j1zYDyLtxHUnQJlXGl+zDmtXyuJEvMpKXGcFfk68eRp1VOe/
A091NAqrITOb4PZIdYgbdTLWaMUe3bF7JO9B5GaGbLJe2SUW/tH5BiJB7ZH0aSoiSzpXGrrl0+XR
o91NEyTtKzmBFtEWsV6JdkEi0ZEKxoaGMxAPwhztkWJDO1g3ScT8IRpqXoqotxawe+SIRkSK1s2m
duYu9kg0aKHxQGvdK5LV1tjz8wMNt14J5K4omBcfn1St4JDJxR7JkbmJulvh0R4pBqA90i4BrfUb
E2iPFLlqh9jRkhRrNkQw1Q6x00BqfGyCGgmuSAgEChICgYKEQCBwj4S4XLCiXLtjFST9kL3zb2f4
HGdxsmwJ5q3BTMCtIIHNg3xsa/z9I4VkqNsXeTpkCu4fycLSYu1ktkdysoUKZI9Ua3fhimQdvBE/
DnW0bHH1LGQZhgYCbhkCmwf52Nb4+0cKy5CA5xC0sfHzj2RhabN2Ip6xAe2Rau0uRIdffxFnYyTj
9KnOh+o7d2OfEr8Fxy06dM+RCFMFSkyCziL1FyRsA3nHetgj1dhdrQPq/AiARtr4voJEpLnQZYYy
GyMZQhb1LthRYRr6U2zxm5zV70cmiKl5jcOWRDFdBK7hzjn9QJz3SI0vf4d/AzoZIxks7rQ9ABdD
Nd6gnsTWCzTAoTb/8qgJg5gyBDo56r67I67+coIO8VqPwVH3GqInpOgFidYS1ZiFI9iQDfRxhID6
WETjiXgXlzr6ywlsj1SXqRBKTFyC5N6d7o8lbDGU1CYWdvmMZq6kJCbprplR47XYkCdccZEKK0jE
+NDZp6HtNitGSybi4J++zom9Lp8L8cuRT6JmDk5K4mieVkB3kwTJpKebJUvVxq1uk2ze5cy3zHYz
YVV6D7sgc7GCJ3TZ/Ae21onKHsnMJoB/JDNzJ+pusVZ7JCdbpki663JGWHskGtQbN6oDO2SVQXuk
SNDeoL5EOYpdkmLNhqhTkEjAOJSjmEFITX3mlW9nopBK9e7wFQmBaDp6esuvFjL5lt8jIRAtvEfq
u7TAr717l5u3IhU6RWFMl+VcTi5SWkswkQFLZDYF+U5BOFmFak4C9AgPAHx2Qkl/pzDWmZfSJrNN
a/C+tCB0svKxYrK69aVFId3Ylb83I4gZqda8QSYynK8FGdZ81W1B7Cyw9huT2k9p/+0qa8JugE6H
BlPiZaRzYKAtcVLoMVRPsiprJZCh3JPRmQM1Vk+xG9BVkOUILsyLE/Gy3pPSgletLl/6+Zv/ZEP5
2Q/z0uXYNfNqghf0oBxZOPNK+StHCwlYLldef/r8/DzcM3V6c+F3H+RpFgZefuVjR/6sytJm3vG9
+5vUtltbLzw0sFTdO7T86zf/6Ubb5t7Cm+Y2Gslwu9ojsFrPz89/6ftnqv+4UVw48+dVU4rq3mOs
+cjoUmLwZOXBEx97jLUfb/8L4nEWOv/Xm/l/uGQnrMZrFHTa/TCu0pO2PW2Fx879cRsrwaUr8hVl
KyTf4/3yhSGWWSnfvNLNOw799mL3bqwvyaF9JVh9NPnrOMecYUX6CGxAanydrzZ8nupJpvICC7PB
IQpdIErBKptvU6qwHyqfggoU5tifK+Ut7cOJbfgNUY69ciSVLYyvcXGdPdisBl8v738eqqxqF1Kw
CcXyhSugraEMS9XFXzBObJq5fTINpUpCBLMcwR38bwXm5uAEpGBAaj+GJ+HcLAtt7t+G21IOhJV4
nYKZtkKPh2YHQKJQuDSV0mKVewDv2lJWOKl8uwfV7V++trRPkiIA6bpU7u0qNEWQ2mEgZVoPt747
nGMdNw7dY6cyg91lHnyisjr8iJKgDG+Ae4GVdpsN1JKQYfNB9d5C+Zwcm4TnVUqz1rEUKw6yqpVh
YgL+iv14329Nv9JohjNcVg8eTy7Kv+41R+df4isXZLNwGu6RLtvSjWvlUHtfe7Uy50D1Wi0l5F/W
qqbRVuipoXukWXtELoHxHsBblfqr5dsd+EFK2hUtGf8tvXBFthmCdHEahu8z6vPnkzDEA4PSrLnO
g2vtXV3wsJJgk0l/ElKHpe5tW+0cuh5SmSMHxX6xR4odAUM1mihIE2tsKqbiffdNDrNffzFz/NoG
MyzdBWyqL6xPPcXZ/ysYNsev7pObR5lj+DDXQ6mVZJ94UNprWqCnhNWsVjWN9giYQqyPCoNT89Z7
DB+SM6vl2yV467aTmv3pZghS4tWZaRi6Vb+RPQo/kPtLms4UXfsTW+e0PpPK/pl8V3mqDYqnE5Le
sVx5+/qFchcXuknQVtZsg9Upz6cNY6MzFK4r/+TU6JulopyDjcYyXOgZeY7V/GfHxaNS2902+tx7
nJJNyZdJ6U+bIbRcObc+/47iB20Z9JTaFGGkPWWmzPomtS1mrfd0KOXbLaDPXM21OsO/3mt//f5m
CBJkl199jq0yU+r6USgo0e1SUEYRXhS1DG1MVBKr1eJ2u/ob4HBH4viitEUAAW7QHjg1r4ELF9tP
LUt7BLZHimVZrPbDp6TjAr/DzzFWb4efOB8eaJMadQz2aG07BoUqb8JDQnY2YZ9gtXiN0+3bBtoK
PbW7WJf0MeJ6Pxfy5peGv7PLPnxzdO3Q67hGt0/R7N6ZXY3xYbGhbZO5bPZx1rptsCA/ID7wU6bP
SeuKADOHmA43BVL/3DCj5eiQNBGxLzuagvT7eg9LjyOgRGF6gVNNCR8vZHN8P7sXEs1q30dhb4oX
le2R9kBSXDjMatJI7Nte5Vv+La6L7btn9YJzOhEOz8B3WMMcOgz8Cc8UzLyONTXbej4PU9V7HZYw
Hq8/r953T/cFGz0WLcChQ/A3kuYtbbXk9IzNHXC/IbNSvt2EwmtcaZef3L0u+USsO0CDIF06UxQ+
mf8+0Kn3ysN+z1ue+SE8MHkNnD/76eKPViA9dQ2kp1fepuX4O7YXyLSvFN9dgMyXL77x9HmmbexJ
gHiAPx5a/OaTVxYZPYaN5s1+Hx65SXpXsnLj2NiZp+HSngOrZ1cayrA8cgd/ObPJt4jl2TtcXtVc
OL16V57CU/ni6gBXNs/n7yqeZqOgF/ZLe01bBjVe5zR7k4G2Qk8KDRSL+SNSq2c1lXBJumfaq21C
dpcJEmRXX3+FHOq9/rVUvLzrOtlQuEq4GChhT2lh1/VaKyEH7meh+y6t15q1pavsUuyuIlulr1mO
XQOq74hQdn0tULrk59+Do72BENq2K25x6YyXiiPAdnVXCRIsHNzaeyH+8uBZO8TuEqQmAU9/IxAo
SAgEChICgYKEQCBQkBAIFCQEotXg7x8pBBy+tKt/SFtO4OAtyOooSPOFYqGlO8YwZtWd/hBnJypu
jo+o5UuyAcpGgeD3kRC+glQ3nL/Ibhh5BOyfOrY5ClLd8VBHSbUxpHqUg/S5Oj5SvQOZfZx4ls3T
dRECVTuHAUup8tVNHjIG2UUe5moEBeMv0NOro5qo2eQPeDsJg1UI7d+GN5H1kq0ahF53auZEDAUH
UeuKpM/WZq9IBpdIju6SZHcutuFn9K9AjZ/Z93RrZZUsqn5A2ZTX+RPjNLAI6J5onMtm/XYwLkgI
f0GiwZQ247e9idPQdBhtxGP9MXoH9BryvkuE7qop6JbOb23Udn2yY4AwrosQl68gaUOG+ssWhWAi
GCdIgyiqjgFCuS5CoGpndMgXbNCG/Uy7k3oW1MWfMa9L0kCqnYfncNsarOfBb2UjggsSeD4Fp44R
BgcwxLgDAb8dfCDFzrDoBXM3GVqx88iMSxCiJkHS3agaPOToPnMUz0gWR7KOy0sADzuKSx5qe7Fj
pOfgiMn+0AA86mJzfEQt7te9MgdxXYS4vNFWsyvfmqMj5VUvU4qvWHcmWs0eKfQLWeqrOTVnXNb2
phRlCNEkQSIRpIiWXz1sSfQFRlyWwEOrCAQKEgKBgoRAoCAhEAgdhocN1HHTrr4XCrUlt52jobb3
L5SY2BIHEmq0yVqpRsMjPRofeCMaK0heA6zOked1QI04kjeenjBZK9VoeKQfV+c8UZIQjVftqMHG
SDE+spgm6bHgbLRkpkUVIybdokk2XYpKTMOJNALR0BUJnBYBopoZGS2QLAqS3WjJQouYrJb4/0Y7
IAcdz/1wqIste1Bo551QoBANFiT7sHO9Z7Y9IoHHtKM5kmNe58N6FHyOfyMQzRck6jGE/XQr6qV2
0aDalvnouT0B8RE0BKIFBIn4P3xwG9fU+gER4rfAuah2YXjjqoRoyYcNykAONIwNT6ndlh2HRYk6
rT6EQw2GWGdQjhCtuCJZjHAocVKijL/MRkumxwSmTAaLJvl5gvx6h7oKg82ICGowPLJRwK0VInrs
PP9IkcgACtJOB/pHqhdRfDUB5Qhx2QtSFFsilCMEChICgYKEQKAgIRAIFCQEAgUJgUBBQiBQkBAI
BAoSAoGChECgICEQKEgIBAIFCYFAQUIgUJAQCBQkBAKBgoRAoCAhEChICAQKkoZMjl8m04LQWZVC
vWlR+CAP5TjkZOrVGPIHSzuRDpIlDFEzJPpBkcr1ShXMpRR2rHaikO67M1eFgpATClDN3WkqDBFF
C/neNA4ghF2QqukhOXD75gvdR3uk0OpmV/Gn/AsH4+PyPzUcHizXfcdqzRwMEv2gEEGaIKrsqhWw
3H1sdQKehp+NwujP2HXCVNfVkYWXzSRuPoYDCGEXpDvUQKm8/3moSKH18uIlOaStFum0NEtXM4KY
muCrQEYQUnktrrAtCl0FKHQJYrrKbmWSfFJn/3I5gV3l0EOpJGE0RKJM+CdFsQvU+wDJXB/05VJQ
ymX4OklOCuJ2gcV3plK5PFsr0pxdVshUFa5donCywOkX9LTsD0kLPT2iyEsKrEycCysTwCKsSxWE
hKF2i7ApwNvgX8MU+/c2HsWLSzJiKXEC7s7m00IiXZJYp8WHOLu+lChk+nAgoSDpyL+khw/BHi1k
Vv+WVqS/3U9UVocf4cvX0K9eGL5Vizswll4Z7If+wUzXMTZq4YlX9axMIpX5/fc7j5dg31C6Kv/s
nkmfGuxW70urxf1srRAg9czQAlSH3rA10/m9sQPSSH8lAW+BXuW7ln+eGZICSy/BgcFTnTP9nH7/
TGdaScv+bM2NDmydH7ldSt4zmEkNamVKPDsyARMjzywaVUNI/QzuYeVMsH8V+Ll6fys98qGqRPzW
pcraMUnUN+dGPsDZ/Zvh1e6hVRxIKEg6VvfpI6oIiv7fW4SUKUeJT+Fr7V1d8DAfZHDVk18raXG3
wFwJymymn1scl+7emHViO7/I8rE0L8o/WaiLZVLuA3wb/iMfzZCEz8A++PI6zN7IF8ZSVmDXDUUf
OzLHA6V97F7XLF9hJFqzc0paieB+Jmj7OVEowdw5Vj61TCJ8C0bhc8bV9r5n/8/+qZ9XtyZfnNyq
Hp/cbyjuw3IFz57sgk2Z7ja/Mwdd1b8o4UC63LHHJCX9MM+vfQ+OzsjfYey9NPqxBw2R/fABHiL/
5+W5b1w3z0Jf/NzIT35/7zooca9c99Wvwgubt0phPbn0T/5fDn0A+q+b77juA/fLHPdc94H/1n9+
S7nfD594ZXu946VLAK/+/plnHnzpxb+WiMrxa69ulve8fJHT/tj9/S9tchZt1z/1VZDC84yWlpaz
74cXJaIsA+c3KWdguPRafvFvX/pvShFYuvH5L83+4cbGwRduXfiz1PDyVb+qyLXWijUPT/3pY5kr
rjfeWZ4/vv9TqwkcSTGjf76Vn9opKFxsP7Usa3uX4NRtTkmK8KKyS3/Pr358+viageDXxscrbJNR
0G5NMjrO3AvK/XuhUAAjn/Joz+h/YtesOHLraDLbJhFV1MCOEz2jygpQ0HjskRKUedCY1savYKhw
omPkkdEO04J5gq02hC1VCaY7lp2+i34XvPS8+Q599d35kW4c2KjaWcF214/C3pQcuqXtfMol3w0z
cih99xMFNnpVCHBQehYgwqGFXFK+NQZ9ipAYxUvSrQ7dIocehUMzMG2IysIQ/A+uVB0enpxnGh6j
llZzDYGyuSeH1WduAsz05TKcvjGtGSzmoOEhHVxgut0FU4oJJjwJpu8tsv9GwHGZKR8CwwxRgNTd
f/iitp9EoCAZ8eGRm5R3Rsnj78o5vtZJT6+8TQ6t3Hjiqmf3ahHnzx7J5Ffg/EDx+md/IN8603ZJ
Gb6ZyauNjy3OlAgb+5K4nC3edXbFEDU3AdN8jGe7QMhK8QfOKPGvTYKoDP8HV88sKVxP37VyZpnT
52m/77gxGygeMXIpTcFkSZ47eB1z4tizGVhk9BOQEGHyeTuJ5akDm/qvByavgafPXLziTCcOpMsd
zfRGISbny+96ds1JBdvbNfyTC87aGewf+dQJPvxhHPvvskWreaNopiBlS5tte1acFCihrS1dcJG+
rduelZ+DiNsVHE8oSC2Cjiby5qLiuBGpgPIs22GPAk9oIQSipfdICAQCBQmBQEFCIFCQEAgUJAQC
gYKEQDQRxsffsq9vs8dvm/9vZ4fgSlbZzbH5Uhv0zD7UjPeDOCv3p6OGrNQcOHkzNDVKiIoSZ8IG
QhbKVLt61cEUy4L8bRyhltJF3pOXoSDxRqQ1Dns1O7FcapQjYpRrD2rG+zQUYR+GNmoOnGjwRglT
UUp8amqjTALUwVgQov6hkiQ1tCebjRWA7tgFyTp5KbOV/Ivqk5d6Q+83lyG1g+cx1zpFS4DU0Fb+
lIlnQko89I0m9WToxv568L0LbVipiYsgEWkupKbJ0Ti9Ect859fKNF5BqnvoBx45CidvhqSemtRc
tEAJ3ZTXJvZkaPpBjwitxDSd+xwRIgb1mAScWNQ8muBFNFtFIibEV98nMe8I9EHKQ4RrW0FGrndB
vZo+iKrWkJ5sAuIyFesIPpCD9KxhPYtoNCpEiU2bDzmN++yRwqaAyLYNxLBzUZst0Mi1bNpICI5N
6cnL6GGDR4c1Zn0OQZQEkfeY5k2qNUpDGNago5JaphWPNCg6YdFumYlIKK2K1rdhjFSvI4TE1P8K
p0gY0sa0HiV1aRgUBSOSFUnRjd20KnO0033Dpa6tDBsPPtT0hPXtkWwM6+YUbMvlwFcOE1/+Nsp6
Curw0su/hg3pycsFbdhCOx8+wh1ox7fT0GqGfXhEaFdIUlOyIsI9bEC0Okgd0aiR4IqEQKAgIRAo
SAgEAgUJgYgaJnsk8+YzzAmrhlmxUP0gmtVwxmKeQwNtnV1T+RtARcxQbzOzNRH1eltlLaVOncoW
Ri4WS7a8ama0RzJA+gpvdwSCpB7zqmG4a30QsRULNfaviZrNPIdAoPMPLqn8DaAiZqjdJGb6rvZI
jqU0UCeeFksO9kjyZbfbIzVjRXKcew1TEu9gKp8jMtyJ2oDBNHCsw80zUfBzqxBIABrJUDPFqK1l
iCd17w7xOHTbsJ5sKoLWqT1EWhJAkIwzGzFOSY42StDAdT/ckI9SjhrO0FVlDVlEx7TEd2C5aGy7
c90JWquVOlqgwyq5xKMIil0zdS+i0Yol6rfmMWkX+pm3WIYVMe8Dg9sj0cAGYm48PTW2Rvbkrlft
SPDuoM5D0GDF4m9B1KJ6gDq+YrFmI9bWC2yPFCSJcxf4G6bsjp4Mje6oBCnE2kj8k5HoB3gEK1aE
whExQ1LLRoU25vxPQ3tyV6I9qGZgD1HvVYrGLEdN2qBGxoZGXzzqeZsGzYh6XY0rksH+hFCLQYpu
o+RqMRO9FYvNwgZqNg/y2Rl5GEBFzNCNr6s9kktqrxKabgQ28QK0R6oBtdgj4TuFFt3a1dRfaI/U
sBXJT1tAOdphktQCKuxlqdo1ZPuKaCxIjX22ezt0xfyzwd/lwkOrCAQKEgKBgoRAoCAhEAgdXv6R
qMuX1s3wOc7iZNkSxJLHbohEA/o1ClQQfzrBHSm58tOtfgKUR08fyB7JyUdSCHskjbXljVWt3YWC
ZB28DTiQYLNsCWDJYzdEol70IagjosD+kYI7UnKBj+2fjY2SPqA9kpOPpKD2SCbW5uNItXYXosOv
v4jNJsk8ZRnmQ/Urn8Y+JX4Ljlt0/Z+/riNVoMQk6CwSatYJnJTWHEvc60DqL1lzQV13LbTWUVCD
IKn+kZxmKItNksk6yajeBRs8NPSn2OI3OavbjCKQ60tHbZY0XMbD1XDnnH4wFHSljik0ohXJ3ICO
NkkG4VN/cjHUbJZImGERw8gnPnstW8IgpgxBquYysXh8YjygfyQvKoEkw7mGeAAsekGitUQ1ZuEI
NmQDOWsNqI9FdRo2bHlCefaq63MKKDFxCZJ7d7o/lrDFuO3Ywyu/Efn/i8sgKSwjwxLeaC025AlX
XKT84eYfifouOHarFmJ4ZESMe6YoJnZfZ0S0xeSooQt0rHKEqHVF0m2LdclStXFCvVwn2W4pdkQ1
Wrb4O/MJ7PVHTeiy+a/BIRMN9BzBh46DlVMgeyQn6kHtkcx9YhH7errrckYbiWwysw0HxE5YZXat
PVK8p787GtSXKEctJEk7TfWMBt2xcgt71o4EjEM5ihmkRs/K5LLoqWqPKD5VaCXVDoHYIaqdjr61
8iLAvrbMUmJHqHYIRCuu1aVf8OsSXNiXSi82XrUrdIrCWCaviXyOX3rTWoKJDFgisynIdwrCySpU
cxKgR3gA4LMTSvo7hbHOvJQ2mW362r4tjG1LZeHFjAFKu0xkBEFvUxWZHC+R2Flg6cakdEr7b1dZ
EzLlvtOhwZR4hsm0IHRWVUK8O3IqPZ0BK4OoVbV6kmXh5ejNCCIrUT7DacTUGs3r95Md5xa0X0sv
/+JO0hgNb09KC161unzp52/+kw3lZz/MS5dj18yrCV7Qg3Jk4cwr5a8cLSRguVx5/enz8/Nwz9Tp
zYXffZCnWRh4+ZWPHfmzKkubecf37m9ug7aPLX/2lb8oz8/PX7riTDUGhkq7/ONGceHMn5sZVvce
Y81HRpcSgycrD5742GMsHW//C+JxFjr/15v5f7hkp6jGM9pbLzw0sFSFvvYhuZP6YVylx1UZ5f5X
lWhpWm4rPHbuj9tYaLvaI7Be+Z/H/tfrGI35fi3JzkJ/kGL3brV9e41d95Xk3+z6v+jn9i40YDAa
VqSPwAakxtf5asPnqZ5kKi+wMGt8UegCUQpW2XyWUlYcOFQ+BRUozLE/V8pb2ocT2/Abohx75Ugq
Wxhf4+I6e7DJ7S7ChQGQRlnh0lQ6DoZKu5QqCREsgnuHkmBuDk5ACgbmeMHgSTg3y0Kb+7fhtpQD
RSWeoVTe/7wUumnDxJDTk6Dcr5aNsbMDwKmWqou/gE32X+qCTG23It+d+GVliUkPW4n2gX7dOt/X
mW+kILXDgCYiHFvfHc6xph6H7rFTmcHuMg8+UVkdfkRJUIY3wL3AlsptJoMlIcNKXb23UD4nxybh
eZXSLFSb3KptUjHvkWayEXExDoZKuzDMsLC5h1+S/m5DNgunWZnYhae7Vg6197VXK3MOFK/VUkpz
GOwBOPOqIVqhJ0G53/FdS+w9yo8Z1hx/BRO9u1mQSp3Hzv+a7YvA4d+Fl/5FeqFxgnRxGobvM+rz
55MwxAOD0qy5zoNr7V1d8LCSYJNJeRJSh6XubVvtHLoeUpkjB8V+sUeKHQGDot9sQeqAwymp3IXB
qfOxMFTbBSb+FQybo1b3yc2jzDGgCJwSSq0k+8SD0l7TAj0lI1oEtq4WjTupET0o3+9L/bYlVum3
0l0s8/D0fTe3bexeQfrHLc/ojScbJ0iJV2emYehW/Ub2KPxA7jZpOlN07U9sndP6TOrVz+S7ylNt
UDydkPSO5crb1y+Uu7jQTYK2rctCW5Pb9aUzxewUu6a2xXgefCjtAhO3jT73HqcEU/JlUl4v9dBy
5dz6/DuKH7Rl0FNC39joTMGZnkGcOq2xshQu9Iw8V4A3Hz/1k+1d/O7jPWvlA32KRmf7d02y8p7G
CRJkl199jq0yU+r6USgo0e1SUOkdeFE06UuJ1Wpxu139DXC4I3F8cVP6JcAN2gOnprdrtlgubXew
IRjXA3+lXaq3w0+om7JZgDGmoaltOwaFKm/CQ0J2NrFty6DFQ+Fi+6llF3o6jt2c4xtctQvzcm9W
++FTVOpitkcq7+Y9UmJlo/ud8r6Ia3Tq9Tev3S6mGrlHSuay2cfZOGuDhV5+48BPmT4nrSsCzBxi
usoUSJJ1w4xBX2KaiNiXHU1B+n29h6XHEVCiML3AqaaEjxeyOb6z3wuJJrdq+n1VMipI2uhsPAyV
dtl3z+oFt8cfh2fgO6xhDh0G/oRnCmZex5qabT2fh6nqvQ5LGI9nKR+FvSk3evrj7PHxcWlXK99g
bO6A+6Uf+7ZXpUcSe6DU2/ReaTToE51f6l1SfsjXPzr449VG6CQGQbp0pih8Mv99oFPvlRt4z1ue
+SE8MHkNnD/76eKPViA9dQ2kp1fepuX4O6ZrZ9pXiu8uQObLF994mu0+JvYkQDzAu3nxm09eWWT0
JI206S9+//mlTGmGSoIU0ystpV3Ks3e4vKq5cHr1rjyFp/LF1QG+Vzmfv6t4mvV2L+yX9pq2DGo8
wIdHbrITVeiBs0q4NFAs5vlerTzCS/R0vvtifgV2OxIfWjx4xT7t51XJB2ljBkBdR4QKVwkXAyXs
KS1kAdEw5MD9wEzfpfVas7Z0lUMUu3f9N78ttUTyxcaNwvrO2mXX14I9wvr8e3C0NxBC27brk+x0
xutxvwDb1V0vSAD520vbmcVGarJ4aBVxGQhS44GfLEYgUJAQCBQkBAIFCYFAoCAhEChICESrwd8/
Ugg4fGlX/5C2nMDBW5DVb4/NF4ruEcMpk/phUlthnb0FGQroWBrdiYzmbQO/iIQIJUh1w/mL7IZx
SMD+qWOb3x4ndzw2+TQ7niE+SQw3TL6HnD68TA2ZPZ0VIRB+qh2lVPnqJg8Zg+zCx5oWQcH4C/T0
6uAmajb5A97Wcenk7MK4bBjpeYis90Jpyad/d5nW+BUrBMJ/RdLnbrNXJINLJEd3SbI7F9soNPpX
oMbP7DtoY1Zvm4rnMoPPPuK1VjkmISbyuu8Zx9KoFdB0SVyQEGEFiQabnY3f9raPMuKoDBHzlTiI
j5s3E40dcZUg3UdTuC0ccV175LThnBUhUJAMA4qaJMrfK4WPCAbaWlFSnzIVndtLSmwiFthZEQIF
yXXIkWCjMuxn2qlXLg+X3oZtDvFNEnwTZVTtLKTjd7mJ2D2CBJ5Pwanz9kR3AGPwK+Lm+NFfbOyr
HfEXttpWDstzPFx+ENEIku5G1eAhR/eZo3hGsjiSNa8UqrLm72HHzcOR5tXHaUnQfRO5Pp328hbk
KytaUTycFSEQOtpqduVbc3Q0TGrmRnHR2Q1oNXuk0C9kqa8CFfMoDfnCFGUI0RKCRCJIERGjmviR
CIuIQKjAQ6sIBAoSAoGChECgICEQCB2Ghw3Uce+uWSKE2aDbTtVQ29sYSkxs7TZK+kkDg32QnNPP
/sicx0IBH38jGitIXgOszpHndVyNOJI3muQZj5cHsT+yHVc3UpCFECUJ0XjVjhpsjBTjI4tpkh4L
zkZLZlpUMWLSLZpk0yVXMQ35aiicSCMQDV2RwGkRIKqZkdECyaIg2Y2WLLSIyWqJ/2+0CnLQ8Wjg
E6003Fsh7bwTChSiwYLkoGC53TPbHpHAY9rRsshiC6idtQPnw+MEVxhEawuSsjQEn+upu5pF/XUw
DzNAt0cDjsdlEYjWEiTi//DBc9y7rj0kgDiGlQp8Bodo1YcNyhOEQMOYWj8n4vJZHvMP6rQgEY7Q
jw9wRUK05oqkGx6ZHjO7WiCB2WjJZD5kymSwaOJ0lS+aOLwVstko6XQC2B+Z89go4NYKET12nn+k
SGQABWmnA/0j1YsovqGAcoS47AUpii0RyhECBQmBQEFCIFCQEAgEChICgYKEQKAgIRAoSAgEAgUJ
gUBBQiBQkBAIFCQEAoGChECgICEQKEgIBAoSAoFAQUIgUJAQCBQkBAIFSUMmxy+TaUHorEqhvrQo
pHulUI5DTqZejSEv2FJNpB3iTamCEXbmo1/MVGqi6YTedNQUETsdxs9xVbuH5MDtWy/cfNOZIgut
be5duGNaujcOOVA/3FL3B1zuO+ZAov7PwozXFR0cN6ukxnEAIewr0h1qoFTe/zxUpFCxfOEKaDPN
6um0NBFXM4KYmuCrS0YQUnkpVOgSxDRbyLpEoVtKmU2LD0EhdSdR5m72r9AlJjJVgYWhcFIQtwtq
vLqC8DwKZDrCSejJZaFLAPN9XhKejaSFnh7xfRO8XGlRIpdPJXvkxIVtUegq6AxKqWSW8RZ5maU4
6X5PRuzpSYolqXzCyYKaL9PHmAlil1Z8uXy8+LlcZ4rXSKbfm07wuiNQkCD/kh4+BHvkwPt+a/oV
U46lFelv9xOV1eFH+PI19KsXhm+VQgcGM13H9kL34KnMEWkYb86N/Ad4ZPjZTT3zgcFTPUPdFWku
75/pTI8dsMRLeT6gBBU6HX/PZLoCVW3t1OgvvaTmGR3YOj97G19hj6Ulcrnhb28pHMfSK4P9OoMr
Oo+vMd4ZqczdY6cyg0wmYXt5ZGBr78iHpPJ1zvQr+YpDq9AzmEnxJIbyVeSlaPEVA/1bjr2291gX
jicUJIbVffompgjKPuAvZo5fa8pRSkh/19q7uuBhKbQFVz35tZIUKsPc4vg6u3TNgXRjfj+LfBzm
zuuZKzCwOL7Gg+swO8d+m+OlPNtKUKHTvlnYnB4qbGkl1eiXlPKe38+ESsknyuSGYEChegvMlVgW
DU8tskIx3vvHSzAIA3MszLiyOi0tsvpUoGuW35HyJViSEsydY+mcylfKGuifhqs35VZAXJYwf2lV
3Qb1rYzOLCv3CndPlfVI9Q95Y/6X74JxFnro/aMwnaJ67sQJtp+aKufkbZX9oqQURiWBrea03Zee
Sv6h0OkaPDs4M3B28OxFpUAG+iotnbqNHWczWQETAyWvMGosqcyT3eb1VZKII+z+ZMWxMjyRQj9b
HIGpNMUBFRd2xJdWCxfbTy175yvCi6Ices+vfnz6OF9kpoDvLm6DQkHfV01Jv9hQY5oju0zLSbgI
w9fGx6tqvAMUOu1QnjzHxnY7KE8NzfQtUMhNa1TbJTYVyJkesB2Wi9Fu471HSs3nDa2kLEk7IwtV
twbk9AsLPx4YWcPxjaqd4XECPAp7U3IoKS4chqRjvhtm5FD67ieUcZ2EQwu5FBt0M4f0PAk41M/T
90l7GAFm+nJpLnI8dVqNd5QJTmcBRv4q+5cj7Do+Pm647wwRDh2Q1C6YUagKcLDK2Ch5FTwKh6WS
CjZKvHwZOXSoypKwUh5k4TZY6NVTTerTgUo/fXf7p+Hf43hCQTLiwyM3KTP4pT0HVs+uOCRJT6+8
TQ6t3Hjiqmf38v3DQPH6Z5+G82fvKv5IW9DGn1mTpCzddklawc6fvmvlzApkJq+G+bPFA2e+r8Y7
QKFzHcB97D/parrvjCVxTXpK8sNnPt2upj6SyVtrMH929cCZiyzu08UfmeJ4+ZblfMVM/qJUpyNM
qaRT703oqR6YvMZQSk5/JX8x88zf43jCPRICgXukiFckBAKBgoRAxI4ObALEroR9Z9+NKxICgaod
AoGChEAgUJAQCBQkBGLHwPjUTvb1rXv8tv52Bov3SkJl18emCz/b6U/WRMCtIFq0IRSgIP50Aid0
56dVljhUzcZGu0HcG93A0kRFzuYe615Dai5crd2FgmTt4YgPMFOiiZp+IeDLh1oIuGXQog2hAAXx
pxM4oRsIuAxB6lwe/QYlrnKks6TWG8Qz1rWGhEbRXYgOv/4iyhypzk6Emqcsw3yotL6pT4nfguMW
HbrnSISpAiUmQWeRuqsWuoG8Y4l7HWrsrtYB9di00NpGQQ2CRKS50GWGUgeF6ZcsNyb1zmeeDtgx
JArRqrtPSL2D3UkBJEEzNlTGw9Vwx8iRoUIr9U2ikaxI5gYkDqUhBuFTf3IxVOMN6klsveA5LojP
XsuW0GfvF7hqJFwLSCs+DTzECa1tfFD3GlLcDUUuSLSWqMYsHMGGrP8eKfCuLqr5i9SSIYgQh6tV
JEVD1ChI7t3p/ljCFuO2Yw+v/EYzV0Y443qTqplR47VYnwkHF6nwaLdoCsRvXaGWALXnpkZKEXUC
IcRnBqUtJkcNXaBjlSNErSuSrKebJUvVxuWndkoKPaFDXmUc8XxK7rAqPSV+WYj6MDFoQpe3PzY6
buT0hBSC1MaHjkP55TDxrq0TdbdYShwL7lSy+rrrckZYC1nPGcsYiVPbDllldmhH+VrI7mAzCpSj
pkpSrNkQdQoSCRiHchQzCKmpz7zy7QoMdJKBVhQkBGJnoLu7e/P6/VtnL8JZcsU32K+Ganb4FSHE
zoT/V4RKvesXtB99SZqIa0UqdIrCWCavlVT+NGmv7spoIgOWyGwK8p2CcLIKVdl9Uo/wAMBnJ5T0
dwpjnXn+nclss9u9yorJ6tabFoUPxuI0QvEnVTW4ldIh+aGqbgtiZ4G135jUfkr7b1dZE7Kps9Oh
wZR4GemcVieZmUpPZ2BKXz0pCJ08bW9GEKVcJCncOQG5XeriqdolrL+syxEsvrSa7M43kOGelBa8
anX50s/f/Ccbys9+mJcux66ZVxO8oAflyMKZV8pfOVpIwHK58vrT5+fn4Z6p05sLv/sgT7Mw8PIr
HzvyZ1WWNvOO793f3IbdO7T86zf/6cbWVlehq1CJgeH8/PyXvn+mqrSLuZP3HmPNR0aXEoMnKw+e
+NhjrP14+18Qj7PQ+b/ezP/DJTtFNV6joNSJd8e4So9Pv+1DLNqQnolNW+Gxc38sfYpzu9ojsF7J
vvHC8stfqc4r3bzj0O9R7MID9/xkQXLvtU9xa8Cvq8tfSb/4mRhWpI/ABqTG11VfQAA9yVSe+wKS
/QiJUlD3i8RwqHwKKlCQnEpcKW9pH05sw28oHwW/ciSVLciuJ/bMHmxyu2/AhRRswnp58RJU4mFZ
uH0yrbaLCbIfqgrMzcEJSEkeMXiJnoRzsyy0uX8bbks50FPidQpKnRQo9CTctGFJL8XODgCnWqou
/oLlKk/QRKW4C9eiwkSqb/6LS0x6AJYkfyX69cLLVye6qw0XpHYY0ESEY+u7wznuC0j2I1TmQc0v
EkgOVt4A90rfwd5mnVoSMqz01XsL5XNybBKeVynNQrN9cJVhYgL+ikt/XA9YDh5PLmrtYoTsh2ob
slk4DfdIF+4p5lo51N7XXq3MOdC7VksJ+ZfNdTLQk3DmVUt6JfYe5ccMtMG72tNiurDrxKjv86+7
8dULILW4479fnxdTvQ0WpIvTMHxfxqBHnk+C7AtT8yNk9IvEsMmkPAmpw1J3ta12Dl0PqcyRg2K/
yL3ljYBB0W+2IFHxvvsmh6UtQhFS8cyM61NPgdouJsh+qEbUOYYPcz2UWkn2iQelvaYFekpYzZrq
BAZ6EopZS3olVum30l2QhtmRpcyx63adIH3jD7d9n6+91GBBSrw6Mw1Dt+o3skfhB/JTA2k6U3Tt
T2yd0/pMKvNn8l3lqTYonk5IesRy5e3rF8pdXOgMPhuyrm5Y4sJ15Z+cGn0zk6NLox+L5x3kz46L
R0FtFwdMyZdJ3reG0HLl3Pr8O4oftGXQU1rqZKLnkn5Kl6qFnpHnpJ4pNV9PiB4nVhd/dDUoGp3D
vyuuf3Yt1WBBguzyq8+xVUbzBcQ9A8mJND9Cul8k3ksFSKxWi9vt6m+Awx2J44tccRfgBm12bnoD
V6T9RBXyl+DUbfFw/B39HKPjLNImNeoY7NHadgwKVZ70kJCdTdgnVi3eUiczPZf0rAvzcm9W++FT
1CRZuwvZ29Y6O6+U90Vcm9Ov+8THKhePNnyPlMxls4+z3td8AR34KdPnpHVF8SMkeTXS/SKBdOKV
aSJiX3Y0Ben39R6WHkdAicL0AqeaEj5eyOb40/O9kGhy83ZI+4k9cEvb+VRMHLe4bqW1iw0iHJ6B
70j+oQ4Df8IzBTOvA8nldPl5mKre67CE8Xj9ebVSJzM9PdqUnrG5A+6XfuzbXj3Bkx/8mdEl6G5C
4mK580t96s5UvXb0L5be0zCeBkG6dKYofDL/fd0X0J63PPND7gtI8SOUnrrG4BeJ4e+Yrp1pXym+
uwCZL1984+nzTAvckwDxAB+si9988soio8efLzX7G+MrN46NnXkaksffFdebk02+RVTbxY4Lp1fv
ylN4Kl9cHeBP2c7n7yqeZr3eC/ulvaYtgxpvrZOZnj09V/GWBorFPN9PlUfukJrg4tkjYwMbsFuR
+NBG8irDU4V99/20sryvgQzrOtlQuEq4GChhT2khC4iGQfWn6/gc69J6rVlbusoBil04+I4v8pnn
nf/vQKPHX31HhLLrwdymJj//HhztDYTQtu36ciydWfTKCdvVXStI0o5wX2n/C69bbHx58KwdYjcL
UmzA098IBAoSAoGChECgICEQCBQkBAIFCYFoZUGihr/mUEBQa54QFKk9ltZYDARiZ69IxEk86smO
QOxoQaKUKl/d5CFjkF24eGgRFIy/QE/PZYPaKFrzqiRAIasnAC1Gu4FAtCY8HI0Rm1ckg0skR3dJ
sjsXp9VFp2jLa3K94OSLCep0uoBAxCxINJjWZfy2t310E5PnRicvjsR8JbZYgroeYicLEtEULH/Z
ogH3Qk6S5Kum0br2WghEa6h2Rod8wZ4MhFo7fH0+2xPg2oTYiQ8bvBcl6r0oWdYgR69Z1JCDOlGn
thhclBA7bUXS3agaPOToPnMUz0gWR7Jmx2LUEqk7ZtVdKClegIzOgEzel/QYdNSDaHG01ezKt+Zo
SzJ8GoeoAa1mjxT6WwrUd8eCkoFA1c4XJIIUpnQodojd/LABgUCgICEQKEgIBAoSAnEZwvCwgTpu
/tWH1KEeChjPoarZLRT0c6pOXI3P/njI8CJJORdrz6G/y1JeWjld8AAsosGC5DXA6hx5NsECE1uH
SMvBCsPop8Q5j57EfrLceKKc80RJQjRetaMGoyDF+MhimqTHgrPRkpkWVYyYdIsm2XQpnJi6JqLh
RBqBaOiKZJnajSZEFtMki4Jkty+y0CImMyP+v3SLOMkDMapvhhAF54MQIQ8PaeedUKAQDRYkn0XA
eM9iexR4TBOnVYIEVw6pQeKwDxEtKkjK0hB8rqfualaAA9xOBkvEGnKz2sDjrIiWFSTi//DBbYGx
WRKRQLscu2pneFzoXQp8BodoYdXO6zEbmHU72xriueLoOyxbNHGSjiBygnKEaEVB0g2PTI+ZXS2Q
wGy0ZDLkM2UyWDTJTxHk1zvUVRgosdNxfUygJJEeYpgqYKkO4NYK0QDsPP9IkcgACtJOB/pHqheE
ohwhWg478KwdaQkSCMQOFyQEAgUJgUBBQiAQKEgIBAoSAoGChECgICEQCBQkBAIFCYFAQUIgUJAQ
CAQKEgKBgoRAoCAhEChICAQCBQmBQEFCIFCQEAgUJASiDtAm5ISvt1hxUZAQCFyREAgUJARi16AN
v0yFiG9ns9tAUJAQ0QkWiT9nU5h65UTVDoHAPRICgYKEQOwa4B4JgYgAHdgEiDqge53S/fqGzUbC
5obQPrjr5ehfTRQkRD1yRNzc/AbMpoVIzXxj4BigmrhHQkQmUjWA1JU7fo6u2XBFQkSt5MWfO0aO
btlQkBCRzfS1zfKqnhXfqlQPR7dsKEiISGZ0Ulu2kLkj1/Aiy4aChGjuSIzfn29DOOLDBkRUC1Qd
o5rGLkc04mriC1lE/QoefzwcZpHSslF13xFyiavxPVKtHP2riYKEQKBqh0CgICEQKEgIBAIFCbFz
UNgJdPFhA6KhyEl/xusikVw3ERyvnXqpu9xmosuIsXtj464MAgNfyCIai/G6KRwfj4p6d2fFTHec
3xuPoJqo2iHiwEQqkSSQzEM1CdVMIlOVVxP2L0eSkBWFVImnq6aEh9jfToGn6L5TmGBp2H/dScin
hVTehXpaSPZAsgr5lJZXod4jQlZI3DnB15rR34JCSkwX+P2cTJndY+lYmTpZLsajBwUJ0bp4S6Ga
XgPhIjwtwr5vVYV9hrhXoZiuFOQ9Bvmn7v/A9KRE5VtcV/ry6UeArxt7XoVbkpXkLS7U/7nCBFF4
Gu4Q9LwyHl+A4neq3/gv8vI1Do8ky8nr+H1OV6YOsO9FXqZbkr/aQkFCtOQmKSctDqUUFEbgtf8b
Hk/A+gDMGbY9c1noqJZK8p3KwCILJOegS2S/5rMnZuVEs1lIzsJc0oX6CaCM+uNQ/TbPa0h2I6M+
Vio9oQnWHMwOyfeN+Hf7oFBmjGezS/iwAdGKciRvQAr9y6nj44WPPijv8EEs8wv7J13yt27BakJP
bkuhhCBRtTxskH/kb9/cHB4v7C8rmYSKkXrhmg3oXlSS26KV/1nsVFmiX+PDBlyREHHg6rZ9PwDI
PtDNtkJTBfXJs/oA+mhpId3JQ1P81iRLsW0lIWVzGa6/3caURsgmukU5r5l6du1XnReNVNrsFKbG
x8fZirSnAFVU7RCti63/PXubtAU6wnb96z+FQ9KInygcUGJTpawyuBMzfUwvKx+GmbKWV5DHduJn
cGjdmfp2YlbaFj12hP0tp3jewyWdejb7ipb0L1Nw+C9NdDnEJSBpdusQ9KIgIVoXmfful4badydv
BNi4U6iwnchKbv8eNfZtieKyPOg/c5GyFGXhrRta3gl5saJ3iGUXK4bM4JUPskvXJNtRbfQmpLzv
7n67Ora/OyR0Z9Skw/uE9WETXY6l64USE6Tz5WSNEoF7JAQiAhgeFCrSbpEsxZyQehpvhLM5lIxC
uGUHobXZWapfJlOKRhy/NaYVHBzNT5QSONHViTpQdfg8GjHW37E08i0DRS0zaYaJKKKhguTVp1F3
NtHEqRY5MpeUKHJiH7vqwKXOH0Jz+q0Jp0lWHZJQvQqUEGM6p9IQQ1FMmSlBOdoVcNIIKaXahfKu
53/l21QdC8ovZWyoWYBaUoNyh2rEQaFCrVS1oIkiNXNTvwGjp+E5/dZLy9JjrIl5tEcA6i6xJvlH
7M4VyTLrGudaov22fa/SqK2phryG1GZtTrf1VUkaqJqDpmjlYv1qjUqValbAuu5EqPtqKheCUH2J
8FyrqP/AN64rTqVRAgaJasKnERHxCpLPHO04pxJ9RDlmM4kA9eZEnLl7fMQp2DdzqWMhiGsaalTJ
vHdsTqUi4KE1y1MA4dtEiovTLhUkqg014jEFR6ScUPcRGbQsDdrTBSIhy0JoSsS+rCJ2nSAR/4cP
0X0akwRa/+zcHJhblCnDcwMP2TLpbc5pPFU74j1DEL8yE/TIuptVO99p0qjtG39S5wFlVZncZMLE
VJcEi1bmIsTES8wpcV4Iif86VtuDfxLt+ojYcYKk6FHE/LbGol7pieRdETX+cot3UIUMVG0MiLUs
lIRU9Izibnjh46KPUe2hgOszab0g9pJ5yJSpwHpmNYxytvMR+ckGx+HUMlNy0IKELTDFF6uXOf5/
+MqO6AXwxnwAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2016-04-04 01:09:51 +0100" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.03" SETTINGS="SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Fortified breast milk versus unfortified breast milk, outcome: 1.3 Head growth (cm/wk).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0YAAAIACAMAAACRjIzvAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2016-04-04 01:12:59 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2016-04-04 01:12:59 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2015-02-17 13:32:09 +0000" MODIFIED_BY="[Empty name]">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-04-04 01:12:59 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>An updated de-duplicated search of MEDLINE via PubMed, EMBASE, CINAHL and <I>The Cochrane Library</I> (2016, Issue 2)</B>
</P>
<P>Searched 29/02/16, using the search terms below, yielded 93 new articles.</P>
<P>
<B>MEDLINE and MEDLINE In-Process</B>
<BR/>Searched 09/12/14 via OVID interface.<BR/>Database: Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations and Ovid MEDLINE(R) &lt;1946 to Present&gt;</P>
<P>Search Strategy:</P>
<P>1 exp Infant, Newborn/ (513323)</P>
<P>2 Premature Birth/ (7404)</P>
<P>3 (neonat$ or neo nat$).ti,ab. (205534)</P>
<P>4 (newborn$ or new born$ or newly born$).ti,ab. (136536)</P>
<P>5 (preterm or preterms or pre term or pre terms).ti,ab. (50338)</P>
<P>6 (preemie$ or premie or premies).ti,ab. (118)</P>
<P>7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (12271)</P>
<P>8 (low adj3 (birthweight$ or birth weight$)).ti,ab. (26861)</P>
<P>9 (lbw or vlbw or elbw).ti,ab. (5920)</P>
<P>10 infan$.ti,ab. (348181)</P>
<P>11 (baby or babies).ti,ab. (54731)</P>
<P>12 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 (862662)</P>
<P>13 Milk, Human/ (16063)</P>
<P>14 Food, Fortified/ (7944)</P>
<P>15 13 and 14 (396)</P>
<P>16 ((fortif$ or supplemented or supplementation) adj4 ((human or breast or expressed) adj2 milk)).ti,ab. (566)</P>
<P>17 15 or 16 (781)</P>
<P>18 12 and 17 (730)<BR/>
<BR/>
<B>EMBASE</B>
<BR/>Searched 09/12/14 via OVID interface.<BR/>Database: Embase &lt;1974 to 2014 Week 49&gt;</P>
<P>Search Strategy:</P>
<P>1 exp newborn/ (475396)</P>
<P>2 prematurity/ (74237)</P>
<P>3 (neonat$ or neo nat$).ti,ab. (245289)</P>
<P>4 (newborn$ or new born$ or newly born$).ti,ab. (158274)</P>
<P>5 (preterm or preterms or pre term or pre terms).ti,ab. (62693)</P>
<P>6 (preemie$ or premie or premies).ti,ab. (159)</P>
<P>7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (15319)</P>
<P>8 (low adj3 (birthweight$ or birth weight$)).ti,ab. (30730)</P>
<P>9 (lbw or vlbw or elbw).ti,ab. (7192)</P>
<P>10 infan$.ti,ab. (394252)</P>
<P>11 (baby or babies).ti,ab. (69392)</P>
<P>12 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 (929097)</P>
<P>13 breast milk/ (20455)</P>
<P>14 diet supplementation/ (65275)</P>
<P>15 13 and 14 (863)</P>
<P>16 ((fortif$ or supplemented or supplementation) adj4 ((human or breast or expressed) adj2 milk)).ti,ab. (677)</P>
<P>17 15 or 16 (1404)</P>
<P>18 12 and 17 (1194)<BR/>
<BR/>
<B>CINAHL Plus</B>
<BR/>Searched 09/12/14 via EBSCO interface, Search modes - Boolean/Phrase.<BR/>Search Strategy:<BR/>S17 S11 AND S16 (222)<BR/>S16 S14 OR S15 (243)<BR/>S15 TI ( ((fortif* or supplemented or supplementation) N4 ((human or breast or expressed) N2 milk)) ) OR AB ( ((fortif* or supplemented or supplementation) N4 ((human or breast or expressed) N2 milk)) ) (153)<BR/>S14 S12 AND S13 (141)<BR/>S13 (MH "Food, Fortified") (2,431)</P>
<P>S12 (MH "Milk, Human") (3,457)</P>
<P>S11 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 (139,268)</P>
<P>S10 TI ( (baby or babies) ) OR AB ( (baby or babies) ) (17,329)<BR/>S9 TI infan* OR AB infan* (54,724)<BR/>S8 TI ( (lbw or vlbw or elbw) ) OR AB ( (lbw or vlbw or elbw) ) (1,486)<BR/>S7 TI ( (low N3 (birthweight* or birth weight*)) ) OR AB ( (low N3 (birthweight* or birth weight*)) ) (6,186)<BR/>S6 TI ( (prematur* N3 (birth* or born or deliver*)) ) OR AB ( (prematur* N3 (birth* or born or deliver*)) ) (2,040)<BR/>S5 TI ( (preemie* or premie or premies) ) OR AB ( (preemie* or premie or premies) ) (194)<BR/>S4 TI ( (preterm or preterms or pre term or pre terms) ) OR AB ( (preterm or preterms or pre term or pre terms) ) (14,213)<BR/>S3 TI ( (newborn* or new born* or newly born*) ) OR AB ( (newborn* or new born* or newly born*) ) (14,806)<BR/>S2 TI ( (neonat* or neo nat*) ) OR AB ( (neonat* or neo nat*) ) (29,882)</P>
<P>S1 (MH "Infant, Newborn+") OR (MH "Infant, Premature") (86,648)<BR/>
<BR/>
<B>Maternity and Infant Care<BR/>
</B>Searched 09/12/14 via OVID interface.<B>
<BR/>
</B>Database: Maternity and Infant Care &lt;1971 to October 2014&gt;</P>
<P>Search Strategy:</P>
<P>1 ((fortif$ or supplemented or supplementation) adj4 ((human or breast or expressed) adj2 milk)).ti,ab. (221)<BR/>
<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;13 publications (14 trials) included&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;22 full-text articles screened&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;1,523 de-duplicated records screened&lt;/p&gt;">
<OUT TEXT="&lt;p&gt;1,501 records excluded&lt;/p&gt;"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;9 articles excluded:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;No protein in fortifier (2)&lt;/li&gt;&lt;li&gt;Control group received fortifed milk (1)&lt;/li&gt;&lt;li&gt;Trial of human milk-based vs cow milk-based fortifiers (1)&lt;/li&gt;&lt;li&gt;Not randomised (1)&lt;/li&gt;&lt;li&gt;Not controlled (1)&lt;/li&gt;&lt;li&gt;Lieterature review (2)&lt;/li&gt;&lt;li&gt;Duplicate (1)&lt;/li&gt;&lt;/ul&gt;"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>